Novel organoalanes in organic synthesis and mechanistic insight in conjugate addition by Willcox, Darren
 Novel Organoalanes in Organic 
Synthesis and Mechanistic 
Insight in Conjugate Addition 
 
 
 
DARREN WILLCOX, MSci 
 
 
 
Thesis submitted to the University of Nottingham for the 
degree of doctor of Philosophy 
 
 
March 2014 
  
2 
 
Abstract 
 
This thesis describes the development of novel 
aluminium hydrides (HAlCl2•Ln) and organoalanes 
(Cl2AlCH=CHR and ClMeAlCH=CHR) for organic synthesis, as 
well as exploring the mechanism by which copper-catalysed 
conjugate addition proceed with diethylzinc and 
triethylaluminium. 
In Chapter 1, the mechanism of copper-catalysed 
conjugate addition of diethylzinc to cyclohexenone and nickel-
catalysed 1,2-addition of trimethylaluminium to benzaldehyde 
has been studied. The kinetic behaviour of the systems allows 
insight into which metal to ligand ratio provides the fastest 
rest state structure of the catalyst to enter the rate 
determining step. The ligand order in these reactions (derived 
from these ligand optimisation plots) provides information 
about the molecularity within the transition state. 
In Chapter 2, the synthesis of somewhat air-stabilised 
aluminium hydrides and their subsequent use in palladium-
catalysed cross-coupling is described. Stabilised aluminium 
hydrides of the type HAlCl2•Ln, [HAl(O
tBu)2] and [HAl(N
iBu2)]2 
were synthesised. The hydroalumination of terminal alkynes 
was optimal using bis(pentamethylcyclopentdienyl) 
zirconocene dichloride, resulting in a highly regio- and stereo-
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chemical synthesis of alkenylalanes which undergo highly 
efficient palladium-catalysed cross-coupling with a wide range 
of sp2-electrophiles. 
Chapter 3, describes conjugate addition chemistry of 
ClXAlCH=CHR (X = Cl or Me) under phosphoramidite/ 
copper(I) conditions (X = Me). Highly enantioselective 
additions to cyclohexenones (89-98+% ee) were attained. A 
highly efficient racemic addition of the alkenylalanes (X = Cl) 
to alkylidene malonates occurs without catalysis. 
Finally, Chapter 4 includes all the experimental 
procedures and the analytical data for the compounds 
prepared in the subsequent chapters. 
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Mechanistic insight in 
conjugate addition by 
ligated cuprates 
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1.0 Introduction 
 
1.1 General introduction 
 
Since the seminal discovery of 1,4-nucleophilic addition to ,-
unsaturated carbonyl compounds by Arthur Michael, 1 
applications of conjugate additions have become fundamental 
procedures for the synthesis of carbon-carbon and carbon-
heteroatom bonds.  The formation of carbon-carbon bonds 
especially is often carried out using organocopper compounds 
either as stoichiometric cuprates, or in catalytic amounts. As 
this is the major theme of this thesis it is appropriate to 
present an overview of this area. 
1.1.1 Conjugate addition of stoichiometric 
organocopper reagents 
 
The first examples of conjugate additions to α,β-unsaturated 
carbonyl compounds date from the early 1950s and used 
stoichiometric amounts of cuprates, mainly lithium cuprates 
(Gilman reagents), as the nucleophiles (Scheme 1).2  
 
Scheme 1 Representative cuprate addition to enones. 
 In order to add an organo-group in an enantioselective 
manner, either the organocopper reagent needs to be chiral 
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and enantioenriched or an external chiral Lewis acid must be 
added. The former can be achieved by synthesising a 
heterocuprate bearing a covalently bound chiral alkoxy-, 
amino or sulfur ligand to act as an asymmetric 'dummy 
ligand', which remains coordinated to the copper throughout 
the transformation.3  
 Initial kinetic studies by Krauss4 on the mechanism of 
conjugate addition of Gilman-type cuprates to enones 
indicated that the reaction follows first order kinetics in terms 
of enone but a more complex order with respect to the 
cuprate. Krause and co-workers noticed that when an excess 
of cuprate was used, the reaction still followed first-order 
kinetics.5 The authors concluded that the mechanism involves 
a reversible cuprate-enone complex which is followed by the 
conversion of the intermediate into the product through a 
unimolecular pathway. 
 The intermediate complex between the cuprate and 
enone has been investigated in several NMR studies.6 In all of 
these reports a common feature is that there is a lengthening 
of the C=C  -bond upon formation of the copper--complex. 
Additionally, in all cases the lithium atom is coordinated to the 
carbonyl oxygen. When Bertz and co-workers probed the 
addition of Me2CuLi.LiX (X = bromide or chloride) to 
cyclohexenone 1 via rapid injection NMR, two cuprate-enone 
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-complexes were detected for which they proposed structures 
2 and 3 (Scheme 2). 
 
Scheme 2 Proposed -complexes in conjugate additions of 
Gilman's reagent to cyclohexenone. 
These two species were identified by carbon-13 NMR 
where a downfield shift in the carbonyl resonance by up to 10 
ppm and a large upfield shift of around 60 ppm or greater for 
the olefin carbons was detected. This chemical shift difference 
in the olefinic region was attributed to the partial 
rehybridisation of the alkene sp2 carbon centres into sp3 
centres.  
Although computational evidence was presented for a 
copper(III) intermediate 4 in such 1,4-additions (Scheme 3), 
it initially remained undetected. However, in 2007 Bertz and 
co-workers demonstrated the presence of this key 
intermediate, using the rapid injection NMR technique, 
carrying out the same reaction in Scheme 2 in the presence 
of trimethylsilyl cyanide. 7  This technique allowed the 
spectroscopic characterisation of a transient copper(III) 
species. An upfield shift was observed from 76 ppm in the -
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complex 3 to 40 ppm in the copper(III) alkyl complex, which 
is considered indicative of a copper(III)-Calkyl species like 5 
(Scheme 3).   
Scheme 3 Carbon-13 NMR elucidation of a copper(III) 
intermediate. The numbers on structures refer to 13C chemical 
shifts 
An excellent review concerning the reactions and mechanisms 
of organocopper reagents, was published in 2012, covers in 
detail the approaches used to characterise intermediates in 
stoichiometric cuprate chemistry is available.8  
1.1.2 Catalytic Ligated cuprates 
 
 In order to facilitate the transition from enantioselective 
stoichiometric cuprate additions to the use of only catalytic 
amounts of copper salts and chiral ligands, the application of 
ligand accelerated catalysis (L.A.C.) is deemed essential. 9 
Typically, copper(I)-catalytic systems are under dynamic 
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ligand exchange and the presence of strongly rate accelerating 
external ligands can lead to the formation of a highly 
kinetically advantaged catalyst. The first major breakthrough 
for copper-catalysed conjugate addition arose when dialkylzinc 
based systems were used to replace Gilman-type cuprates. In 
the early 1990s Alexakis and co-workers reported the first use 
of diethylzinc in 1,4-additions to cyclohexenone in the 
presence of a catalytic amount of copper and a chiral ligand 
(L1) (Scheme 4). 10  Although only a low enantioselectivity 
was achieved (32%), this pioneering work is of high 
importance as the reaction quickly became a benchmark for 
the testing of new ligands. Finally, the introduction of 
phosphoramidite ligands, for example L2 by Feringa and co-
workers11 led to routine attainment of extremely high levels of 
enantioselectivity (>98%), cementing copper's place as a 
metal of choice for asymmetric conjugate additions. Previously 
only rhodium complexes had afforded such high levels of 
enantioselectivity.12  
 
Scheme 4. Initial examples of catalytic conjugate addition of 
diethylzinc. 
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1.1.2.1 Choice of primary organometallic reagent 
 
Prior to the 1990s, lithium cuprates were the typical 
nucleophiles for conjugate addition. However cuprates can 
also be synthesised from many other primary organometallic 
systems, including: magnesium, zinc, aluminium, zirconium 
and others. 13  It is therefore appropriate to give a brief 
overview of the most common organometallic reagents used in 
copper-catalysed conjugate additions. 
 Since the seminal work by Alexakis, dialkylzinc reagents 
remain a common choice for conjugate addition due to their 
low background reactivity in the absence of catalytic additives. 
This lower dialkylzinc background reactivity means that many 
functional groups tolerate the presence of alkylzinc units such 
that functionalised organozinc reagents can be used to attain 
high enantioselective additions without chemoselectivity 
issues.11,14 One disadvantage of diorganozinc reagents is that 
only a small selection of them is commercially available: 
diethylzinc, dimethylzinc, di-n-butylzinc, diisopropylzinc and 
diphenylzinc. Functionalised organozinc reagents can however 
be readily synthesised from either organoiodide/diethylzinc 
exchanges or via hydroboration/transmetallation processes. 
Although all diorganozinc reagents can be used in conjugate 
addition chemistry, commercially available diethylzinc is the 
one most commonly employed. Dimethylzinc is seldomly used, 
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even though comparable enantioselectivities to diethylzinc 
additions can be achieved. Its limited use is due to its stronger 
zinc-carbon bond which lowers the innate reactivity and highly 
increased reaction times are normally required even for 
relatively activated substrates, such as enones. One drawback 
to the inherent lower reactivity of diorganozinc based systems 
is that there are very few examples of additions to substrates 
with lower reactivity than simple enones, such as ,-
unsaturated esters (Scheme 5).15,16 
 
Scheme 5 ACA reactions of dialkylzincs to challenging 
substrates. 
 Triorganoaluminium reagents have recently become a 
popular choice of organometallic for conjugate addition 
reactions as they have a higher reactivity than the 
corresponding dialkylzincs. Like dialkylzinc reagents, the 
commercial availability of triorganoaluminium reagents is 
limited. Only trimethylaluminium, triethylaluminium, tri-n-
propylaluminium, tri-n-butylaluminium, triisobutylaluminium, 
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tri-n-hexylaluminium and tri-n-octylaluminium are readily 
available. Due to the enhanced reactivity of 
triorganoaluminium reagents they can undergo copper-
catalysed ACA reactions with a range of Michael acceptors, 
including challenging trisubstituted enones (Scheme 6). 17 
This enhancement of reactivity is due to the higher Lewis 
acidity of aluminium compared to zinc (prior coordination of 
the enone carbonyl is believed to be important in substrate 
activation). Unlike dimethylzinc, trimethylaluminium is highly 
active in conjugate addition and is the main choice when 
installing a methyl group into target compounds. 
Scheme 6 Use of trialkylaluminium reagents in catalytic ACA 
reactions. 
 All early attempts at asymmetric catalytic conjugate 
addition (prior to 1990) were based on the seminal work by 
Kharash 18  who used Grignard reagents, but these provided 
only limited stereoselectivities.19  This limited success was due 
to the high background reactivity of the unligated magnesium 
cuprate coupled to the poor L.A.C. effects shown in the 
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ligand/solvent combinations initially used. The major 
advantages of using Grignard reagents is their ready 
commercial availability coupled to their ease of preparation. 
Unfortunately, unless an appropriate ligand is chosen, 
uncatalysed 1,2- or 1,4-addition reactions dominate the 
reaction manifold. The choice of optimal ligands for catalytic 
asymmetric Grignard reagents are different to those used for 
other organometallics, typically diphosphines or N-heterocyclic 
carbenes (NHCs) ligands are preferred. 
 The family of organometallics that can be used for 
copper-catalysed ACA chemistry is still growing, with 
organozirconium, 20 , 21  and organoboron 22  reagents being 
recent examples.  
1.1.2.2 Ligands 
 
The ligands used for efficient copper-catalysed conjugate 
addition are crucial, not only for enantioselectivity, but for also 
maximising competition against background (racemic) reaction 
contributions. The major types of ligands used for conjugate 
addition are phosphorus-based (phosphites, phosphoramidites 
and phosphines) or NHCs. Due to the vast number of ligands, 
only a brief discussion will be given here as there are several 
excellent reviews covering the area.23 
 The most popular ligands used in copper(I)-catalysed 
conjugate additions are phosphoramidites (Figure 1). These 
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are based on a rigid (often chiral) C2-symmetric diol or phenol 
together with an amine. Either component can be the 
asymmetric element.24 
 
 
Figure 1 Representative phosphoramidites. 
 
On changing the rigid backbone of the phosphoramidite 
ligands to simple aryl or alkyl substituents, phosphinamines 
are derived (Figure 2). These are sometimes referred to as 
SimplePhos ligands. These have been noted to give catalysts 
of improved activity and sometimes superior enantioselectivity 
over phosphoramidites.25  
 
Figure 2 Representative SimplePhos ligands. 
 Phosphine ligands have been successfully used in 
copper-catalysed conjugate addition but their use is generally 
restricted than phosphoramidites (Figure 3). Monodentate 
phosphines perform better with dialkylzinc or 
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trialkylaluminium reagents.15,26,27 Bidentate phosphines are of 
greater utility when Grignard reagents are used resulting in 
catalysts delivering high enantioselectivities, particularly in the 
case of ,-unsaturated esters (e.g. use of L28).28 
 
Figure 3 Representative monodentate and bidentate 
phosphine ligands. 
Another class of ligands that can be used in conjugate 
additions of carbon nucleophiles are NHCs (Figure 4). The 
first reported use of these ligands was by Woodward and 
Fraser,29 with the first enantioselective procedure reported by 
Alexakis.30 Since these initial reports, many chiral NHC ligands 
have been used in conjugate addition, including NHC ligands 
with secondary coordination sites.16 When Grignard reagents 
are used, the NHC precursor (typically an imidazolium salt) 
can be used directly, but when dialkylzinc or trialkylaluminium 
regents are used, a silver precursor (such as L34-L37) is 
required due to the slow rate of deprotonation of the 
imidazolium precursor.17, 31 
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Figure 4 Representative NHC ligand precursors. 
1.1.2.3 Substrate scope 
 
There are many classes of Michael acceptor substrate that can 
be used for conjugate asymmetric addition and several 
reviews have been published concerning this topic in the 
period 1992-2014.23 The most popular substrates are cyclic 
and acyclic enones, nitroolefins and ,-unsaturated esters. 
 Within the cyclic enone family, cyclohexenone (1) is the 
most extensively studied. Such enones are highly reactive due 
in part to their conformation being locked s-trans. Other cyclic 
enones that have been used are substituted in the -position 
to the carbonyl (16 and 17), in the -position (18 to 22) and 
also in the 4-position (23). These substrates are potentially 
useful for kinetic resolutions, the formation of ,-quaternary 
centres and buttressed tertiary centres respectively. Cyclic 
dienones have also been deployed resulting in high 
enantioselectivities (up to 98%) based on C=C enone 
differentiation. Acyclic enones are more demanding substrates 
as they can undergo s-cis and s-trans conformational 
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interconversion (26 to 29). Typically rather different ligands 
to those used for cyclic enones are required (Figure 5). 
 
Figure 5 some representative enones. 
Nitroolefins (30 to 34) have also been successfully used in 
copper-catalysed conjugate addition reactions (Figure 6). The 
1,4-products generated are synthetically useful moieties, as 
the nitro group can be transformed into many other functional 
groups such as aldehydes, amines etc. Lactones (7 and 8), 
chromones (35), lactams (36 and 37), piperidones (38) and 
,-unsaturated esters (39 and 40) (Figure 6) have also all 
been used in conjugate addition resulting in products with high 
optical purity. The products from these latter reactions are 
important building blocks in total synthesis.  
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Figure 6 Representative nitroolefins, lactones, chromones, 
lactams, piperidones and unsaturated ester substrates for ACA 
reactions. 
1.1.3 Mechanistic investigations of copper-
catalysed conjugate addition 
 
 Various mechanistic tools have been applied in order to 
shed light on the mechanism(s) of copper-promoted conjugate 
addition. However, most of these have focussed on simple 
'ligandless' Gilman-type cuprates.8 These are of less relevance 
to the work in this thesis, so here we focus on the literature 
covering ligated copper catalysts. Obtaining accurate kinetic 
data and reaction orders for copper-catalysed conjugate 
addition by ligated cuprates is challenging.  Schräder and 
co-workers attempted to identify the reaction order of the 
catalyst for the copper-catalysed conjugate addition of 
diethylzinc to cyclohexenone in terms of both the catalyst and 
diethylzinc. 32  In these series of experiments, the ratio of 
copper to ligand L38 was fixed at 1:2 (Scheme 7). In this 
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case the order of the ACA reaction with respect to the ligand 
cannot be determined. 
 
Scheme 7 Schräder's kinetic study. 
On closer inspection of this work, there are some potential 
issues with the data collection: i) smooth continuous decay of 
the enone was not always observed, due to rapid quenching of 
the kinetic aliquots not always being attained; ii) before the 
first data point was collected, a significant conversion of the 
enone had already occurred (>40%) in some cases. The 
primary data was fitted to pseudo-first order behaviour, even 
in cases when neither limiting reagent was in large excess. On 
the basis of these kinetic results, it was proposed that the 
reaction was first order in both catalyst and diethylzinc. 
Reductive elimination of a copper(III) species derived from 42 
was suggested to be the rate-determining step. The presence 
of two zinc species in the transition state is based on 
observations that stoichiometric cuprates require a 2:1 ratio of 
organometallic to Cu(I) halide for successful conversion.33  It 
was suggested from these studies that species 41 would be 
most in accord with the first order kinetics in diethylzinc, due 
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to rapid association of the cuprate with a second zinc. The 
number of copper centres and ligands present in the putative 
-complex cannot be determined from Schräder's studies. 
Structures having one 41, two 42 or three 43 ligands leading 
to a key rate-determining copper(III) intermediate have all 
been proposed in the wider literature (Figure 7).32 
 
Figure 7 Proposed -complexes for ACA of organozinc 
reagents. 
Thus far, no direct kinetic or NMR data has been presented to 
discriminate between 41, 42 and 43, and all three are just 
proposals. Gschwind and co-workers suggested that 43 was 
the key -complex based on diffusion-ordered NMR (DOSY) 
studies, which correlates the volume of the complex to the 
number of ligands attached to the copper centre. The studies 
were carried out on the pre-catalytic mixtures of copper(I) 
chloride and L2.34 At a copper(I) chloride to L2 ratio of 1:1, 
the major species present is an undefined trimer (CuClL2)3 
44a. When the concentration of the ligand is increased, a 
tetrahedral-trigonal dimer, Cu2Cl2(L2)3 44b is observed 
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(Scheme 8). This species is in equilibrium with others via 
ligand association processes. 
 
Scheme 8 The main structures determined via DOSY 
experiments. 
Presently, these NMR studies have not been extended to real 
catalytic mixtures containing terminal organometallics by 
Gschwind. 
 Feringa and co-workers studied the kinetics of the 
conjugate addition of ethylmagnesium bromide to ,-
unsaturated esters and thioesters.35 These systems have been 
the subject of kinetic analyses using the crystallographically 
characterised dimer 45 as the catalyst precursor. The overall 
reaction was fitted to second order kinetics (rate  
[enone][RMgX]) but showed first order dependence in total 
copper concentration. Additionally, 1H and 31P NMR studies 
were used to characterise the intermediates present in 
solution. When methylmagnesium bromide was added to 45, 
there was rapid conversion to monomer 46 plus a minor, 
unidentified species (Scheme 9). When the ,-unsaturated 
ester was added to 46, a -complex proposed to be 47a is 
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formed. However, unlike stoichiometric lithium cuprates, 
neither this -complex nor the copper(III) intermediate 47b 
are detectable by NMR spectroscopy. Therefore, support for 
the formation of a copper(III) intermediate over a direct 
carbocupration pathway came only from the (Z) to (E) 
isomerisation of initially geometrically pure Michael acceptors 
that is observed in these systems. This was thus taken to 
indicate a reversible back reaction from 47b, leading to (Z) to 
(E) conversion in the starting material via (E/Z)-47a 
(Scheme 9). 
 
Scheme 9. Proposed catalytic cycle for the addition of RMgBr 
to α,β-unsaturated esters and thioesters. 
Computational studies have also been used help 
elucidate the reaction coordinate in ligated copper-catalysed 
conjugate addition. Woodward and co-workers probed the 
validity of -complexes 41, 42 and 43 using DFT. 36 This was 
achieved by looking at the conjugate addition of dimethylzinc 
to acetal 48 in the presence of copper(II) acetate and L2 
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(Scheme 10). Computational screening of 41, 42 and 43 
(among others) was carried out and indicated that complex 
49, analogous to 43, is highly favoured. From this study, two 
common themes emerged: penta-coordinate phosphoramidite 
ligated copper(I) species were all highly energetically 
unfavourable and structure 41 could not be attained, even 
though docking of additional zinc to the -complex is facile, 
due to the interaction between the copper and zinc units being 
too weak. 
 
Scheme 10 -complex identified via DFT using PBE1PBE 
hybrid functional and a VDZP basis set. 
 
1.2 Aims of research 
 
Given that ACA reactions rely almost exclusively on ligand 
accelerated catalysis by Ma[CubRcXdLe] ligated cuprates (R and 
X are anionic transferable and non-transferable groups 
respectively, L = a donor ligand and M = ZnR, AlR2 or MgX; a-
e are integers), it is surprising that so few publications deal 
with discovery of optimal ligated copper catalysts through 
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reaction rate studies. The principle aim for this part of our 
research was to answer two questions: firstly “can a kinetic 
study be used to define an optimal ‘[RCuLn]
m-’ catalyst 
quickly?”; and secondly; “is there any significance to the 
copper to ligand ratio measured in such experiments?”.  
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1.3 Results and Discussions 
1.3.1 The kinetic protocol 
 
 Typical approaches for the determination of both 
mechanism and structure do not give quantitative information 
on catalyst stoichiometry as a function of ligand properties. 
Plots ln(k1) vs. [L]/[Cu] were selected as ln(k1) is directly 
related to the overall reaction's activation energy such that 
the maximum of the parabola indicates an optimal 
copper:ligand system composition for product turnover 
(Figure 8). The degree of parabola curvature also gives some 
indication of the degree of speciation in the catalytic mixture. 
In one limiting case a sharp peak at a single [L]/[Cu] value is 
expected if essentially just one, fast acting, catalytic species is 
present. Conversely, a very flat profile is expected if numerous 
species with similar kn[CuaLb] values can access product 
turnover from various compositions. For a range of ligands, 
such plots (ligand optimisation plot) might provide insight into 
how the steric and electronic factors of the ligands affect the 
catalyst, aiding further optimisation and mechanistic 
understanding. To the best of our knowledge, such an 
approach has appeared not to have been carried out. 
Additionally, the tangent to the slope of such plots should 
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provide an estimate of the ligand molecularity in the transition 
state 
 
Figure 8. A representative Arrhenius plot (•) and its 
corresponding projection onto the stoichiometry of the catalyst 
(□). 
 For this approach to work three stringent criteria must 
be met: (i) ligand exchange must be fast compared to the 
catalysed reaction – or an equivalent mechanism must operate 
to provide a diverse catalyst library, (ii) k(M:Loptimal) > 
k(M:Lrest) must be true for the entire metal to ligand range 
studied, (iii) the fit of the primary kinetic data to a single 
appropriate model over the metal to ligand range must be 
accurate. Fortunately, all of these criteria are often fulfilled in 
asymmetric catalysis. For this technique to be used in an 
effective manner, the simple protocol outlined below (Figure 
9) was followed. 
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Figure 9. Standard procedure for the ligand optimisation plot. 
The initial step of the procedure involves the addition of all the 
reagents, including the internal standard, followed by the 
enone for each copper to ligand ratio to be analysed. At 
specific time intervals aliquots were removed from the 
reaction mixture under a stream of dry argon using a pre-
cooled pipette (liquid nitrogen) and then quenched with acid 
and analysed by GC. The raw data obtained was then used to 
plot a decay curve (in excel) for the starting material for both 
a first and second order dependance. The rate constants are 
then obtained using a non-linear least squares regression 
analysis (SOLVER in excel). From the derived rate constants a 
plot of the natural logarithm of the rate contant against the 
mole percentage of ligand allowed a copper to ligand ratio to 
be determined.      
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 The technique was applied to the conjugate addition of 
diethylzinc to cyclohexenone (Scheme 11). It is critical that 
only one parameter is changed at any given time, therefore 
the concentration of the copper source (0.00256 M), 
diethylzinc (0.308 M), enone (0.256 M) and internal standard 
(0.014 M) were kept constant as was the temperature of the 
reaction (-40 oC). This means that the only parameter to 
change was the concentration of the ligand in the reaction 
mixture. 
 
Scheme 11 The standard reaction protocol for the kinetic 
analysis. 
 The analysis of organometallic systems can be 
problematic, for example, it was noted that simple pseudo first 
order logarithmic plots can hide higher order kinetics.37 We 
were anxious to avoid such issues.  
 After the kinetic runs had been carried out, the primary 
data were fitted to both first and second order rate (near 
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equal concentrations) equations. The kobs values for these 
were then obtained using the non-linear least squares 
regression package SOLVER in Excel. 38  Once these were 
calculated, the quality of the data was assessed using a 
statistical package (Solver Stat.) to give R2 ‘goodness of fit’ 
data for each of the kinetic models and the average of the fits 
were taken to see which model fits the experiemntal data the 
best (Table 1, see also step C Figure 9). The values 
highlighted in bold represent the chemical model best fitted. 
Ligand 
Range studied/ 
 mol % (No. of 
runs) 
R2 average for 
1st order fit 
R2 average for 
2nd order fit 
L39 1-2.5 (4) 0.868  0.929  
PMe3 1-2.5 (4) 0.966  0.957  
PCy3 1-2.5 (4) 0.973  0.949  
P(2-Furyl)3 0.5-2.5 (5) 0.949  0.895  
P(4-FC6H4)3 0.5-2 (4) 0.960  0.918  
PPh3 1-2.5 (4) 0.927  0.830  
P(OPh)3 1-3 (4) 0.970  0.900  
(R,S,S)-L2 1.5-3 (4) 0.964  0.895  
 
Table 1. ‘Goodness of fit’ (R2) of primary kinetic data to first 
and second order kinetics for the reaction shown in Scheme 
11.  
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1.3.2 Reproducibility of kinetic runs 
 The paucity of published kinetic studies on 
copper(I)/ligand-catalysed additions of organometallics to 
enones is not without reason. Sampling by Krause’s aliquot 
procedure (the normal approach) is susceptible to a number of 
issues, including: (i) lack of innate precision in organometallic 
concentration and purity issues through their time-dependant 
modification by traces of oxygen and water, (ii) the high 
lability and air sensitivity of phosphine-ligated cuprates 
(compared to stoichiometric Gilman-type cuprates), and (iii) 
the presence of competing oxygen induced radical background 
1,4-addition reactions. The technical difficulties mentioned 
above are clearly demonstrated in the most sensitive of the 
systems we studied: copper(II) acetate/triphenylphosphine (1 
mol%/1.5 mol%).  While separate triphenylphosphine runs 
easily provide acceptable fits to either pseudo first order 
(Equation 1 in Figure 9) or second order near equal 
concentration (Equation 2 in Figure 9) models, unless special 
precautions are taken duplicate runs typically provide non 
reproducible rate constants with large error bars (Figure 10). 
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Figure 10 Reproducibility issues in the most labile systems. 
Extensive trials revealed that the reproducibility issues within 
Figure 10 could be minimised by: (i) sampling under argon 
(as opposed to nitrogen), (ii) use of more strongly ligated 
copper-ligand combinations than in situ copper(I) 
acetate/triphenylphosphine (e.g. increasing cuprate Lewis 
acidity or ligand donor power), (iii) avoiding 
[Ligand]/[copper] < 1 regimes, where complex behaviour 
was often observed, (iv) conducting all runs with identical 
organometallic batches over a short period of time for all 
ligands trialled  – ensuring at the least valid relative 
comparisons and (v) plotting ln(k1) vs. mol% L to allow 
identification of the fastest Copper:Ligand catalyst 
combination within the ratios investigated. Such parabolic 
plots were found to be somewhat self-compensating of minor 
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reproducibility in the primary data and led to much more 
robust fastest copper:Ligand(fast) determinations (often even 
across different reagent batches). Finally, the use of the 
copper(II) precursors was not an issue as reduction in situ to 
copper(I) salts was found to be rapid (typically >99% 
completed within 180 sec.). 
1.3.3 Ligand effect in conjugate addition  
   
The ligands we have analysed fall into two groups: those 
attached to strong -donor and those ligated by strong -
acceptors. 
  The results obtained from following the protocol of 
Figure 9 were used to generate ligand optimisation plots 
which will allow the determination of the estimated 
copper:ligand ratio which provides the fastest overall rate for 
-donor ligands studied and these are summarised in Table 2. 
  The results showed that when strong -donor ligands 
(those with low d values in the literature) such as 
tricyclohexylphosphine and trimethylphosphine, are used the 
copper to ligand ratios tend to be higher than that for weaker 
-donor ligands (those with higher d values) 
  
40 
 
 
Table 2. 1,4-addition of diethylzinc to cyclohexenone using σ-
donor ligands. 
Entry Ligand σ-donor 
value (d)[a] 
-donor value 
(p)[a] 
copper 
to ligand 
ratio 
1 L39 - - 1:1.4 
2 PMe3 8.55 0 1:2.0 
3 PCy3 1.40 0 1:2.0 
4 PPh3 13.25 0 1:1.7 
5 P(2-furyl)3 - - 1:1.3 
6 P(p-FC6H4)3 15.7 0 1:1.2 
[a] Using the QALE approach for defining relative σ-donor/-acceptor 
ability. Small d values correlate with strong σ-donors; non zero values of 
p indicate -acceptor ability.39 
  From Table 1 the ‘goodness of fit’ (R2) data for NHC 
precursor L39 indicates that the reaction best follows second 
order kinetics, i.e. a dependence on both the enone and zinc 
concentration (bottom equation in C in Figure 9). The free 
carbene (L39 deprotonated with potassium t-butoxide) was 
also tested so a comparison with L39 could be conducted. 
When the imidazolium species L39 was used, the reaction 
proceeded cleanly (not much scatter in the primary kinetic 
data), conversely when the free carbene was employed the 
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reaction proceeded much slower and poor kinetic plots 
resulted. A possible explanation for this is that when 
imidazolium L39 was used, it was deprotonated cleanly by the 
diethylzinc. Alternatively, when L39 is pre-deprotonated with 
potassium t-butoxide, t-butanol is formed as a by-product and 
this changes the speciation of the active catalyst. Due to the 
level of scattering observed in the primary kinetic data, it was 
not possible to generate a meaningful ligand optimisation plot 
and only salt L39 was used. 
 The value of the copper to ligand obtained from the 
ligand optimisation plot for L39 indicates that there are 1.4 
ligands attached to per copper centre (Figure 11). This is in 
line with the predicted transition state proposed by Gschwind 
from the NMR studies which suggests that it could take the 
form of 51 (Figure 12).34 However, the error on this estimate 
is quite high (±0.2). When 0.5 mol% ligand was tried the 
paucity of the data was too great to obtain meaningful rate 
constants 
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Figure 11. Comparative copper(II) acetate:L optimisation 
plots for the systems studied (at -40 oC). X-axes: mol% L per 
1 mol% copper precursor used; y-axes: ln(k1). For: a) L39, b) 
trimethylphosphine, c) tricyclohexylphosphine and d) 
triphenylphosphine. 
  
When strong σ-donor phosphine ligands are employed 
(entries 2 and 3 in Table 2), the reaction mechanism is 
different to that of L39, with the ‘goodness of fit’ of the 
primary kinetic data is better on fitting a first order kinetic 
model. From the derived ligand optimisation plot, the copper 
to ligand ratios for trimethylphosphine and 
tricyclohexylphosphine suggests that the most populated rest 
state species in the reaction mixture which leads to 1,4-
addition contain a Cu(PAlkyl3)2 unit. Assuming that copper(I) 
attains a maximum coordination number of 4 then structures 
52 and 53 seem the most likely arrangements leading up to 
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the transition state if reductive elimination of a CuIII-like 
transition state is the rate determining step (Figure 12). 
 
Figure 12. Possible -complexes proposed via DFT 
calculations. 
 When tri(2-furyl)phosphine and tri(4-
fluorophenyl)phosphine are used as ligands (entries 5 and 6 in 
Table 2), the R2 data indicates that these ligands best fit an 
overall first order reaction rate, i.e. dependent on enone 
concentration only. From the ligand optimisation plots a range 
of values for the predicted catalyst rest state structure is 
obtained. Within the error bar of the reaction (±0.2), these 
values suggest that these catalysts have similar structures to 
51. It is also evident that the amount of -acceptor character 
influences the strength of the bond between the phosphine 
and the copper centre. The copper to phosphorus bond is 
significantly weaker than that of the corresponding -donor 
ligands resulting in a more labile system and greater scatter is 
observed in the ligand optimisation plots. 
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Figure 13. Comparative Cu(OAc)2:L optimisation plots for the 
systems studied (at -40 oC). X-axes: mol-% L per 1 mol-% 
copper precursor used; y-axes: ln(k1). For: a) tri(2-
furanyl)phosphine and b) tris(4-fluorophenyl)phosphine. 
 
 To help with the elucidation of these -complexes, we 
collaborated with Prof. Verios who ran DFT calculations for us 
using trimethylphosphine as a model ligand. 40  A viable 
structure that could be identified was 53, which provides a 
lower energy route for conjugate addition which matches the 
experimentally observed stoichiometry. When the reaction 
involving the Cu2L4 stoichiometry was modelled, it was found 
that the reaction occurred in three steps. The initial step 
involves the addition of an external trimethylphosphine ligand 
via a dissociative process, which creates a higher energy 
intermediate. This is followed by the dissociation of the 
acetate linker from the copper centre containing the ‘R’ group, 
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which is then followed by the addition of the methyl group 
across the olefin double bond, resulting in a lower energy 
state (Figure 14). 
 
Figure 14. Free energy profile (B3LYP, kcal mol-1) for the 
methyl addition to cyclohexenone, with a Cu2L4 stoichiometry. 
 When strong -acceptor phosphorus ligands were 
employed, the ‘goodness of fit’ on the primary kinetic data 
shows that the best fits was to overall first order kinetics. 
From the data it was evident that the higher the -acceptor 
capability of the ligand (higher values of p) the higher the 
number of ligands seem to be in the rest-state of the catalyst 
(Table 3).  
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Table 3. 1,4-addition to cyclohexenone using -acceptor 
ligands. 
Entry Ligand σ-donor value 
(χd)[a] 
-donor 
value (p)[a] 
copper 
to ligand 
ratio 
1 P(C6F5)3 34.80 4.10 N/A 
2 P(OPh)3 23.60 4.10 1.0:2.3 
3 (R,S,S)-L2 - - 1.0:3.3 
[a] Using the QALE approach for defining relative σ-donor/-acceptor 
ability. Small d values correlate with strong σ-donors; non zero values of 
p indicate -acceptor ability.37 
 When tris(pentafluorophenyl) phosphine (entry 1, Table 
3) was employed in the reaction, it was evident that the 
reaction was far too slow to be of any use, because after one 
hour the reaction had not reached the optimal three half lives 
normally required for accurate kinetic analysis. Because of this 
it was not possible to obtain a ligand optimisation plot for this 
ligand. 
 For ligand (R,S,S)-L2, the Cu:Lfastest studies indicate 
that a wide range of speciation in the reaction mixture with a 
slight preference for coordinatively saturated XCu(L2)3 (X = 
ethyl, acetate) as the catalytic rest state when [L2]/[Cu] >1 
(Figure 15a). A Cu2L2 motif for the rest state is, we believe, 
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the most likely. One potential structure is 51 (S = any 
credible 2-electron donor; e.g. toluene solvent, enone O-
ligation, ethylzinc acetate, etc.). Given that rapid copper-
ligand exchange is a known feature of such catalysts such a 
model is in accord with literature experimental data including 
the observation that potentially chelating substrates are 
frequently excellent substrates for ACA reactions, whereas 
substrates akin to 16 with R > Me are poorly represented in 
successful ACA transformations. Coordination vs. steric 
repulsion to the second copper centre in 51 (with 
displacement of one S) would be in line with these 
observations.  Structure 51 is identical to the suggestion of 
Gschwind when S = L2. Given the fast exchange of ligands in 
these complexes, capture of additional L2 by 51 is certainly 
possible. However, based on the kinetic evidence presented 
here, additional P-ligation in selective transition state is 
neither vital for turnover nor is it a major component in the 
r.d.s. The role of these additional phosphoramidites seems to 
be small additional conformational biasing within structure of 
51 leading to the minor NLEs seen in section 1.3.7 and the 
maximisation of ee for additions when [L2]/[Cu] is >1. We 
sought evidence to support solvent interaction with transition 
state 51. Dichloromethane is known to bind copper(I) centres 
more effectively than toluene and crystallographically 
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characterised examples are known. To the best of our 
knowledge no equivalent binding of dichloromethane to 
zinc(II) centres has been reported. In line with solvent 
exchange into transition state 51, increasing the concentration 
of dichloromethane in the toluene solvent from 0.02 to 2.0 M 
results in a tenfold increase in reaction rate. 
  
 
Figure 15. Comparative Cu(OAc)2:L optimisation plots for the 
systems studied (at -40 oC). X-axes: mol% L per 1 mol% 
copper precursor used; y-axes: ln(k1). For: a) (R,S,S)-L2  and 
b) triphenylphosphite.  
 
 From copper to ligand studies for triphenylphosphite, a 
structure based on 51 is the transition state precursor, but 
with a slight propensity for an EtCu(triphenylphosphite)2 
catalyst rest state. In all cases involving acceptor ligands, 
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slightly higher ratios were observed in comparison to -donor 
ligands. For these ligands it is clear from the curvature of the 
ligand optimisation plot, they bind copper(I) much less 
strongly than the -donor ligands, thus leading to a slightly 
increased error bar in the stoichiometry.  
 It is suggested that -acceptor ligands lower the energy 
barrier for reductive elimination to occur from a transient 
copper(III) species derived from 51, 52 and 53, therefore 
increasing the reaction rate. However, in the DFT calculations, 
no copper(III) intermediates could be identified and the 
reaction coordinate is more akin to carbocupration of the 
enone. 
1.3.4 Effect of the copper source    
 The Lewis acidity of the cuprate was also subjected to 
the same kinetic analysis under the same conditions 
previously mentioned. The highly labile in situ generated 
copper(I) acetate was changed to the more Lewis acidic 
copper(I) triflate which was generated in situ. 
Triphenylphosphine was the ligand of choice because it 
allowed a direct comparison between the two copper salts 
(Scheme 12). 
50 
 
 
Scheme 12. Standard reaction conditions when using 
copper(II) triflate as the copper source. 
 After closely examining the ‘goodness of fit’ of the 
primary kinetic data, it was evident that the overall reaction 
best fits first order kinetics, i.e. having only a dependence on 
enone concentration. Although the error bar on the copper(II) 
acetate/triphenylphosphine data is too high to allow any but 
the most general comparison (values of copper:Lfast ~1.7 and 
k1max ~1 x 10
-3 s-1 were determined) it is clear that increasing 
the Lewis acidity of the cuprate does not alter the speciation 
compared to the acetate moiety (copper:Lfast ~1.7) but 
significantly increases its reactivity (k1max ~7.5 x 10
-3 s-1). For 
the copper(II) triflate/triphenylphosphine system the 
Gschwind Cu2L3 core seems be the bulk rest state but whether 
this is maintained in the transition state for conjugate addition 
or behaviour akin to 52 is attained, cannot be deduced due to 
the quality of the data. However, it is clear that the zinc(II) 
triflate counter-cation provides very significant rate 
acceleration. Coordination of ethylzinc triflate (generated 
during catalyst formation) to the ligation sites of 51 (or a 
related structure) would be expected to significantly affect the 
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binding affinity of the enone to the adjacent copper-ethyl site. 
Finally, it is important to note that our data do not provide 
information on the number of zinc atoms in the transition 
state. 
 
Figure 16. Comparative copper(II)triflate/triphenylphosphine 
optimisation plot (at -40 oC). X-axes: mol-% L per 1 mol-% 
copper precursor used; y-axes: ln(k1).  
1.3.5 Effect of the terminal organometallic 
reagent 
 The effect of the terminal organometallic nucleophile 
was also examined by changing the terminal organometallic 
from diethylzinc to triethylaluminium. In order to directly 
compare the nature of the -complex for the aluminium 
species, the conditions needed to be kept the same as for that 
of diethylzinc. To do this the concentration of copper(II) 
acetate (0.00256 M), triethylaluminium (0.364 M) and internal 
standard (0.014 M) were kept constant throughout all of the 
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runs, the ligand was fixed as (R,S,S)-L2 and the solvent of 
choice was diethylether (Scheme 13). Diethyl ether was 
chosen as the solvent over toluene because toluene led to 
rapid oligomerisation of cyclohexenone. 
 
Scheme 13. Standard reaction conditions for the addition of 
triethylaluminium to cyclohexenone. 
 The ligand optimisation plot data, based on first order 
kinetics, provides a copper:L2fast ~2.4 ligands per copper. 
Based on the curvature of the ligand optimisation plot for this 
system it is closely analogous to that of diethylzinc/L2. 
Therefore we predict a structure based on 51 but with the 
ZnEt unit replaced by AlEt2 as the intimate precursor to the 
ACA transition state. Based on the Cu:Lfast data speciation 
within the catalyst pool is high but the major components are 
EtCu(L2)n (n = 2,3).  
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Figure 17. Comparative copper(II) acetate/(R,S,S)-L2 
optimisation plot (at -40 oC). X-axes: mol-% L per 1 mol-% 
copper precursor used; y-axes: ln(k1).  
1.3.6 Ligand rate dependencies  
 
It is clear from the ligand optimisation plots for all systems 
studied, that only trimethylphosphine, tricyclohexylphosphine, 
triphenylphosphite, L2 (both with diethylzinc and 
triethylaluminium) and copper triflate/triphenylphosphine gave 
reliable data to estimate the r.d.s ligand dependency. The 1,4-
addition rate dependency on the ligand concentration for these 
systems is non-linear – at concentrations above k1max the 
overall rate falls due to the presence of increasing 
concentrations of catalytically inactive, presumably 
coordinatively saturated, species. It is highly desirable to 
estimate the value of n in {rate ∝ [L]n} is determined as this 
would shed light on the number ligands present at the critical 
rate determining step of these ligated cuprate catalysts. To 
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the best of our knowledge such information has remained 
kinetically undetermined. To attain initial estimates of the 
ligand reaction orders we have applied linear fits to the initial 
slopes of the 1 mol% to the Lfast mol% data from the ligand 
optimisation plots. (Except for run e where the 1 mol-% data 
point was excluded). The values attained from this simple 
analysis are given in Table 4. The error bar on these average 
ligand order rate dependencies is quite high – we estimate it 
to be ±0.2. Nevertheless, the numbers derived here are 
important as no other values are available in the literature. An 
alternative approach to attaining [L]n involved the fitting of 
tangents to the midpoint of the rise of the ln(k1max) data 
against parabolic fits of ln([L]) and this gave similar results 
(within error) except for the copper triflate/triphenylphosphine 
system. This was the only case where the attained values 
were very different (triphenylphosphine order of 1.9 vs. 2.6) 
for these two different approaches. The copper 
triflate/triphenylphosphine system was the most labile from 
which reproducible data could be attained and it is clearly at 
the limits of our technique with an unacceptable error. 
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Table 4. data derived from the ligand optimisation plots 
Ligand Size, VBur 
/% [a] 
Best rate 
ratio[b] 
Cu:Lfast
 
Ligand 
order[b] 
[L]n 
PMe3 27.3 2.0 2.2 
PCy3 38.8 2.0 1.2 
PPh3 {+ Cu(OTf)2}
[e] 34.8 1.7 var.[e] 
P(OPh)3 36.5 2.3 1.1 
L2 34.9
[f] 3.3 0.4 
L2 {with AlEt3}
[h] 34.9[f] 2.4 0.4 
[a] Literature values were used or calculated by the method of Cavallo for the LAuCl 
complex (with Bond radii scaled by 1.17, Rsphere = 3.5 Å, and d(M-L) = 2.0 Å);
[7] lower 
%VBur corresponds to less steric demand for L. [b] The maximum error bars on the 
Cu:L ratios giving the fastest overall reaction and ligand reaction orders are 
estimated at ±0.2.   
 
The results from Table 4 show that the number of ligands in 
the fastest rest state of the catalyst which enters into the 
transition state (ligand optimisation plot) is generally higher 
than the number of ligands in the transtion state (ligand 
order). However, this is not the case for trimethylphosphine, 
where the rest state of the catalyst is akin to the transition 
state. 
1.3.7. Non-linear studies 
Non-Linear Effect (NLE) study of L4 where strong deviations 
from linearity were not observed in the addition of diethylzinc 
to cyclohexenone using copper(II) triflate. To allow a direct 
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comparison an NLE study on L2 using diethylzinc under our 
exact conditions was conducted (Figure 18a) – as this is 
absent in the literature. There is only a slight positive NLE 
deviation across the entire range of ligand enantiopurity. The 
apparent first order rate constant of the reaction with copper: 
(R,S,S)-L2 = 2 at -40 oC was determined to be 7.9 x 10-4 s-1 
for a sample of (R,S,S)-L2 with 50% ee. This value is broadly 
similar to that for the equivalent run using 100% ee (R,S,S)-
L2 (5.3 x 10-4 s-1 page 48). Within the maximum error on the 
single rate determinations (ca. 4 x 10-4 s-1), the data suggests 
that the NLE most probably derives from a slight kinetic 
advantage for a heterochiral species over its homochiral 
equivalent and not from any ‘reservoir effect’ - where a very 
significant decrease in the rate is expected due to the 
population loss of the catalytically competent species. To 
support these ideas a brief Arrhenius study was made of the 
50% ee (R,S,S)-L2 system between -35 and -45 oC. To 
conduct this, the rate constants were derived according to 
Figure 9, and a linear trendline fitted and the activation 
parameters obtained. A reaction Eact of 15±2.7 kcal mol
-1 was 
determined. The accuracy of the data did not warrant 
extraction of H‡ and S‡ but the activation energy is very 
similar to other reported dialkylzinc/enone systems.36 Finally, 
it has been suggested that below Cu:L ratios of 1:1.5 the 
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enantioselectivity delivered by L2 falls dramatically – but no 
figure is provided in widely available literature as far as we 
can determine. When copper(II) acetate: (R,S,S)-L2 values of 
1 mol%:0.5 mol% were used the conjugate addition product 
was attained with a final ee value 96%, the same as that 
(94%) attained with literature ‘optimal’ copper:ligand ratios of 
1:2 within the error for the ee determination (±3% maximum, 
and generally better than ±2%). In general, in all of our 
kinetic runs the ee values (96±2%) for the diethylzinc 1,4-
addition product was independent of both the copper: (R,S,S)-
L2 ratio used in the reaction and the time of sampling. The 
simplest explanation of this behaviour is that a single identical 
entity is responsible for the stereoselective transition state, 
and that this is extracted by self-assembly from the rest-pool 
of entities through ligand acceleration effects. This condition is 
vital for our analysis of the copper:ligand ratios in the various 
transition states proposed here. Deviations in the 
diethylzinc/(R,S,S)-L2/copper(II) acetate ee data were 
generally observed in the first 180 seconds when CuII 
reduction and catalyst genesis is not quite complete. We also 
determined the NLE of the triethylaluminium addition (Figure 
18b). This shows essentially linear behaviour up to 50% ee 
ligand purity and then a significant negative deviation; 
however, kinetic data in the latter regime were not attained. 
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Nevertheless, we could show that the enantioselectivity for the 
1,4-addition (79±3%) final product were again invariant over 
a range of copper: (R,S,S)-L2 ratios (2:1 to 1:3) at the 
endpoint of the reaction. However, in the 
triethylaluminium/(R,S,S)-L2 system the ee value of the 
product showed time dependance (rising from <54% to 
79±3% ee over the first 9 minutes (ca. 90%) of conversion in 
all cases). Because of these observations it cannot be 
guaranteed that the asymmetric addition arises from a single 
entity with the (R,S,S)-L2 molecularity of Table 4. 
 
.  
 
Figure 18. Non Linear Effects (NLEs) for copper(II) acetate (1 
mol %) and Feringa’s phosphoramidites (L2) (2 mol %) 
catalysed additions of (a) diethylzinc (in toluene); (b) 
triethylaluminium (in diethyl ether). The maximum error bars 
on the ee determination are ±3%. 
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1.3.8. Method of continuous variation analysis 
 
Job’s plots are commonly used to determine metal-to-
ligand ratios in complex formation reactions. In this technique, 
the total amount of ligand and metal are fixed, whereas the 
individual amounts of ligand and metal are varied 
continuously. A physical property is measured and a plot of 
the physical property versus mole fraction of the metal yields 
a curve with ascending, then descending branches whose 
sides meet at a maximum. This maximum denotes the 
optimum mole fraction of the metal at which complete 
complex formation occurs. However, Job's plots for 
organometallic chemistry are poorly represented.  
As well as conducting ligand optimisation plots, A Job’s 
plot analysis was also conducted according to Figure 9 where 
a fixed amount of ligand and copper (4.5 mol% total) was 
used while varying the mole fraction of both within this 
totality. Due to the shallow maxima in -acceptor ligands the 
speciation of triphenylphosphine, triphenylphosphite, tris(para-
fluorophenyl) phosphine were analysed via the Job's plot 
method along with L39 (Figure 19). 
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Figure 19 Job’s plots for copper(II) acetate and a) L39, b) 
tris(4-fluorophenyl)phosphine c) triphenylphosphine and d) 
triphenylphosphite. X-axes: mole fraction of copper and 
ligand; y-axes: ln(k1) 
 
For both the triphenylphosphite and tris(para-
fluorophenyl)phosphine systems, the traditional Job’s 
continuous variations plot provided a copper: 
triphenylphosphite ratio of 1:1.9 and a copper:tris(para-
fluorophenyl)phosphine ratio of 1:1.6. The fit of the primary 
kinetic data in both the ligand optimisation plots and the Job’s 
plots are comparable (R2ave 0.97 vs. 0.99) for 
triphenylphosphite indicating a similar maximum error of ±0.2 
in the derived copper:Ligand ratio. Thus, while there are 
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numerous species in the catalytic ‘rest state pool’ of this 
system the most populous, by both techniques, is 
XCu{P(OPh)3}2 or XCu{P(4-FC6H4)3}2  (X = OAc or Et).  
The kinetic analyses require a regime where the rate of 
ligand exchange between ‘rest state species’ is significantly 
faster that the rate determining step for conversion of enone 
to 1,4-addition product. While this is known to be the case for 
P-ligands we have used, the same cannot be assured for Cu-
NHC species where build-up of a small ‘non exchanging 
XCu(SIMes)2 pool’ cannot be discounted. A kinetic Job’s plot of 
the behaviour of L39 also suggested this might be the case as 
it provided Cu:L39 of 1:1.2 (±0.2 max error) as the most 
populous rest state species. A paucity of data at ligand 
loadings between 0-1 mol-% prevented realistic estimates of 
the carbene ligand r.d.s. reaction order. Although we could not 
reliably determine the ligand order for reactions based on L39 
(due to a lack of reproducible data at [L39]/[Cu] <1) the 
involvement of (L39)Cu-Et seems likely, based on the 
maximum at Cu:L39 of 1.4 and 1.2 (both ±0.2) observed in 
the ligand optimisation and Job’s plots. 
Unfortunately the paucity of the kinetic data for the 
triphenylphosphine system leads to a poor fit in the Job’s plot 
analysis and therefore no meaningful data can be obtained. 
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1.3.9. Conjugate addition of Grignard reagents 
to -unsaturated esters 
 
 The conjugate addition of ethylmagnesium bromide to 
methyl crotonate was also studied using the ligand ratio vs. 
rate plot technique outlined in Figure 9 (Table 5). 
Table 5. Copper-catalysed 1,4-addition of ethylmagnesium 
bromide to methyl crotonate. 
Entry Cu salt Ligand Cu: no of Ligands 
1 CuI L28 1.0:1.1 (slow) & 1.0:1.2 
2 CuBr.SMe2 L27 - 
 
 These were carried out using the same bottle of 
Grignard reagent and freshly distilled methyl crotonate, with 
fixed concentrations of the copper salt (0.00323 M), 
ethylmagnesium bromide (0.387 M), internal standard (0.013 
M) and methyl crotonate (0.323 M). The reaction temperature 
was also kept constant (-78 oC). The primary kinetic data 
indicated that the overall reaction neither followed simple first 
order kinetics (dependence on enone concentration), nor 
second order kinetics (dependence on enone and Grignard 
concentration). The reaction could only be fitted to an overall 
double first order kinetic model (equation 2), potentially 
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indicating that there are two catalytically active species 
present, each following separate first order kinetics. This 
suggestion concurs with the phosphorus NMR study carried 
out by Feringa, in which he found there were two distinct 
species present which have different chemical shifts to one 
another.35  
[A]t = ([A]0exp(-kobst))fast + ([A]0exp(-kobst))slow                 (2) 
Where [A]0 is the initial enone concentration, [A]t is the 
calculated enone concentration, kobs is the observed rate 
constant and t is the time. 
 Unfortunately, no meaningful kinetic data could be 
obtained for the use of L27, due to the active catalyst being 
far too fast at -78 oC, and the majority of the starting material 
had been converted to product in less than 5 minutes. For this 
reason, there were not enough data points to obtain an initial 
rate from the data. Because of this our attention was turned 
to another catalyst system which was reported in the 
literature by Loh, in which copper(I) iodide and (S)-tolyl-
BINAP (L28) were used (entry 1, Table 5).41  
 This catalytic system reacted slowly enough to provide 
meaningful kinetic data at -78 oC. From the ligand ratio vs. 
rate plot a copper to ligand ratio could be obtained for both 
the fast and slow reacting catalysts. The fast reacting catalyst 
has a stoichiometry of one copper to two phosphorus donors, 
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which is consistent with the -complex proposed by Feringa. 35 
The slow reacting catalyst has a copper to ligand ratio of 
1.0:1.2, which indicates that the structure of the -complex is 
slightly different, and that this -complex possibly contains a 
dinuclear copper species. However, no structure has yet been 
proposed for this observation. 
1.3.10. Nickel-catalysed 1,2-addition to 
aromatic aldehydes 
 While we have concentrated primarily on 1,4-additions 
of terminal organometallics, we believe that the ligand 
optimisation plot technique has the potential for wider use. 
Therefore, the technique has been extended to probe the 
mechanism of 1,2-addition of trimethylaluminium to 
benzaldehyde under nickel(II) acetoacetate catalysis in the 
presence of L2 (Scheme 14). 
 
Scheme 14. Standard reaction conditions for the addition of 
trimethylaluminium to benzaldehyde. 
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Analysis of the data collected via Figure 9 showed that the 
overall reaction follows zero order kinetics, i.e. no dependence 
on the nucleophile or aldehyde (equation 4). 
[A]t = [A]0-kobst                          (4) 
Where [A]t is the calculated concentration of benzaldehyde, 
[A]0 is the initial concentration of benzaldehyde, kobs is the 
observed rate constant and t is the time. 
 From the reaction rate data obtained, a ligand 
optimisation plot wad derived and the stoichiometry of the 
nickel to ligand ratio was found to be 1.0:1.0.  This is in 
accord with the proposed transition state structure 58 (Figure 
20). When more traditional optimisation procedures, based on 
enantiopurity of the product alcohol, were used, these proved 
unhelpful, as the alcohol’s enantioselectivity is independent of 
the nickel to L2 stoichiometry.42 
 
 
Figure 20. a) Proposed transition state in the nickel-catalysed 
addition of trimethylaluminium to benzaldehyde; b) ligand 
optimisation plot at -20 oC X-axes: mol-% L per 1 mol-% 
copper precursor used; y-axes: ln(k1). 
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 What was also evident from the primary data is that 
when the ligand concentration exceeds 2 mol percent, the 
activity of the catalyst drops dramatically, due to coordinate 
poisoning of the nickel species.  
1.4 Conclusions 
 
 The kinetic behaviour of catalytic copper(II) acetate (1 
mol-%) and ligands (at ranges from 0.5 mol-% to 3 mol-%) 
for the addition of diethylzinc to cyclohexenone have been 
investigated. Diethylzinc addition promoted by copper(II) 
triflate (1 mol-%) and triphenylphosphine (1-2.5 mol-%), 
triethylaluminium addition by Feringa’s phosphoramidite (at 
ranges from 0.5 mol-% to 3 mol-%), ethylmagnesium 
bromide addition by diphosphine ligands to enoates and 
nickel-phosphoramidite catalysed addition to 
trimethylaluminium to benzaldehyde have also been 
investigated. Non-linear dependency of the reaction rate 
constant as a function of the ligand concentration is observed 
with rate constant maxima at copper to ligand ratios of 1.4-
3.3 for a fixed [CuI] of 1 mol-%. Ligand orders were also 
determined for a select few catalyst systems the average 
ligand orders are: [PMe3]
2, [PCy3]
1, [P(OPh)3]
1 and [L2]0.5 
within the error (±0.2) on the determinations. These numbers 
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are in accord with known substrate dependencies, non-linear 
effect studies and other mechanistic data.  
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Chapter 2 
 
 
 
 
Synthesis of air-stabilised 
alanes and application in 
hydroalumination chemistry 
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2.1 Introduction 
2.1.1 Aluminium hydrides 
 
Alanes are neutral aluminium compounds which posses 
aluminium-hydrogen bonds. By this definition anionic ‘ate’ 
species containing anionic hydrides (such as the ubiquitous 
lithium aluminium hydride AlH4
-) are excluded and not further 
discussed in detail. Numerous alanes have been characterised, 
of which the major types are summarised in Figure 21. 
 
Figure 21 Major classes of alanes. 
The structural chemistry of amidoalanes is dominated by 
the formation of oligomers of AlHn(NR2)3-n (n = 1-2). Such 
monomers can be bonded either typically by Al-N-Al bonds as 
in 59, 60 and 61 or atypically via hydride bridges 62 when 
very sterically encumbering groups are present (Figure 22). 
The Lewis acidity at the aluminium centre implied by these 
empirical formulae of the monomers underpins the vast 
majority of the chemistry of amidoalanes and this is 
moderated by the donor properties (steric and electronic) of 
the amido group.43  
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Figure 22 Structures of amidoalanes. 
If sterically unencumbered dimethylamide units are present, 
both 60 and 61 can be formed, depending upon the 
aggregation. Dimer 60 has an Al-N bond length of 1.966 Å for 
the bridged amide and 1.804 Å for the terminal amide but the 
Al-H bond length is undefined.44 The trimer 61 has an Al-N 
bond length is 1.936 Å with an Al-H bond length of 1.55 Å.45 
When extremely bulky amines are used such as 2,2,6,6-
tetramethylpiperidine, only motif 62 is formed, with an Al-N 
bond length of 1.835 Å and a 1.68 Å Al-H bond.46 
Amidoalanes are typically synthesized via the reaction of 
secondary amines with a source of alane (AlH3) in molar ratios 
of 1:1 for the dihydride 59 or 2:1 for the monohydride 60 or 
61 (Scheme 15). Another approach to preparing such 
amidoalanes is via the reaction of elemental aluminium and 
hydrogen under ultra high pressures (3000-4000 psi) in the 
presence of the corresponding secondary amine. This 
approach has recently been targeted as a potential method for 
hydrogen storage. A wide variety of these amidoalanes have 
been synthesised and their structures and chemistry explored. 
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Scheme 15 Synthesis of amidoalanes. 
Imidoalanes exhibit high degrees of oligomerisation. The 
Al-H containing sub-unit tends to aggregate into cubic 
tetramers-63, hexagonal prismatic hexamer-64 or even 
higher oligomers (Figure 23).47 The synthetic approaches to 
these alanes are very similar to that of amidoalanes: a source 
of alane (AlH3) is reacted in the presence of a primary amine 
in a molar ratio of 1:1.46 
 
Figure 23 Structure of imidoalanes. 
 Alkoxyalanes, typically adopt a dimeric structure, in 
which the alkoxide substituents occupy the two bridging 
positions, thus forming a M2O2 central ring (Figure 24). When 
the alkoxide moiety is t-butoxy, both 65 and 66 can exist.48 
When the dihydride is formed, 65 is commonly observed, in 
which the bond length of Al-OtBu is ca. 1.81 Å, with an Al-H 
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bond length of 1.55 Å. When the monohydride is formed, 66 is 
observed, with the bridging Al-O-Al having a bond length of 
about 1.82 Å, while a shorter bond length of 1.67 Å is 
observed for the terminal Al-OR (in the case R = tert-
butoxide). An Al-H bond length was also determined at 1.51 Å.     
 
Figure 24 Common structures for alkoxyalanes. 
 Haloalanes are rather underrepresented in the literature 
but both monohaloalanes (H2AlX) and dihaloalanes (HAlX2, 
where X = F, Cl, Br, I) are known. 49  The first reported 
attempted structure of a Lewis base adduct of such haloalanes 
was due to Semenenko in 1973 (Scheme 16).50 However, no 
bond length data could be obtained due to disorder in the 
crystal structure between the hydrides and chlorides.  
 
Scheme 16 First reported synthesis of haloalanes. 
 The early synthesis of haloalanes involves reactions of 
an alane adduct with either anhydrous hydrogen halides or 
mercuric halides giving moderate to good yields (up to 50%). 
Another approach is the reaction of lithium hydride with the 
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corresponding aluminium trihalide in the presence of a Lewis 
base, giving the haloalane in up to 60% yield. Haloalanes can 
be synthesised directly from a reaction between aluminium 
powder, aluminium trihalide and hydrogen gas. Unfortunately, 
this procedure required elevated temperatures (80-150 oC) 
and elevated pressures (up to 10,000 psi), but good yields of 
the haloalanes were attained (Scheme 17).51   
 
Scheme 17 early syntheses of haloalanes. 
 Oxygen-containing Lewis base adducts of haloalanes can 
be synthesized by the same approach of Semenenko 
(Scheme 16) followed by the addition of the corresponding 
oxygen-donor ligand. 52  For the tetrahydrofuran adduct the 
solvent was simply changed from diethyl ether to 
tetrahydrofuran.52 During this study the authors noted it was 
possible to do a halide-hydride redistribution from alane and 
two equivalents of aluminium trihalide in tetrahydrofuran 
(Scheme 18). 
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Scheme 18 Synthesis of oxygen Lewis base adducts of 
dichloroalane. 
 Recently, it has been shown that it is possible to 
synthesise haloalanes stabilised by NHC ligands. This can be 
achieved in two ways: i) by a ligand substitution of a labile 
and volatile donor on the alane (e.g. AlH3•NMe3) with the 
deprotonated NHC, 53  or by a hydride-halide exchange of a 
pre-existing aluminium halide NHC complex.54 
 By replacing hydrides on the aluminium centre with 
heteroatom containing groups (halides, amino, alkoxy-groups) 
the reactivity of the remaining hydrides is reduced due to the 
inductive effects of these groups. Due to this tunability of the 
alane both alkoxy- and amidoalanes have been widely utilised 
in organic synthesis. 
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2.1.2 Synthesis of alkenylalanes 
 
The synthesis of alkenylalanes can be achieved via three 
routes: i) transmetallation from alkenyllithiums or Grignard 
reagents; ii) hydroalumination of alkynes and iii) alkyne 
carboalumination (Scheme 19). 
Scheme 19 Protocols for alkenylalane synthesis. 
2.1.2.1 Transmetallation procedures 
 
 The synthesis of alkenylalanes via transmetallation from 
organolithium and Grignard precursors is surprisingly 
underrepresented in the literature. Such approaches were first 
reported by Paley and Snow in 1990. 55  Vinylmagnesium 
bromide was reacted with ethylaluminium dichloride and the 
intermediate alkenyl alane subsequently cross-coupled 
(Scheme 20). The authors noted that the use of dimethyl- 
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and diethylvinyl alanes were unsuccessful in the cross-
coupling. 
Scheme 20 first synthesis of vinylalanes via transmetallation. 
 Carreño and co-workers reported the synthesis of 
alkenylalanes from alkenyl iodides. 56  Initial lithium-iodine 
exchange followed by reaction with dimethylaluminium 
chloride in hexane at ambient temperature afforded 80. 
Alexakis reported a similar procedure using diethylether as 
solvent. However, this latter approach required a more 
complicated temperature control protocol (Scheme 21). 
 
Scheme 21 Synthesis of alkenylalanes from alkenyl halides. 
Due to the lack of commercially available alkenyl iodides, a 
modified procedure was also reported by Alexakis and co-
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workers based on alkenyl bromides. Initially alkenylbromides 
are reacted with t-butyllithium (2 equivalents) in diethyl 
ether; this was followed by a transmetallation onto 
dimethylaluminium chloride to yield the corresponding 
alkenylalane (Scheme 21). 
2.1.2.2 Hydroalumination 
 
 Hydroalumination can be defined as the syn addition of 
an aluminium hydride across an unsaturated carbon-carbon 
bond via a formal [2+2] cycloaddition. Woodward-Hoffman 
analysis of hydroalumination reactions show that this process 
is thermally allowed (Figure 25).  
 
Figure 25 Woodward-Hoffman analysis of hydroalumination. 
2.1.2.2.1 Uncatalysed hydroalumination  
  
Wilke and Müller57 reported the first hydroalumination of 
terminal alkynes using diisobutylaluminium hydride under both 
neat conditions and in hydrocarbon solvents. Depending upon 
the nature and branching of the substituent on the alkyne, 
competing metallation and over-hydroalumination is also 
observed. If n-alkyl substituents are present in the alkyne, 
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only low levels of undesired products are detected. If electron-
withdrawing or conjugated substituents are present, such as 
phenyl, 2-cyclohexene, then the alkynyl proton becomes more 
acidic leading to significant amounts of acetylides and the 
reaction is poor overall (Scheme 22).58 
  
Scheme 22 Uncatalysed hydroalumination and associated 
side reactions. 
 One approach to avoid the formation of aluminium 
acetylides in the presence of acidic alkynyl protons was due to 
Eisch.59 In this pioneering work, Eisch and co-worker reported 
the thermal hydroalumination of silyl-substituted alkynes 
resulting in a regioselective addition with the aluminium  to 
the silicon (Scheme 23). The regioselectivity observed could 
be explained by the stabilisation of the partial negative charge 
into the low lying * orbital on the silicon or the sabilisation of 
a beta positive charge through the carbon-silicon  bond. 
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Scheme 23 Hydroalumination of silyl-substituted alkynes. 
Eisch noted that the solvent played a major part in the 
stereoselectivity of the reaction. When coordinating solvents 
were used, a syn-addition across the triple bond was observed 
but when non-coordinating solvents were used, an anti-
addition was observed. This stereochemical outcome was 
attributed to a destabilisation of the double bond, formed in an 
initial syn-addition, via the unoccupied p-orbital on the 
aluminium followed by isomerisation to minimise the steric 
interactions between the trimethylsilyl group and the iso-butyl 
group. Whereas in coordinating solvents (such as 
tetrahydrofuran), the empty p-orbital is coordinated and 
unable to participate in stabilising the -positive charge 
(Scheme 23). 
2.1.2.2.2 Nickel-catalysed hydroalumination  
 
 Eisch and co-workers discovered that nickel salts, in 
particular nickel acetylacetonate, could catalyse the 
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hydroalumination of terminal alkynes. 60  Recently, Hoveyda 
and co-workers revisited this work in order to find a protocol 
that could be used for the hydroalumination of terminal 
alkynes bearing electron withdrawing or conjugated 
substituents. After screening a range of commercial nickel 
salts, it was found that, dichloro(1,3-
bis(diphenylphosphino)propane)nickel (NiCl2(dppp)) would 
furnish the , internal alkenylalane with excellent 
regioselectivites of  >98:2, whereas 
bis(triphenylphosphine)nickel(II) dichloride (NiCl2(PPh3)3) 
would generate the more synthetically useful -alkenylalane, 
but the regioselectivity decreased to 7:93 (Scheme 24).61 
  
Scheme 24 Nickel catalysed hydroalumination. 
2.1.2.2.3 Titanium and zirconium catalysed 
hydroalumination 
 
 Taapken and co-workers demonstrated that terminal 
alkynes can undergo hydroalumination with 
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diisobutylaluminium hydride in the presence of 
bis(cyclopentadienyl)zirconocene dichloride. 62  This reaction 
was carried out in refluxing dichloromethane for 24 hours, 
followed by treatment with diethylchlorophosphate to give 88 
(Scheme 25). Additionally, Ashby and Noding showed that 
bis(diisopropylamino)alane, in the presence of either 
bis(cyclopentadienyl)titanocene dichloride or titanium 
tetrachloride, was able to undergo hydroalumination with 
internal and terminal alkynes to generate the corresponding 
olefin in near quantitative yields. When the reaction was 
quenched with deuterium oxide high levels of deuterium 
incorporation was observed (Scheme 25).63 
 
Scheme 25 Titanium and zirconium catalysed 
hydroalumination. 
2.1.2.3 Zirconium-catalysed carboalumination 
 
 The first examples of carboalumination of alkynes were 
a thermal reaction between trialkylalanes and gaseous 
acetylene to generate (Z)-selective alkenyldialkylalanes.64  
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 The first zirconium-catalysed carboalumination was 
reported by Negishi in 1978 where group four transition 
metals were shown to be active for methylmetallation of both 
terminal and internal alkynes. 65  This process is extremely 
general in terms of the alkyne used, however, both 
trimethylaluminium and zirconocene dichloride needs to be 
present for this reaction to proceed. If trimethylaluminium or 
MeZrCp2Cl are used independently, no reaction occurs 
(Scheme 26). 66  This approach followed by subsequent 
functionalisation has been used in the synthesis of natural 
isoprenoids for example: geraniol, monocyclofarnesol, and 
farnesol.67 
 
Scheme 26 Zirconium catalysed carboalumination. 
 Wipf and co-workers reported a modified procedure for 
the zirconium-catalysed carboalumination of alkynes. Addition 
of up to 2.0 equivalents of water was noticed to promote a 
dramatic increase in the carboalumination rate even at -70 oC. 
This rate acceleration was exclusive to water because when 
alcohols, hydrogen sulfide, silanols etc, were tried, the effect 
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was not observed. The authors proposed that a ligand 
exchange occurs at zirconium, to create a catalytically active 
oxo-bridged dimer.68 
2.1.3 Cross coupling of alkenylalanes 
 
Cross-coupling of terminal organometallic reagents with 
electrophiles under either palladium or nickel catalysis has 
become one of the most important and studied classes of 
reactions in organic synthesis. The organometallic reagents 
employed are typically: organoboron (Suzuki), organosilicon 
(Hiyama), organotin (Stille), organomagnesium (Kumada) and 
organozinc (Negishi). The use of organoaluminium reagents is 
significantly underrepresented and is typically described as a 
sub-set category of various Negishi-type couplings. 
 The first reported examples of a tandem 
hydroalumination and cross coupling procedure was reported 
by Negishi and Baba, in which alkenylalanes were reacted with 
aryl iodides or bromides 69 or alkenyl halides70 in the presence 
of catalytic tetrakis(triphenylphosphine)nickel to generate the 
substituted styryl compound and the 1,4-dienes respectively 
in good to moderate yields at 25 oC. The authors also noted 
that the use of tetrakis(triphenylphosphine)palladium could 
also generate the desired products but at a slower rate. 
Kumada and co-workers showed that it was possible to 
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conduct cross-coupling reactions using nickel(II) 
acetylacetonate as a pre-catalyst with aryl phosphonates as 
the coupling partner at ambient temperature (Scheme 27).71 
 
Scheme 27 Cross coupling of alkenylalanes. 
 Under Negishi's initial cross-coupling conditions, the 
coupling of alkenylalanes to alkenyl halides only gave low 
yields of the desired product. In order to increase the yields 
for the cross-coupling of alkenylalanes to alkenyl halides, the 
addition of different additives for the coupling to 1-bromo-2-
iodoethene was explored. It was found the addition of a zinc 
salt had an accelerating effect on the reaction. 72  Recently 
(2004), Negishi reported that the use of indium trichloride as 
a co-catalyst could dramatically increase the yield of the 
corresponding coupling products.73 
 In the early 1980s Negishi and co-workers reported the 
use of zirconium-catalysed carboalumination followed by a 
palladium catalysed cross coupling onto allylic electrophiles to 
generate the corresponding skipped dienes, such as -
farnesene in 86% yield (Scheme 28).74  
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Scheme 28 Palladium cross-coupling to allylic halides. 
Although there are many cross-coupling protocols that 
can be used for benzylic halides, very few describe the use of 
alkenylalanes. An initial example was attained by Negishi and 
co-workers using alkenylalanes generated via 
carboalumination and subsequent palladium cross-coupling 
with benzyl bromide or chloride to generate allylated arenes in 
high yields (up to 93%).75 In the late 1990s it was found that 
alkenylalanes generated by the thermal hydroalumination 
would undergo efficient nickel-catalysed cross coupling in good 
to excellent yields. Lipshutz showed that this protocol could be 
used to synthesise ubiquinones (CoQn) and demethylated 
ubiquinones via either carboalumination or hydroalumination 
of the corresponding alkyne (Scheme 29). 76  Very recently 
(2012), Gau and co-workers showed that alkenylalanes 
generated via hydroalumination could undergo an efficient 
nickel catalysed cross coupling at room temperature, to a wide 
range of benzyl halides containing electron-donating and 
electron-withdrawing groups with excellent yields. It was also 
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shown that benzyl chlorides would efficiently undergo the 
cross-coupling with excellent yields.77    
 
Scheme 29 Application of nickel-catalysed alane cross-
coupling. 
In the early 2000s Schumann and Schmalz showed that 
stabilised alkenylalanes could be used in palladium-catalysed 
cross-coupling of both haloarenes and chloroarene-chromium 
tricarbonyl complexes. The corresponding styryl compound 
was generated in high yields (up to 98%) using 5-10 mol% 
bis(triphenylphosphine)palladium dichloride. This reaction 
proceeds well for aryl halides containing ethers and esters but 
when haloanilines were used no reaction occurred (Scheme 
30).78 
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Scheme 30 cross-coupling of a chloroaryl-chromium 
tricarbonyl complex. 
2.2 Aims of research 
 
 Diisobutylaluminium hydride is an organoaluminium 
hydride which is used widely in many aspects of organic 
synthesis. Although diisobutylaluminium hydride is cheap and 
commercially available, neat diisobutylaluminium hydride is a 
pyrophoric liquid which requires air-sensitive techniques for 
safe usage. Due to its pyrophoric nature, neat samples need 
to be transported via sea freight, which can take long periods 
of time to arrive from US production facilities. Additionally the 
steric demand of the iso-butyl groups can mean that 
transmetallation on to ligated transition metals is generally 
slow. Finally, the iso-butyl group can itself be a transferrable 
group resulting in competing transfer (iso-butyl or hydride via 
b-elimination from iso-butyl). The aim of this research was to 
synthesise aluminium hydrides having small, non-transferrable 
groups attached to aluminium preferably with reduced 
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pyrophoricity. The latter was envisaged to be achieved by 
dimer formation or the addition of an external stabilising 
ligand. A couple of classes of aluminium hydrides that could 
deliver on some of these requirements were the haloalanes (in 
particular dichloroalane), di-t-butoxyalane and 
diisopropylamidoalane.  Once the pyrophoricity was 
addressed, the alane would be tried in hydroalumination of 
alkynes to see if the alkenylalanes could be generated cleanly 
in high yields and subsequently applied in a Negishi-type 
coupling (Scheme 31). 
   
Scheme 31 Aims of this research. 
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2.3 Results and Discussion 
 
2.3.1 Synthesis of aluminium hydrides 
  
Dichloroalanes were synthesised via the procedure of 
Flagg and Schmidt,52 in which lithium aluminium hydride is 
dissolved in diethyl ether and a solution of aluminium 
trichloride in diethyl ether added. After stirring for 15 minutes, 
the lithium chloride by-product was removed by cannula 
filtration to give an ethereal solution of dichloroalane, which 
on solvent removal yielded the bis(diethyl ether) complex. 
Unfortunately, the bis(diethyl ether) adduct 67 is a pyrophoric 
liquid. However, coordinated diethyl ether is somewhat labile 
and therefore this adduct was a useful precursor for the 
synthesis of other species. The addition of other Lewis base 
donors to an ethereal solution of dichloroalane•bis(diethyl 
etherate) afforded a wide range of new Lewis base adducts 
quickly and in excellent yields. Only nitrogen and oxygen 
Lewis base adducts are shown in Scheme 32. Sulfur-donor 
adducts were tried but due to poor sulfur coordination to the 
aluminium, the diethyl ether was not displaced. 
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Scheme 32 Synthesis of Lewis base adducts of dichloroalane. 
 The physical properties of the individual corresponding 
adducts formed were difficult to predict. For example, the 
bis(tetrahydrofuran) adduct of dichloroalane was isolated as a 
colourless, free flowing powder, with the bis(2-methyl 
tetrahydrofuran) adduct was a low melting solid (m.p. 24-26 
oC). Changing the ether ring size significantly affected the 
nature of the alane. Adducts containing tetrahydrofuran rings 
(68 and 97) were appreciably easier to handle than their 
corresponding liquid pyran analogue (73). When Lewis bases 
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containing two potential sites of coordination were reacted 
with dichloroalane•bis(diethyl etherate) (providing 70, 98, 99 
and 100) all the adducts were obtained in excellent yields 
with the adduct precipitating from the solution immediately 
upon addition of the Lewis base. These ligands presumably 
form polymeric structures which are insoluble in diethyl ether. 
All of the alanes of Scheme 32 can be synthesised on large 
scales (~50 grams). 
 Spectroscopic characterisation for these dichloroalane 
adducts was limited by their reactivity and intrinsic NMR 
properties. The hydride NMR resonances for these compounds 
were not always visible. This is not unusual as the reduced 
symmetries of these Lewis base complexes leads to strong 
quadrupolar relaxation by the aluminium centre (27Al, I = 5/2, 
100%). This relaxation and associated coupling often results 
in much broadened Al-H signals that can be very difficult to 
observe. Nevertheless, except for a select few of the alanes 
(67 and 73) Al-H stretches could be identified by IR 
spectroscopy (Table 6). 
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 Table 6 Spectroscopic data for dichloroalane adducts. 
Entry Adduct IR Al-H 
(cm-1) 
1H NMR 
(ppm)a 
1 67 - 0.91, 3.62, 4.30 (Al-H) 
2 68 1845 3.97, 1.38 
3 73 - 1.18, 1.29, 3.80 
4 70 1884 3.42 
5 98 1797 0.34, 0.48b 
6 99 1930 -c 
7 100 1843 1.94, 2.28, 3.18 
8 102 1899 1.46, 1.63, 1.71 
a) NMR spectrum in deuterated benzene; b) NMR spectrum in deuterated 
tetrahydrofuran due to insolubility in benzene; c) insoluble in all solvents. 
 
 
 From the IR spectra, the Al-H stretching modes have an 
increased wavenumber with the presence of the two chlorides 
with respect to alane (1801 cm-1) except for 98. Ashby79 has 
proposed that the addition of inductively electron withdrawing 
groups (such as chlorides) on an alane lowers the electron 
density at aluminium leading to greater Al-H covalency (less 
hydridic character for H). This can be seen in the increased 
n(Al-H) values for most of the adducts. The reason for the 
anomalous behaviour of 98 is not understood. 
 It is worth noting that the chemical shifts of the Lewis 
base donors attached to the aluminium exhibit shifts 
compared to the free Lewis base. For example, the 1H 
resonances of free diethyl ether moiety in deuterated benzene 
are H 1.11 (CH3) and (3.26) (OCH2), whereas when the ether 
is coordinated to aluminium, the chemical shifts change H -
0.2 (CH3) and H +0.36 (OCH2). The latter observation is 
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consistent with the decreased electron density at the 
methylene group  to the oxygen when the latter is 
coordinated to the Lewis acidic alane. 
2.3.1.1 Air-stability of alanes 
 
Having achieved a rapid and simple procedure for the 
reliable synthesis of dichloroalane adducts their stability, and 
potentially pyrophoric nature, was explored. Aluminium 
hydrides like many other metal hydrides react quantitatively 
with hydrolytic solvents (alcohols, water, acids) to produce 
hydrogen gas. The volume of hydrogen gas can be directly 
measured providing a convenient method for determining the 
purity, concentration (when in solution) and air-stability of 
these hydrides. Each individual alane adduct of Scheme 32 
was weighed out (in a glove box) into a sealed Schlenk tube. 
This provided a standard, for the pure dichloroalane adduct 
species - so that the sample could be assumed to be pure. 
Subsequently, for each alane, a range of samples were 
exposed to laboratory air for increasing times (testing every 
15 minutes). Their 'handling time' was defined as the period 
when >90% of the alane purity remained by hydrogen 
evolution. For comparison lithium aluminium hydride was also 
tested which remained >90% for at least 3 hours (Table 7). 
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Table 7 handling time of dichloroalane adducts 
Entry Alane Handling time (min)a 
1 LiAlH4 >3 h 
2 68 30 
3 70 45 
4 99 30 
5 100 <15 
6 102 15 
7 [HAl(OtBu)2]2 30
b 
8 HAl(NiPr2)2 30
b 
 a) Handling time is defined as the period when the alane is 90-100% 
pure; b) carried out by Dr. A. Vinogradov, personal communication. 
 
 The results showed that none of the dichloroalane 
adducts, or di-t-butoxyalane and diisopropylamidoalane were 
as air stable as lithium aluminium hydride, which has an 
appreciably long handling time (entry 1). However, all of these 
alanes showed increased air-stability compared to 
diisobutylaluminium hydride (pyrophoric). When the polymeric 
dichloroalane (dioxane) adduct (70) was tested the handling 
time was 45 minutes (entry 3); presumably its improved 
stability is due to its polymeric nature. Dichloroalane adducts 
of bis(tetrahydrofuran) 68, (DABCO) 98 and also di-t-
butoxyalane all showed increased handling times of 30 
minutes (entries 2, 4 and 7). Dichloroalane (diglyme) adducts 
showed a small level of air-stability (entry 6) whereas the N-
methylmorpholine adduct showed very little air stability and 
was hydrolysed in air in less than 15 minutes (entry 5). 
Dichloroalane adducts 68, 70 and 99, as well as di-t-
butoxyalane and diisopropylamidoalane, could all be stored 
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under standard Schlenk conditions under argon. Their 
increased air-stability allows these reagents to be promptly 
weighed out on the bench without any special protocols for 
one off reactions. 
 For comparison, the dibromoalane•bis(tetrahydrofuran) 
adduct was also prepared. However, a different route to that 
used for dichloroalane•bis(tetrahydrofuran) was needed due 
to the solubility of the lithium bromide by-product in diethyl 
ether. Dibromoalane•bis(tetrahydrofuran) was prepared by 
pre-forming the alane etherate adduct which could be 
separated from lithium chloride via cannula filtration, prior to 
ligand redistribution upon addition of aluminium tribromide 
(Scheme 33). The melting point of this adduct was lower than 
the chloride adduct (58-60 oC compared to 74-76 oC).  
 
Scheme 33 Synthesis of dibromoalane•bis(tetrahydrofuran).  
Although dichloroalane adducts 68, 70 and 99, di-t-
butoxyalane and diisopropylamidoalane all showed somewhat 
increased air-stability, dichloroalane•bis(tetrahydrofuran) 68 
was taken forward to use in the rest of our studies. This choice 
was based on: convenience of synthesis, its low molecular 
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weight, and the compatibility of tetrahydrofuran with many 
catalytic processes. 
2.3.1.2 Summary of alane synthesis 
 
 Dichloroalane derivatives are shown to be somewhat air-
stabilised aluminium hydrides which are easily accessible on 
large scales (up to 50 grams) (Figure 26). It is possible to 
weigh these reagents on the bench and to still use them 
without loss of alane activity - provided this is done promptly. 
 
Figure 26 Dichloroalane•bis(tetrahydrofuran) in air (left) vs. 
neat diisobutylaluminium hydride in air (right). 
 
2.3.2 Hydroalumination of alkynes 
 
With conditions in hand to synthesise large quantities of 
dichloroalane•bis(tetrahydrofuran), the hydroalumination of 
terminal alkynes was explored. Conditions to generate the 
corresponding alkenylalane dichloride with optimal regio- 
chemo-selectively and high yield needed to be found. A range 
of transition metals, which have previously found to be 
effective in hydroalumination chemistry, was screened via a 
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high throughput gas chromatography procedure. The 
hydroalumination of 1-decyne with 
dichloroalane•bis(tetrahydrofuran) was employed, to see what 
yields of the corresponding 1-decene could be achieved 
(Table 8). 
 
Table 8 hydroalumination catalyst screen.a 
Entry Catalyst 
Yield of 
decene (%)b 
Yield of 
decane (%)b 
0 none 6 1 
1 ZrCl4 51 23 
2 TiCl4.2THF 78 20 
3 Cp2TiCl2 85 13 
4 Cp2ZrCl2 86 13 
5 Cp*2TiCl2 80 1 
6 Cp*2ZrCl2 84 15 
7 Ni(dppp)Cl2 93 6 
8 Ni(PPh3)2Cl2 98 2 
a) reaction carried out on a 0.5 mmol scale; b) determined by GC with 
dodecane as internal standard after quench. 
 
 The results showed that without any catalyst present, a 
very low background reaction occurred. When tetrachloro 
derivatives of group 4 metals were used, moderate yields of 1-
decene was obtained with moderate levels of over reduction 
(entries 1 and 2). Near quantitative yields of 1-decene was 
obtained when nickel catalysts were used (entries 7 and 8), 
with only small amounts of over hydroalumination to decane 
observed. High yields of 1-decene were observed when 
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cyclopentadienyl derived substituents were present on the 
catalyst with higher amounts of over reduction compared to 
the nickel catalysts (entries 3 to 6).  
To evaluate the regioselectivity of the hydroalumination, the 
reaction was quenched with deuterium oxide. 2H{1H} NMR 
studies revealed the point(s) of attachment of any aluminium 
organometallic formed through the hydroalumination catalysis. 
As the 2H NMR spectrum was proton decoupled, trials showed 
that relative integration of the remaining singlets was an 
excellent way to monitor chemo and regioselectivity (Table 
9). Extensive studies of nickel(II) pre-catalysts were avoided 
due to several reports and our own preliminary studies 
indicating that when nickel catalysts are used, such reactions 
frequently provide low levels of deuterium incorporation. This 
is attributed to a radical hydrogen abstraction from the 
tetrahydrofuran resulting in the corresponding reduced 
product, but not the formation of the required 
alkenylaluminium reagent.  
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Table 9 Regioselectivity of hydroalumination determined by 
2H NMR.a 
Run Catalystb (E)-
109 
(Z)-
109 
110  111 112 113b 
1 Cp2TiCl2  
(5 mol%) 
53 2 0 42 1 2 
2 Cp2ZrCl2  
(5 mol%) 
74 0 15 5 5 0 
3 Cp*2TiCl2  
(5 mol%) 
75 3 0 6 14 3 
4 Cp*2ZrCl2 
(5 mol%) 
87 0 1 2 7 3 
5 Cp*2ZrCl2 
(2 mol%) 
82 0 0 2 11 2 
6 Cp*2ZrCl2 
(1 mol%) 
82 0 0 2 15 2 
7 Cp*2ZrCl2 
(0.5 mol%) 
75 0 0 3 18 3 
a) Reactions carried out on 1 mmol scale; b) By 2H{1H} NMR spectroscopy 
on D2O quenched reaction mixture. 
 
 
 What was pleasing to note from this procedure was the 
results observed were in agreement with the catalyst screen in 
Table 8. Titanocene dichloride was highly active but showed 
poor regioselectivity leading to high quantities of 111 (entry 
1). Simple zirconocene dichloride inhibited the activity, 
providing poorer and variable conversions but all with high 
regioselectivity favouring (E)-109 but significant amount of 
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acetylide 110 was also detected (entry 2). Speculation into 
this variable conversion could be due to the formation of 
stable dichloroalane adducts, perhaps related to Cp2Zr(-H)(-
H2AlCl2)ZrCp2. 
Bis(pentamethylcyclopentadienyl)titanium dichloride had two 
undesirable features: firstly, with dichloroalane it gave unclean 
reactivity generating (Z)-109, 111, 112, 113 and hydrogen 
transfer products (entry 3); secondly, its literature preparation 
is problematic and low yielding leading to very uninviting costs 
for its purchase. Fortunately, 
bis(pentamethylcyclopentadienyl)zirconium dichloride pre-
catalyst is highly potent for terminal alkyne hydroalumination 
using dichloroalane (entry 4), the only significant by-product 
being some 112. It is also noted that the amount of catalyst 
for this transformation could be decreased to 1 mol percent 
without any significant drop in conversion and regioselectivity 
(entries 5 and 6), However, when 0.5 mol percent catalyst 
was used the regioselectivity decreased to 75% with increased 
amounts of the over reduction product 112 (entry 7). 
2.3.2.1 Palladium catalysed Negishi coupling 
 
 Having a protocol in place for the highly regioselective 
formation of (E)-alkenylalanes, conditions were explored in 
order to apply these reagents in cross-coupling. Fortunately, 
very little optimisation was required for this protocol, as the 
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conditions that were optimal were analogous to the cross-
coupling of DABAL-Me3.
80  When carrying out the initial 
screening on the cross coupling of styrylaluminium dichloride 
the addition of DABCO to form the DABAL-(alkenyl)Cl2 reagent 
in situ led to a maximised yield of the desired (E)-product 
(Table 10).  
 
Table 10 A screening of additive effects.a 
Entry Additive Yield (%)b 
1 None 81 
2 DABCOc 94 
a) reaction performed on a 2 mmol scale; b) determined by GC; c) 0.5 
equiv used with respect to alkyne. 
  
 Satisfyingly, the presence of neither the zirconium 
catalyst nor small amounts of 112 inhibited the coupling and 
the presence of a co-activator was not required.  
 
2.3.2.2 Scope and limitation of alkenylalane 
 
The generality of this optimal procedure with a range of 
alkynes was next tested (Scheme 34). 
102 
 
 
Scheme 34 Alkenylalane screen in palladium-catalysed cross-
coupling reaction. 
 The results showed that alkynes which are typically 
problematic under diisobutylaluminium hydride 
hydroalumination (i.e. those which contain acidic protons or 
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halides), underwent hydroalumination with dichloroalane and 
subsequent cross-coupling which yielded the alkenylarenes, 
115, 116, 117 and 118 in good to moderate yields (up to 
94%). Alkyl alkynes underwent tandem 
hydroalumination/cross-coupling giving the expected products 
in excellent yields. Non-branched alkynes produced coupled  
products in up to 98% yield (119 and 120) and alkynes which 
contained different levels of branching were also coupled in 
excellent yields (121, 122 and 123). When alkynes bearing 
pendent alcohol groups were subjected to hydroalumination 
with 1.5 equivalents of dichloroalane•bis(tetrahydrofuran), 
with respect to the alkyne, under 
bis(pentamethylcyclopentadienyl)zirconium dichloride catalysis 
followed by cross-coupled with bromobenzene the major 
product that was isolated was the olefin. This arises from 
alkyne hydroalumination but without any subsequent cross-
coupling. When the amount of alane was doubled to 3 
equivalents, the cross-coupling took proceded in the presence 
of an indium(III) chloride co-catalyst, 125 was isolated in 
61% yield. The indium(III) chloride was chosen as it had been 
previously used for the cross-coupling of alkenylalanes with 
successful results but its role is unknown. When the benzyl 
protected alkynol was used product 124 was obtained in 75% 
yield with only 1.5 equivalents of dichloroalane. When the 
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pivolyl ester and the nitrile functionalised alkynes were 
employed, none of the desired products were obtained. In the 
case of the pivolyl ester, only the free alkynol was observed, 
which indicated that the rate of ester cleavage is greater than 
the rate of catalysed hydroalumination. In the case of the 
nitrile alkyne, no reaction was observed in the 
hydroalumination reaction which might be attributed to the 
formation of a Lewis base adduct with the zirconium catalyst 
deactivating it.   
2.3.2.3 Scope and limitations of electrophilic coupling 
partner 
 
 The generality of the optimal procedure was examined 
using (E)-octenylaluminium dichloride as a fixed nucleophilic 
coupling partner with various aryl and heteroaryl halides 
(Scheme 35). 
 Aryl bromides that contain other potentially electrophilic 
centres such as esters, nitriles and nitro- groups all underwent 
cross-coupling in excellent yields (up to 95%). However, the 
nitro substituted aryl halide gave 129 in lower yields (55%). 
When the position of the nitrile substituent was altered, the 
yield of the product was not affected (131 and 132). When 
aryl halides that contain carbonyl groups more reactive than 
an ester moiety were used, none of the desired cross-coupled 
product was observed. Aryl halides containing slightly 
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electron-donating groups with different levels of steric bulk 
also underwent cross-coupling, producing the desired products 
in excellent yields (up to 99%). When the position of the alkyl 
substituent was explored, high yields were still observed 
(133, 134 and 135).  
 
Scheme 35 Aryl bromide screen for the cross-coupling of 
alkenylalanes. 
When aryl halides containing a nucleophilic centre were 
screened, 138 was obtained in good yields with no biaryl self-
coupled product observed. 
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 The use of heteroaryl halides in the Negishi cross-
coupling of alkenylalanes is underrepresented in the literature, 
therefore to see the generality of the cross-coupling such 
systems were explored (Scheme 36).  
 
Scheme 36 Hetero-aryl bromide screen in the cross-coupling 
reaction. 
Oxygen and sulfur containing heterocycles underwent cross-
coupling in good to excellent yields, with the 3-substituted 
heterocycles producing the desired product in higher yields 
than the corresponding 2-halo heterocycle. However, the cross 
coupling of nitrogen containing heterocycles required further 
optimization due to the Lewis basicity of the nitrogen moieties. 
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Amines and pyridine functionalities are known to able to 
complex the alkenylaluminium reagents strongly, potentially 
deactivating at least one equivalent of the alane. It was found 
that the cross coupling of 3-bromopyridine with 1.4 
equivalents of octenylalane gave a low yield, but when 2.1 
equivalents of (E)-octenylalane was used, a more synthetically 
useful yield of 3-octenylpyridine was achieved (63%, 142). 
The cross coupling of other nitrogen containing heterocycles, 
such as isoxazoles (143) thiazoles (144), indoles (145) and 
quinolines (146), with 2.1 equivalents of alkenylalane, all 
proceeded in high yields but indium trichloride (10 mol%) was 
required as a co-catalyst. 
Like the nitrogen containing heterocycles, vinyl halides 
proved to be particularly challenging, yielding only 7% of the 
desired product. When indium chloride was used as the co-
catalyst again, the reaction proceeds in a cleaner fashion 
yielding the corresponding diene in 63% yield (Scheme 37). 
Benzylic halides on the other hand reacted cleanly under the 
optimised conditions to form the allylated arene in excellent 
yields (up to 92%). 
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Scheme 37 Cross-coupling to vinyl halides and benzyl 
bromides. 
To see how our dichloroalane tandem protocol fared against 
the literature procedures, it was compared against the 
traditional hydroalumination-cross-coupling protocol using 
diisobutylaluminium hydride (Figure 27). In this comparison, 
only the aluminium hydride was changed and the cross-
coupling reagents kept the same. 
 
Figure 27 Comparison of hydroalumination procedures. 
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The results showed that the hydroalumination carried 
out using dichloroalane led to higher chemical yields in all 
cases compared to Negishi’s diisobutylaluminium hydride 
hydroalumination. In particular, the hydroalumination of 
phenylacetylene using diisobutylaluminium hydride, led to 
large amounts of the alkynyl-cross coupled product (up to 
30%) under Negishi's conditions.  
 
  
110 
 
2.3 Conclusions 
  
Adducts of dihaloalanes, mainly dichloroalane and 
dibromoalane can be synthesised with relative ease in a two 
step process starting from commercial lithium aluminium 
hydride and aluminium trihalide (X = chloro and bromide). 
High yields and an ability to work on large scales (up to 50 
grams) characterise this procedure. These alanes exhibit low 
pyrophoricity with effective handling times of up to 30 minutes 
in air, meaning that they can be weighed out promptly on the 
bench without the need for special techniques. 
 Hydroalumination of terminal alkynes proved most 
effective with the previously unused catalyst, 
decamethylzirconocene dichloride, which generated the (E)-
alkenylalanes in high yields with excellent regio- and 
stereochemistry with minimal acetylide formation.  
 The tandem hydroalumination/palladium cross-coupling 
reaction of acetylenes was also been explored in great detail, 
with the (E)-selective alkenylalane cross-coupling, under 
palladium catalysis in the presence of DABCO, with various 
aryl halides, sulfur, oxygen and nitrogen containing 
heterocycles, vinylic and benzylic bromides all proceeding in 
high yields. 
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Chapter 3 
 
 
 
 
Conjugate addition of 
alkenylaluminum reagents 
to α,β-unsaturated carbonyl 
compounds 
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3.1 Introduction 
 
3.1.1 Conjugate addition to diactivated 
carbonyls 
 
 The introduction of a second electron withdrawing group 
at the 1'-position of an α,β-unsaturated carbonyl compound 
significantly increases its reactivity towards catalytic conjugate 
addition of dialkylzinc and trialkylaluminium species. Feringa 
in 2004 showed that this is indeed the case, by adding a 
suitable protecting/activating group to the nitrogen of α,β-
unsaturated lactams (29), the addition of dialkylzincs, under 
copper catalysis in the presence of L2,  yielded 147 in good 
yields (up to 70%) with excellent enantioselectivity (up to 
95% ee) (Scheme 38).81  
 
Scheme 38 1,4-addition of dialkylzinc to lactams. 
 Thus far, only alkyl organometallic reagents and 
relatively unreactive allylsilanes 82  have been employed 
successfully in the enantioselective conjugate addition to 1,1'-
diactivated enones.  
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 Alexakis investigated the copper-catalysed ACA of 
dialkylzinc reagents to alkylidene malonates 148. 83  In the 
presence of copper(II) triflate and ligand L40, the 1,4-addition 
products 149 were obtained in good to excellent yields with 
enantioselectivies ranging between 64-73% (Scheme 39a). 
When triethylaluminium was used instead of diethylzinc, no 
enantioselectivity was observed. Feringa also investigated the 
copper-catalysed conjugate addition to alkylidene malonates 
using dimethylzinc in the presence of copper(II) triflate and 
ligand L2. The 1,4-adducts were obtained in good to excellent 
conversions with excellent enantioselectivity up to 98% 
(Scheme 39b).84 
   
Scheme 39 1,4-addition of ZnR2 to alkylidene malonates. 
 Woodward and co-workers investigated the copper-
catalysed conjugate addition of organoalanes to 3-
acylcoumarins. 85  In the presence of copper(II) acetate 
monohydrate and L6, the 1,4-addition product was obtained 
in high yields (up to 94%) with good to excellent 
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diastereoselectivity (up to 99:1) and enantioselectivity (up to 
96%) (Scheme 40). 
 
Scheme 40 1,4-addition of trialkylaluminium to 3-
acylcoumarins. 
Within this work, the addition of alkenylalanes, derived from 
the hydroalumination of alkynes with diisobutylaluminium 
hydride, to acylcoumarins was also investigated. This reaction 
proceeds in good to excellent yields but with no 
enantioselectivity. The lack of enantioselectivity was attributed 
to the high background reaction due to the higher reactivity of 
the sp2-hybridised carbon atom compared to an sp3 carbon. 
 Apart from this report, there are very few reports of the 
conjugate addition of alkenyl organometallics to 1,1'-
diactivated enones. In the early 1990s, Knochel and Cahiez 
investigated the conjugate addition of stoichiometric 
alkenylcopper reagents to alkylidene malonates (Scheme 
41). 86  The 1,4-addition products 153 were synthesised in 
excellent yields. 
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Scheme 41 1,4-addition of alkenylcopper to alkylidene 
malonates. 
 Recently (2013), Alexakis and co-workers have shown 
that it is possible to add a series of alkenylalanes, derived by 
transmetallation and hydroalumination, to α,β-unsaturated 
lactams 29. 87  In the presence of 10 mol% 
copper(II)naphthenate and SimplePhos ligand (R,R)-L10, 
moderate to good yields of the 1,4-adduct 154 were achieved 
(30-70%) with good to excellent enantioselectivies (up to 
90%) (Scheme 42).  
 Scheme 42 conjugate alkenylation of lactams. 
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3.1.2 Uncatalysed conjugate addition of 
alkenylalanes to enones 
  
The first use of alkenylalanes, synthesised via 
hydroalumination, in conjugate addition was reported by Hooz 
and co-workers.88 It was noted that only enones which could 
adopt the cisoidal conformation were active towards conjugate 
addition (Scheme 43). When enones such as cyclohexenone, 
which adopt the transoidal conformation, were used, the 
conjugate addition was inefficient. 
Scheme 43 1,4-addition to cisoidal enones. 
This difference in reactivity between the cisoidal and transoidal 
conformations of enones is attributed to the formation of a 
six-membered transition state. This transition state is only 
possible for enones which are able to adopt the cisoidal 
conformation. The postulated transition state also explains 
why the reaction proceeds in non-coordinating or weakly 
coordinating solvents, because solvents such as 
tetrahydrofuran, coordinate to the aluminium strongly and 
prevent the coordination of the carbonyl moiety therefore 
completely suppressing the reaction. 
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 The first conjugate addition of an alkenylalane to a 
transoidal enone 1 was reported by Wipf, 89  where a 
stoichiometric amount of an elaborate higher order acetylene 
based cyanocuprate was used to achieve good regioselectivity 
and yields (up to 95%) of the 1,4-addition adduct 157 
(Scheme 44).  
 
Scheme 44 1,4-addition to transoidal enones. 
3.1.3 Copper-catalysed conjugate addition of 
alkenyl organometallics 
 
This section covers reported examples of copper-catalysed 
conjugate addition of alkenyl organometallics to enones and is 
divided according to the organometallic nucleophile. Although 
there are numerous examples of rhodium-catalysed conjugate 
addition of alkenyl organometallics, they will not be discussed 
within this section as they are not a topic of this thesis and an 
excellent recent review is available .90 
3.1.3.1 Alkenyl magnesium reagents 
 
Lippard and co-workers, 91  reported in their seminal 
work, the addition of vinylmagnesium bromide to 
cyclohexenone, using a preformed copper(I) complex 159, to 
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yield the 1,4-adduct in 92% isolated yield but with only 9% 
enantioselectivity (Scheme 45). 
Scheme 45 ACA of vinylmagnesium bromide. 
 Schmalz and co-workers, a couple of decades later, 
reported the first highly enantioselective copper-catalysed 
addition of prop-1-en-2-ylmagnesium bromide to 1.92 In this 
work, it was noticed that a phosphine-phosphite ligand based 
on TADDOL L41 in the presence of copper(I) bromide 
dimethyl sulfide yielded the 1,4-adduct 160 with high 
enantioselectivity, 92%, but only moderate yield, 49%. An 
important discovery was the use of 2-methyltetrahydrofuran 
as solvent, which led to higher enantioselectivities compared 
to other ethereal solvents. Furthermore, the same author 
noted that the conjugate addition of prop-1-en-2-
ylmagnesium bromide to both cyclopentenone and 
cycloheptenone could also be achieved in good yields (53 and 
62% respectively) and enantioselectivity (up to 89%) 
(Scheme 46). 93  The addition of trimethylsilyl chloride was 
crucial in the conjugate addition to cyclopentenone to obtain 
good yields, reducing the propensity of the enolate generated 
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to undergo conjugate addition with another molecule of 
cyclopentenone. 
 
Scheme 46. ACA of alkenyl Grignard reagents. 
3.1.3.2 Alkenyl Silicon reagents 
 
 The only report of a copper-catalysed conjugate addition 
of alkenylsilanes is from Hoveyda.94 The alkenyltrifluorosilanes 
were synthesised via a two step procedure i) platinum-
catalysed hydrosilylation using trichlorosilane, followed by ii) 
treatment with sodium fluorosilicate to synthesise the 
corresponding trifluorosilane in good overall yields (Scheme 
47). 
 
Scheme 47 Synthesis of alkenyltrifluorosilanes. 
Hoveyda showed that these alkenylsilanes can undergo 
conjugate addition in the presence of a copper-NHC complex, 
generated from copper(I) bromide and chiral NHC (L42), to 
generate the conjugate addition products 162-165 in good 
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yields (up to 97%) and moderate to high enantioselectivities 
(up to 92%) with the highest enantioselectivities being 
achieved for cycloheptenone and cyclooctenone (Scheme 48). 
The addition of a fluoride source, 
tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF), 
was required to activate the alkenyltrifluorosilane by 
generating a reactive pentavalent silicon species analogous to 
the Hosomi-Sakurai reaction. The transmetallation of this 
activated alkenylsilane onto copper is facile.   
Scheme 48 Copper-catalysed ACA of alkenyltrifluorosilanes. 
3.1.3.3 Alkenyl aluminium reagents 
 
 As mentioned in Chapter 2, alkenylalanes are readily 
accessible via three main synthetic methods i) 
carboalumination, ii) hydroalumination and iii) lithium-halogen 
exchange.  
 Alexakis, Woodward and co-workers reported the first 
enantioselective conjugate addition of alkenylalanes to 
cyclohexenone and cycloheptenone, by a tandem 
carboalumination-ACA procedure. Moderate yields, up to 54%, 
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and enantioselectivities, up to 77%, of the addition products 
166 and 167 could be achieved using 
copper(I)thiophenecarboxylate in combination with 
phosphoramidite L2. 95 a The enantioselectivity could be 
increased, to 85%, when copper(I)thiophenecarboxylate was 
used in combination with chiral ferrophite (L43) (Scheme 
49).95b It was also noted that the carboalumination catalyst 
(zirconocene dichloride) did not interfere with the conjugate 
addition. 
  
Scheme 49 Tandem carboalumination-ACA protocol. 
 The first example of conjugate addition of an 
alkenylalane to a trisubstituted enone, forming an all carbon 
stereogenic centre via a tandem hydroalumination-ACA 
protocol, was reported by Alexakis. It was found that when 
copper(I) thiophenecarboxylate was used in combination with 
L10, good enantioselectivies was achieved. The choice of 
solvent was critical, when diethyl ether was used, high 
enantioselectivities (up to 80%) were obtained but a 
significant amount of undesired 1,2-addition product was 
observed. When tetrahydrofuran was used in the presence of 
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copper(I)tetrakisacetonitrile tetrafluoroborate, no undesired 
1,2-product was obtained but a decrease in enantioselectivity 
to 73% ee was observed (Scheme 50). 
 
Scheme 50 first reported tandem hydroalumination-ACA. 
 A recent report from Alexakis and co-workers represents 
a new tandem hydroalumination-ACA protocol using 
phosphinamine ligands. When these electron rich ligands are 
used in the presence of copper(II) naphthenate, the reaction 
proceeds with excellent regio- (up to 91% 1,4-adduct) and 
enantioselectivity (up to 89%).96 Also in this report, the use of 
co-activation with trimethylaluminium was noted for the first 
time, which was crucial when sterically demanding 
alkenylalanes are used. A wide variety of both E and Z-
alkenylalanes could be used in this protocol as well as - and 
-substituted alkenylalanes (Scheme 51), which were 
generated via the nickel catalysed hydroalumination.97     
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Scheme 51 Modified tandem hydroalumination-ACA. 
 What is noticeable within these reports is that a higher 
catalyst loading is required for the conjugate addition of 
alkenylalanes compared to alkylalanes, this could be due to 
trace amounts of aluminium acetylides, produced as an 
unwanted side product in hydroalumination, which could 
poison the copper-catalyst by acting as a dummy ligand after 
transmetallation from aluminium to copper.98 
 One approach to avoid the formation of the problematic 
aluminium acetylides was reported by Hoveyda and co-
workers.99 This strategy involved the clean hydroalumination 
of silyl-protected alkynes without the formation any aluminium 
acetylides. A strongly donating sulfone-based NHC-copper 
complex, generated from the corresponding silver carbene 
complex L37, was able to promote the conjugate addition of 
these alkenylalanes, in moderate to high yields (up to 95%) 
with excellent enantioselectivities (up to 97%), in short times 
(0.25 h) and at room temperature (Scheme 52). 
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Scheme 52 ACA of silicon substituted alkenylalanes. 
 This methodology is very general; both in terms of the 
alkenylalane, with aryl-, alkyl- and conjugated alkynes all 
being compatible, and also enones, in particular, the addition 
to notoriously difficult cyclopentenones proceeds with 
excellent yields of 1,4-products 169-171. However, for the 
addition to cyclohexenones, lower chemical yields of the 
desired products 172-175 were obtained due the transfer of 
the iso-butyl group (up to 33%) and additions to 
cycloheptenones were inefficient (conv. up to 40%), thought 
to be attributed by steric hindrance by the silicon moiety. 
 Another approach to avoid the formation of aluminium 
acetylides is to synthesise the alkenylalanes via a halogen-
lithium exchange followed by transmetallation. The first 
reported use of alkenylalanes generated via this sequence in 
conjugate addition chemistry was by Alexakis and co-workers, 
where (E)-1-iodohexene underwent treatment with n-
butyllithium to generate the alkenyllithium reagent, which 
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subsequently transmetallated onto diethylaluminium chloride 
to furnish the corresponding alkenylalane.100 The formation of 
the alkenylalane required very precise temperature control. 
When the alkenylalane was used in conjugate addition, with 
copper(I) thiophenecarboxylate in combination with 
phosphoramidite L7, the 1,4-adduct 176 with synthesised 
with good optical purity (82%) in excellent yield (93%). It 
should be noted that the catalyst loadings could be reduced 
from 30 mol% in the early attempts to 10 mol% (Scheme 
53). 
 
Scheme 53 ACA of alkenylalanes generated from alkenyl 
iodides. 
As only a few alkenyliodides are commercially available, the 
procedure was modified so that alkenylbromides (for which 
there is greater commercial availability) could be used. 
Alexakis and co-workers treated the alkenylbromides with t-
butyllithium in diethyl ether; this was followed by a 
transmetallation onto dimethylaluminium chloride to yield the 
corresponding alkenylalane.101  The stoichiometry between t-
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butyllithium and dimethylaluminium chloride is critical as an 
excess of either reagent decreases the enantioselectivity of 
the 1,4-addition product, therefore the alane solution was 
stirred at room temperature for 18 h to ensure complete 
conversion to the alkenylalane.  It was found that copper(I) 
thiophenecarboxylate in the presence of phosphinamine L6, 
would efficiently add these alkenylalanes to 3-methyl-2-
cyclohexenone to generate the 1,4-adduct in good yields with 
excellent optical purity. Other Michael acceptors were also 
tried but either low conversion of low enantioselectivity was 
observed (Scheme 54). 
 
Scheme 54 ACA of alkenylalanes derived from 
alkenylbromides. 
 Recently, it was shown that both hydroalumination and 
transmetallation protocols can be employed to the addition to 
N-substituted-2,3-dehydro-4-piperidones.102  Alexakis and co-
workers showed, that under a catalyst system of 
Cu(II)naphthenate  and ligand L6, good to moderate yields of 
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the 1,4-adduct could be obtained in excellent 
enantioselectivities (up to 97%). The corresponding 
piperidones can be used as precursors to pharmaceutically 
active piperidines and alkaloids (Scheme 55). 
Enantioselective addition of alkenylalanes generated from 
vinylmagnesium bromide was also reported for the first time. 
 
Scheme 55 ACA to N-substituted-2,3-dehydro-4-piperidones. 
 An efficient and practical approach for the conjugate 
addition of sterically encumbered alkenyl alanates to 
trisubstituted enones, to generate highly congested 
quaternary stereogenic centres, such as 177 in good yields 
(up to 63%), was reported by Alexakis and co-workers.103 The 
alkenyl alanates are generated in high yields via a nickel-
catalysed hydroalumination of alkynes to generate internal 
alkenylalanes, which are subsequently reacted with 
methyllithium.  Cis-decalin systems can be synthesised from 
the conjugate addition product 177 by treatment with 
potassium hydride, resulting in a simple preparation of these 
bicycles (Scheme 56). 
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Scheme 56 Conjugate addition of alkenyl alanates. 
3.2 Aim of research  
  
The success of alkenylaluminium dichlorides in palladium 
catalysed cross-coupling caused us to consider their use in 
other metal-promoted transformations, in particular 1,4-
additions to Michael acceptors. What particularly caught our 
attention was the under-representation of the conjugate 
addition of alkenyl nucleophiles to 1,1'-diactivated enones, 
particularly alkylidene malonates. Also noted was the lack of 
use of alkenylalanes in the conjugate addition to simple 
enones, such as cyclohexenone. Inspired by this lack of 
literature, we wondered if our alkenylaluminum reagents 
(generated via the methodology developed in Chapter 2) could 
contribute to these problems in alkenyl additions to such 
classes of Michael acceptors (Scheme 57). 
 
Scheme 57 Objectives of this work. 
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3.3 Results and discussions  
3.3.1 Conjugate addition to alkylidene 
malonates 
  
It is known that many conjugate addition reactions to 
1,1'-diactivated enones are extremely facile. It is known that 
organoaluminium dihalides are extremely strong Lewis acids 
and this should promote any reaction. Our initial investigations 
focused on the effect of temperature on the addition of (E)-
octenylaluminium dichloride (179) to dimethyl 2-
ethylidenemalonate (180) to see if any background reaction 
could be minimised (Table 11). Diethyl ether was chosen as 
solvent for this screening due to the literature precedent for 
its use in conjugate additions to acylcoumarins.85  
 
Table 11 Temperature effects in alkenylalane addition to 
alkylidene malonates.a 
Entry Temperature oC Isolated yield % 
1 0 76 
2 -20b 51 
3 -40b 50 
4 -78 48 
a) reaction carried out on a 0.5 mmol scale; b) temperature controlled 
using a cryostat.   
 Although the background reaction was suppressed 
slightly by decreasing the temperature of the reaction mixture 
130 
 
(entry 1-4), the amount of product obtained in this non-
catalytic reaction was still around 50% even at -78 oC, 
indicating that even at low temperatures the background 
reaction is facile. When the solvent was changed from diethyl 
ether to more coordinating solvents such as tetrahydrofuran 
and 1,4-dioxane at -40 oC, 181 was obtained in similar yield 
as in diethyl ether (51% and 49% respectively). In order to 
try and decrease the Lewis acidity at the aluminium centre 
and thus minimise the background reaction, other Lewis base 
additives were screened (Table 12). 
 
Table 12 Effect of Lewis base on background reaction.a 
Entry Additive Isolated yield % 
1 Tetrahydrofuranb 51 
2 1,4-dioxaneb 49 
3 DABCOc 46 
4 N-methylpyrrolidine 52 
5 N-methylmorpholine 49 
a) reaction carried out on a 0.5 mmol scale; b) used as solvent; c) 0.5 
mmol used to form a 2:1 adduct with organoalane. 
Unfortunately, even when nitrogen containing Lewis bases 
were used, 181 was obtained in similar yields (entry 3-5). 
This suggests that the chelating carbonyl moieties are better 
at coordinating an aluminium centre, thus making the 
alkylidene malonate more electrophilic and consequently the 
background reaction more facile. What was interesting was 
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the yield obtained for N-methyl morpholine and 1,4-dioxane 
was the same, and this could be due to aluminium being 
chelated by the substrate hence binding to the oxygen rather 
than the nitrogen sites. Due to the unsuccessful attempts to 
minimise the background reaction, the racemic reaction was 
optimised at 0 oC in diethylether to see what functional groups 
could be tolerated (Scheme 58). 
 
a) reaction carried out by Marc Garcia.104 
Scheme 58 1,4-Addition to alkylidene malonates by 
alkenylalanes. 
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 The results showed that both linear and branched alkyl 
substituents on the alkylidene malonate were well tolerated, 
producing 181, 182, 183 and 185 in good yields. Strained 
cyclopropyl substituents were also tolerated in good to 
excellent yields (compounds 184 and 186) with both a 
sterically demanding alkenylalane and a linear non-branched 
alkenylalane. Aryl substituents on the alkylidene malonates 
were tolerated with both alkenylalanes giving 187 and 189 in 
65% and 63% yield respectively. However, when electron-
donating substituents were added to the aryl ring in the para-
position, a lower yield was observed of 48% (188). 
Substituents with a strong positive mesomeric effect, such as 
a methoxy group in the para-position, were not tolerated in 
the reaction leading to low yields of an inseparable mixture of 
compounds.  
Conversely the addition of an electron-withdrawing group in 
the electronically disconnected meta-position led to good 
yields of 190 being isolated. When the aromatic moiety was 
changed from a phenyl derivative to a 2-thiophene group, this 
compound had very low reactivity towards the alkenylalane, 
with the corresponding product 191 being isolated in only 
16% yield. Because of the high propensity of alkylidene 
malonates to show background reactions, attention was 
switched to less activated substrates. 
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3.3.2 Copper-catalysed conjugate addition of 
alkenylalanes  
3.3.2.1 Initial findings 
  
To begin our investigation into whether 
alkenylaluminium dichlorides were competent nucleophiles in 
the copper-catalysed conjugate addition to non-activated 
enones, the reaction of 179 with 2-cyclohexenone 1 at -30 oC 
in diethyl ether was used as the model system (Table 13). 
The temperature was chosen based on previous additions of 
alkenylalanes to cyclohexenone.95  
 
Table 13 Initial screening of conditions for addition to 
cyclohexenone.a 
Entry Cu cat. Conversion %b Yield %b 
1 none 0 0 
2 Cu(OAc)2 44 <1 
3 Cu(OAc)2.H2O 54 1 
4 CuTC 58 <1 
5 Cu(OTf)2 60 <1 
6 Cu(MeCN)4BF4 47 <1 
7 CuBr.SMe2 78 1 
8 Cu(II)Np 81 <1 
a) reaction carried out on a 0.5 mmol scale; b) determined by GC using 
dodecane as internal standard. 
 
 The results showed that in the absence of a catalyst, no 
background reaction occurred (entry 1). However, when a 
copper pre-catalyst was added in the presence of (S,R,R)-L2 
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the conversion of starting material increased dramatically (up 
to 81%), but the yield of 192 was extremely low in all cases 
resulting only in polymerisation products (entries 2-8). The 
lack of reactivity in run 1 may be due to the electron-
withdrawing ability of the chlorides, resulting in a 
strengthening of the aluminium-carbon bond. Similarly the 
high conversion of 1 was attributed to its Lewis acid catalysed 
polymerisation. To overcome the lack of reactivity of 179, the 
nucleophilicity of the alkenylalane needed to be increased and 
its Lewis acidity modified. To increase the reactivity one of the 
chlorine atoms on the aluminium centre was exchanged with a 
methyl group. A methyl group was chosen because it is 
effectively a non-transferrable group on aluminium (D(Al-Me) 
is 68 kcal mol-1) and the organometallic reagents for carrying 
out the exchange are readily available. To see if this new 
reagent was a competent nucleophile, the reaction shown in 
Table 13 was explored using copper(I)thiophenecarboxylate 
(10 mol%) as the copper source (Table 14). 
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Table 14 Mixed alane addition to cyclohexenone.a 
Entry Temperature 
(oC) 
MeMet. Conv. 
(%)b 
Yield 
(%)b 
ee 
(%)b 
1 -30 MeLi (1.0 equiv.) 96 2 n.d 
2 -30 MeLi (2.0 equiv.) 97 12 n.d 
3 25 MeLi (1.0 equiv.) 81 13 82 
4 25 MeMgBr (1.0 equiv.) - - - 
5 25 Me3Al (1.0 equiv.) 91 27 12 
6 25 MeLi (1.0 equiv.)c 90 33d 82 
a) reaction carried out on a 0.5 mmol scale; b) determined by chiral GC; c) 
reaction carried out for 1 h only; d) isolated yield. 
 The results showed again that the reagent derived from 
the addition of one equivalent of methyllithium to the alane 
mixture was unreactive in the conjugate addition at low 
temperature (Table 13 entry 1) meaning that the 
transmetallation from aluminium to copper is extremely slow 
at this temperature.  
Two equivalents of methyllithium were used to generate a 
similar reagent to that of Alexakis which was demonstrated to 
be an extremely competent nucleophile for the addition of an 
alkenyl group.101  Unfortunately, under the same conditions 
that were reported, the reagent in our hands gave high 
conversion but only 12% yield (entry 2). When the 
temperature was increased from -30 oC to +25 oC and one 
equivalent of methyllithium was used to generate the mixed 
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alane, the yield of 192 increased from 2% to 13% with an 
enantioselectivity of 82% (entry 3). If the organometallic 
reagent was changed from methyllithium to methylmagnesium 
bromide, no reaction occurred at all (entry 4), whereas 
changing to trimethylaluminium, the cheapest organometallic 
available, the conversion remained high and the yield 
increased to 27% but the enantioselectivity decreased 
dramatically to only 12% (entry 5). This decrease in 
enantioselectivity could be due to the cleavage of the BINOL 
backbone on (S,R,R)-L2 and generating an aminophosphine 
ligand. From these results it was concluded that methyllithium 
at +25 oC was the best temperature and organometallic and 
these conditions were taken forward. When the reaction 
conversion was monitored for the reaction it was found that 
after only one hour, 90% of the starting material had been 
consumed but only 33% of the desired product was isolated 
with the same enantioselectivity (82%) as for the 
corresponding reaction left for 16 hours. During the 
purification process of this reaction, a white solid was also 
isolated and it was revealed to be the cyclic tetramer of the 
unaccounted-for starting material (Scheme 59). These cyclic 
tetramers have been identified before in a methylaluminoxane 
promoted Schlenk equilibrium to generate diorganozinc 
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reagents which were subsequently used in conjugate 
addition.105 
 
Scheme 59 Formation of the undesired cyclic tetramer. 
 As can be seen from Scheme 61 the initial step is a 
copper-catalysed conjugate addition of the alkenylalane 
followed by a Lewis acid mediated Michael addition of the 
corresponding aluminium enolate onto another equivalent of 
cyclohexenone, where the enolate formed reacts further with 
an equivalent of cyclohexenone in Michael fashion. The final 
ring closure occurs via an aldol reaction of the enolate onto 
the ketone to generate a quite complex scaffold in a small 
number of steps. 
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3.3.2.2 Equivalents of alkenylalane  
 
Reports by Alexakis and co-workers noted that the 
number of equivalents of alkenylalane had an effect on the 
enantioselectivity. Due to this, use of a different number of 
equivalents of alkenylalane was considered (Table 15). Unlike 
the dramatic effects noted by Alexakis, the enantioselectivity 
of our model system did not show too much change between 
2.0 equivalents and 1.3 equivalents. This could be attributed 
to our hydroalumination protocol being clean with negligible 
amounts of acetylide produced, as well as the excess alkyne 
being removed prior to the addition of methyllithium, thus 
eliminating the formation of lithium acetylides and subsequent 
transmetallation onto the copper. However, it was observed 
that the yield of 192 actually increased with lower equivalents 
of alkenylalane (entry 1-3). 
 
Table 15 Effect of alkenylalane equivalents.a 
Entry Alane equiv. Conv. 
(%)b 
Yield 
(%)b 
ee. 
(%)b 
1 2.0 90 33 82 
2 1.5 93 37 82 
3 1.3 93 39 76 
a) reaction carried out on a 0.5 mmol scale; b) determined by chiral GC. 
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3.3.2.3 Effect of solvent on ACA of alkenylalanes 
 
 Encouraged by the results so far, we decided to screen 
several solvents, both coordinating and non-coordinating, for 
the copper-catalysed conjugate addition of 179 to substrate 1 
(Table 16). These results showed that, weakly coordinating or 
non-coordinating solvents had little effect of the 
enantioselectivity of the reaction (entries 3 and 4) However, 
toluene led to a higher yield of 192 compared to diethyl ether, 
possibly due to the formation of a more reactive species with 
little coordination from the solvent. When tetrahydrofuran was 
used as the solvent, the desired product was obtained in only 
12% yield and the product was racemic (entry 1). This could 
be attributed to the strength of the complex formed between 
tetrahydrofuran and the aluminium centre, leading to an 
inefficient catalyst of different structure. Although ethyl 
acetate did produce 192 in 20% yield, no enantioselectivity 
was observed (entry 2). The precise reason for the lack on 
enantioselectivity is unclear but it is likely due to similar issues 
as were seen with tetrahydrofuran. 
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Table 16 solvent screen.a 
Entry Solvent Conv. 
(%)b 
Yield 
(%)b 
ee. 
(%)b 
1 THF 92 12 0 
2 EtOAc 98 20 0 
3 Et2O 93 37 82 
4 PhMe 72 43 89 
5 PhMe/Et2O (1:1)
c 82 21 82 
6 PhMe/MTBE (1:1)c 67 54 84 
a) reaction carried out on a 0.5 mmol scale; b) determined by chiral GC; c) 
alane mixture dissolved in PhMe and copper mixture in diethylether or t-
butylmethyl ether. 
 
 When mixed solvent systems were tried, the alane 
hydroalumination was dissolved in toluene due to the results 
obtained (entry 4), whereas the copper mixture was dissolved 
in the ethereal solvent. It was found that both diethyl ether 
and t-butyl methyl ether led to high enantioselectivities 
(entries 5 and 6); however, the toluene/t-butyl methyl ether 
system gave far superior yields with lower conversion to the 
cyclic tetramer. When other non-coordinating solvents were 
tried in place of toluene such as n-hexane or n-heptane, the 
alkenylalane generated was completely insoluble making the 
mixture non-transferrable to the copper mixture. 
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3.3.2.4 Effect of addition mode on the ACA of 
alkenylalanes 
 
 In order to increase the yield of the 1,4-product and 
minimise the formation of the undesired tetracycle, we looked 
at changing the mode of addition for the reagents (Table 17). 
In the previous reactions we first added the alkenylalane 
mixture in toluene to the ethereal mixture of copper-salt 
followed by the Michael acceptor ("normal" addition). 
  
Table 17 Effect of addition mode.a 
Entry Addition mode Conv. 
(%)b 
Yield 
(%)b 
ee. 
(%)b 
1 Normalc 67 54 84 
2 Reversed 88 71 60 
3 Slow addition of enonee 68 66 76 
4 
Slow addition of  
enone and alanee 
57 20 90 
a) reaction carried out on 0.5 mmol scale; b) determined by chiral GC; c) 
alane the enone; d) enone then alane; e) added over 30 min. 
 
Interestingly, the addition of alkenylalane 179 to the catalyst 
and substrate ("reverse" addition) had an important effect on 
the yield of the corresponding product. Whereas the "normal" 
addition mode afforded 192 in 54% yield and 84% 
enntioselectivity (entry 1), the "reverse" addition increased 
the yield to 71% but a significant decrease in 
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enantioselectivity to 60% was observed (entry 2). When 1 
was added slowly over 30 minutes (syringe pump) to a 
mixture of the alkenylalane and copper catalyst, the 
conversion was similar to that observed in the "normal" 
addition; however, a higher yield of 66% was obtained but a 
lower enantioselectivity 76% was observed (entry 3). 
Compared to the "reverse" addition, the slow addition gives 
the product in lower yield but higher enantioselectivity, thus 
indicating that there are possibly different active copper 
species formed, one with higher catalyst activity but lower 
selectivity and another with lower activity but higher 
selectivity. The slow addition of both the enone and 
alkenylalane over 30 minutes led to a high level of 
enantioselectivity, 90%, but unfortunately a 20% yield was 
obtained with 37% 'missing mass' (entry 4). The result for the 
slow addition of both enone and alane makes the argument for 
different catalyst species stronger. 
3.3.2.5 Copper salt optimisation 
  
From previous studies on the conjugate addition of 
organoaluminium reagents, copper thiophene carboxylate 
gave the best enantioselectivities and yields of the 
corresponding 1,4-adducts, however other copper salts have 
successfully been used for the conjugate addition of alkenyl 
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nucleophiles. Therefore several copper salts were tested for 
their ability to promote the conjugate addition of our 
alkenylalane 179 (Table 18). 
 
Table 18 screen of copper salts.a  
entry Cu cat. Conv. 
(%)b 
Yield 
(%)b 
ee. 
(%)b 
1 Cu(OTf)2 89 6 64 
2 (CuOTf)2.PhMe 85 47 78 
3 Cu(MeCN)4BF4 86 34 80 
4 CuCl + AgNTf2
c  93 7 90 
5 CuTC 68 66 76 
a) reaction carried out on 0.5 mmol; b) determined by chiral GC; c) 15 
mol% AgNTf2 used.  
 
 In all cases, with the exception of copper 
thiophenecarboxylate, the conversion of the starting material 
was high >80%. Interestingly all copper salts gave moderate 
to good enantioselectivity. When copper (II) triflate was used, 
a poor yield was obtained with moderate enantioselectivity 
(entry 1). This low activity could be due to the alkenylalane 
being unable to reduce the copper(II) down to copper(I) to 
enter into the catalytic cycle. When copper(I) triflate was 
used, the conversion was similar to copper(II) triflate but the 
yield increased significantly from 6% to 47% as did the 
enantioselectivity (entry 2). When copper(I) 
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tetrakis(acetonitrile) tetrafluoroborate, was used, high 
conversion and enantioselectivity was achieved but the yield 
was relatively low (entry 3). Copper halides are not commonly 
used for the conjugate addition of organoaluminium reagents, 
but a recent publication showed that it is possible to use a 
combination of copper(I) chloride and silver triflimide to 
catalyse the conjugate addition of alkylzirconium reagents to 
trisubstituted enones.106 However, when this combination was 
tried a poor yield was obtained in excellent enantioselectivity 
(entry 4). After screening a few copper salts it was decided 
copper thiophene carboxylate gave the best results giving the 
desired product in 66% yield and 76% enantioselectivity. 
3.3.2.6. Ligand Screen 
 
With optimised reaction conditions in hand, a range of 
monodentate and bidentate phosphorus based ligands as well 
as some N-heterocyclic carbenes were screen to see if further 
improvements were possible (Figure 28 and Table 19). 
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Figure 28 Ligands used in this study. 
 Several noteworthy findings from the ligand screening 
were prominent. When bidentate phosphine ligands L46 and 
L26, which are powerful ligands for the ACA of 
trimethylaluminium, were used, no reaction was observed 
(entries 6 and 7). SimplePhos ligands (entries 8 to 16), which 
have afforded excellent results for the conjugate addition of 
alkenylalanes to enones, resulted in excellent yields but 
moderate enantioselectivities. If the R group in the 
SimplePhos ligands was changed from aryl to alkyl (entries 9, 
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11 and 13), a significant drop in both yield and 
enantioselectivity was observed. The reason for this is unclear 
but it could be due to the change in conformational bias where 
an aryl group is 'held' in an atropos manner due to the lack of 
flexibility compared to alkyl substituents. Catalyst screening 
using SimplePhos ligands also indicated that changing the 
electronics and sterics of the R group had an effect on both 
the enantioselectivity and yield (entries 12, 14 and 15). 
Changing the amine moiety of the ligand also had little effect 
on the enantioselectivity (L12 vs. L15 vs. L49). Monodentate 
phosphines (entries 4 and 5), produced 192 in moderate 
yields, but unfortunately as a racemate (entry 4). The result 
from ligand (S)-L44 indicates that the atropos nature of biaryl 
systems is not a major contributor to the enantioselectivity 
delivered to the final product. Phosphoramidite ligands 
(S,R,R)-L2, (S,R,R)-L3 and produced the desired products in 
high optical purity, when a BINOL core was present, and in 
good yields (entries 1 to 3). When a biphenol core was present 
(R,R)-L7 (entry 3) the enantioselectivity decreased 
dramatically. However, unlike the SimplePhos ligands, the 
amine moiety plays a major role for producing the product in 
high enantioselectivies. Phosphoramidite ligands which 
contained the 2-naphthyl- derived amine afforded better 
optical purity than the corresponding phenyl-derived amine 
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((S,R,R)-L2 vs. (S,R,R)-L3). Like phosphoramidite ligands, 
phosphite ligands could deliver the product in moderate yields 
but with a lower enantioselectivity (entry 19). N-Heterocyclic 
carbenes bearing pendant coordinating groups (L50 and L51) 
were ineffective ligands for the addition of alkenyl groups from 
the monomethyl derivative of 179.   
 
Table 19 ligand screen.a 
Entry Ligand Conv. (%)b Yield (%)b ee. (%)b 
1 (S,R,R)-L2 68 66 76 
2 (S,R,R)-L3 95 65 88 
3 L4 91 65 38 
4 L44 92 56 0 
5 L45 87 26 0 
6 L46 - - - 
7 L26 - - - 
8 L10 84 81 20 
9 L14 90 49 6 
10 L12 84 63 50 
11 L13 >99 19 0 
12 L47 90 54 44 
13 L19 90 36 10 
14 L15 87 81 56 
15 L48 93 23 38 
16 L49 >99 27 56 
17 L50 91 17 10 
18 L51 70 16 8 
19 L40 90 59 50 
a) reaction carried out on a 0.5 mmol scale; b) determined by chiral GC. 
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3.3.2.7. Summary of optimisation 
 
 The optimisation experiments showed that the nature of 
the alkenylalane and temperature is, at least, as important as 
the chiral copper catalyst to afford high yields of the desired 
product. The combination of all the optimisation reactions had 
led to a set of conditions which showed that the conjugate 
addition of alkenylalanes to cyclohexenone can be achieved in 
high enantiomeric excess. 
3.3.2.8. Alkenylalane scope in ACA to cyclohexenone 
 
 With the optimised conditions in hand, the scope of 
alkenylalanes was explored against cyclohexenone (Scheme 
60). Volatile alkynes behaved capriciously under the original 
hydroalumination conditions when carried out at smaller scales 
(<5 mmol). Over vigorous initial heating can cause significant 
alkyne to escape leading to variable yields in normal Schlenk-
ware. However, this issue could be overcome using a GC septa 
equipped 1.0 mL vials which has minimum headspace. This 
change worked well for both volatile and non-volatile alkynes 
up to a one mmol scale.  
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a) isolated yield; b) determined by chiral GC; c) determined by chiral 
HPLC. Absolute stereochemistry confirmed by analogy.  
 
Scheme 60 Alkenylalane scope for the addition to 
cyclohexenone.. 
 The results showed that a range of alkenyl substituents 
could be introduced. Alkenylalanes generated from linear, 
non-branched alkynes could add to cyclohexenone in good 
yields (192 and 193) with high levels of enantioselectivity up 
to 90%. When conjugated alkenylalanes were used, the cyclic 
derivative (195) was obtained in moderate yield (40%) but 
excellent enantioselectivity (96%), whereas the acyclic variant 
(194) was obtained in good yield (70%) but at a lower 
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enantioselectivity (90%). When the cyclohexyl derivative was 
used, 196 was obtained in higher yields than the 
corresponding cyclohexenyl derivative (51% vs. 40%), but a 
significant drop in optical purity was observed. Styrylalane 
could also be added to cyclohexenone in moderate yield 
(52%) and good levels of optical purity (80%). These are the 
first reported enantioselective copper-catalysed conjugate 
additions of alkenylalanes to cyclohexenone. 
 Unfortunately when the Michael acceptor was changed 
to cyclopentenone, high levels of conversion of the starting 
material was observed (>95%), but, no 1,4-adduct was 
observed. This could be explained by polymerisation of the 
starting material via successive conjugate additions of the 
highly reactive enolate to the Michael acceptor. Trapping with 
trimethylsilyl chloride had no effect on the reaction with high 
conversion still noticed. 
3.3.3. ACA to trisubstituted enones 
 
 With the successful addition of alkenylalanes to 
cyclohexenone, it was decided to see whether these 
alkenylalanes were competent nucleophiles for the addition to 
trisubstituted enones to generate all carbon quaternary 
centres. A very small amount of optimisation was required and 
that was in the addition mode in which the reagents were 
151 
 
added (Table 20). The addition mode was screened because 
the problem with the cyclic tetramer would not be possible 
due to the enolate being unable to carry out the subsequent 
Michael addition. 
 
Table 20 Mode of addition to trisubstituted enones.a  
Entry Addition mode Yield (%)b ee. (%)c 
1 Slow addition of enone 48 90 
2 Normal 48 89 
3 Reverse 53 94 
a) Reaction carried out on a 0.5 mmol scale; b) isolated yield; c) 
determined by chiral GC. 
 
 The mode of addition did not make too much difference 
in terms of chemical yield with the reverse addition giving 
slightly more of the desired product. However, there was a 
more pronounced difference in optical purity; with the reverse 
addition again provide higher levels of enantioselectivity. With 
the addition mode now optimised for the enantioselective 
addition of 179 to substrate 18, the scope of the reaction in 
terms of nucleophile and electrophile was screened (Scheme 
61). Cyclopentenones with -methyl substituents were tried 
and like the case with unsubstituted cyclopentenones, a high 
level of conversion was observed, but none of the desired 1,4-
adduct was observed.  
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a) Isolated yield; b) determined by chiral GC. Absolute stereochemistry 
confirmed by analogy. 
Scheme 61 ACA to trisubstituted enones.  
 What is evident from these results is that the 
alkenylalanes are competent nucleophiles for the 
transformation with the enantioselectivities being higher (up 
to 98%) than for the addition to cyclohexenones (c.f. 90%). 
This increase in enantioselectivity could be due to the steric 
factor of the -substituents being larger (methyl > hydrogen) 
and creating better facial selectivity. Again alkenylalanes 
derived from linear alkynes could be added to both methyl and 
ethyl substituted enones generating the 1,4-adducts (198, 
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199, 202 and 203) with high levels of enantioselectivity (up 
to 96%) in moderate yields. In the case of (E)-hexenylalane, 
the yield of 203 (46%) was lower than that of 199 (68%) 
indicating that the steric profile of the substituent plays a 
major role on the chemical yield. Challenging alkenylalanes, 
those derived from conjugated alkynes and 
cyclopropylacetylene, were also added to methyl substituted 
enones to generate 200 and 201 in moderate to good yields 
with excellent enantioselectivity. 
Preliminary studies indicate that the scope of the 
reaction could be extended to (in the racemic sense) products 
204-206, derived from linear enones (Figure 29) and to 
hydroalumination of problematic ethynyltrimethylsilane 
(leading to 207). However, the present conditions do not 
provide synthetically useful enantioselectivities (39%) or 
yields (11%). 
 
Figure 29 Conjugate addition to linear enones. 
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3.4. Conclusion  
  
A protocol has been developed which allows the addition 
of alkenylalanes, derived from air-stabilised aluminium 
hydrides, to cyclohexenones and -substituted cyclohexenones 
in excellent enantioselectivies (up to 98%) using commercially 
available phosphoramidite ligands, with moderate to good 
yields. This protocol unfortunately requires more optimisation 
to be compatible with cyclopentenones and linear aliphatic 
enones.107  
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Chapter 4 
 
 
 
 
Experimental Section  
  
156 
 
General remarks 
  
Infrared spectra were recorded using Bruker Tensor 27 
FT-IR spectrometer with absorptions given in wavenumbers 
(cm–1). Proton, 13C, 19F and 31P NMR spectra were recorded on 
Bruker (DPX400, AV400 or AV(III)400) spectrometers and 2H 
NMR spectra were recorded on Bruker AV400 spectrometer. 
Proton and 13C NMR chemical shifts are given in ppm relative 
to tetramethylsilane (0.00 ppm). Proton-NMR spectra were 
referenced to CDCl3 (7.26 ppm) or C6D6 (7.16) and carbon-13-
NMR spectra were referenced to CDCl3 (77.16 ppm) or C6D6 
(128.06). 108  Phosphorus-31 NMR chemical shifts were 
reported in ppm relative to phosphoric acid. Data are reported 
as follows: chemical shift, integration, multiplicity: s (singlet), 
d (doublet), t (triplet), q (quartet), or combinations, brs 
(broad singlet), m = multiplet, and coupling constants (Hz). 
Mass spectra were obtained on Brucker microTOF 
spectrometer. Optical rotations were measured at the sodium 
D-line with a 1 dm path length cell using an ADP400 
polarimeter, and are reported as follows: []D
T in degrees, 
concentration (g/100 cm3), and solvent. Melting points were 
determined using a Gallenkamp melting point apparatus and 
are uncorrected. Gas chromatography was performed on 
either a Varian 430 or Varian 3900 apparatus using either a 
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Lipodex A or octakis(2,6-di-O-methyl-3-O-pentyl--
cyclodextrin stationary phase. Chiral HPLC analysis was 
performed on a Varian Prostar Chromatograph using Daicel 
Chiracel OD-H stationary phase. 
 All procedures involving air or moisture sensitive 
reagents were performed under atmospheres of argon or 
nitrogen using standard Schlenk techniques. Reaction solvents 
were dried and distilled immediately prior to use from 
appropriate drying agents. Toluene, tetrahydrofuran, diethyl 
ether and t-butyl methyl ether were distilled from sodium-
benzophenone ketyl. Dichloromethane and acetonitrile were 
distilled from calcium hydride.  
 Analytical thin layer chromatography (TLC) was 
performed on Merck pre-coated aluminium-backed TLC plates 
(silica gel 60 F254) and visualised by UV lamp (254 nm), 
potassium permanganate (KMnO4) stain. Flash 
chromatography was performed using silica gel 60 (220–240 
mesh) from Fluka. Technical grade solvents were employed. 
 Organolithiums and Grignard reagents were commercial 
products and titrated using the Gilman double titration 
method. Solutions of triorganoaluminium and dialkylzinc 
reagents were purchased from Acros organics or Aldrich. 
Enones and alkynes were distilled prior to use and stored over 
4 Å molecular sieves.  
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General procedure 1: Kinetic studies using 
phosphorus ligands 
 
In a flame-dried two-necked flask under argon, phosphorus 
ligand (0.5-3.0 mol%), copper(II) acetate (18.0 mg, 0.0991 
mmol) and nonane (1.0 mL) were added to dried toluene 
(25.0 mL) and stirred at room temperature for 30 minutes. 
The solution was cooled to -40 oC and diethylzinc (1.0 M in 
toluene, 12.0 mL, 12.0 mmol) was added to the mixture and 
stirred at this temperature for 10 minutes. At time point t0, 
cyclohexenone (1.00 mL, 10.3 mmol) was added. Aliquots 
were withdrawn under an argon counterflow at regular 
intervals (using a Pasteur pipette that had been previously 
cooled to -196 oC in liquid nitrogen) and immediately 
quenched with hydrochloric acid (2 M). The organic phase of 
each aliquot was analysed by GC. After 1 hour the residual 
reaction was quenched with hydrochloric acid (2 M) and 
extracted with diethyl ether (2 x 3 mL). The organic phase 
was separated and purified by column chromatography (silica, 
4:1 pentane/diethyl ether) to typically provide 3-ethyl 
cyclohexanone as a colourless oil. 
General procedure 2: Kinetic studies Using 
SIMES 
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In a flame-dried two-necked flask under argon, L39 (0.5-3.0 
mol%), copper(II) acetate (18.0 mg, 0.0991 mmol) and 
nonane (1 mL) were added to dried toluene (25 mL) and 
stirred at room temperature for 30 minutes. The solution was 
cooled to -40 oC and diethylzinc (1 M in toluene, 12 mL, 12 
mmol) was added to the mixture and stirred at this 
temperature for 10 minutes. At time point t0 cyclohexenone 
(1.00 mL, 10.3 mmol) was added. Aliquots were withdrawn 
under an argon counterflow at regular intervals (using a 
Pasteur pipette that had been previously cooled to -196 oC in 
liquid nitrogen) and immediately quenched with hydrochloric 
acid (2 M). The organic phase of each aliquot was analysed by 
GC. After 1 hour the reaction was quenched with hydrochloric 
acid (2 M) and extracted with diethyl ether (2 x 3 mL). The 
organic phase was separated and purified by column 
chromatography (silica, 4:1 pentane/diethyl ether) to typically 
provide 3-ethyl cyclohexanone as a colourless oil. 
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General procedure 3: Kinetic studies of 
Triethylaluminium with phosphoramidite 
ligands 
 
To a flame-dried two-necked flask under argon, phosphorus 
ligand (0.5-5.0 mol%), copper(II) acetate (18.0 mg, 0.0991 
mmol) and nonane (1 mL) were added to diethyl ether (25.0 
mL) and stirred at room temperature for 30 minutes. The 
solution was cooled to -40 oC and triethylaluminium (1.30 M in 
hexanes, 10.0 mL, 13.0 mmol) was added to the mixture and 
stirred at this temperature for 10 minutes. At time point t0 
cyclohexenone (1.00 mL, 10.3 mmol) was added. Aliquots 
were withdrawn under an argon counterflow at regular 
intervals (using a Pasteur pipette that had been previously 
cooled in liquid nitrogen) and immediately quenched with 
hydrochloric acid (2 M). The organic phase of each aliquot was 
analysed by GC. After 1 hour the reaction was quenched with 
hydrochloric acid (2 M) and extracted with diethyl ether (2 x 3 
mL). The organic phase was separated and purified by column 
chromatography (silica, 4:1 pentane/diethyl ether) to typically 
provide 3-ethyl cyclohexanone as a colourless oil. 
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General procedure 4: Kinetic studies of the 
conjugate addition of ethylmagnesium bromide 
to methyl crotonate 
 
In a flame-dried and argon filled two necked round bottom 
flask; copper salt (0.1 mmol, 1 mol%) and ligand (0.25 – 3.0 
mol%) and tridecane (1.00 mL internal standard) were stirred 
at room temperature for 30 minutes in dichloromethane (25.0 
mL). The solution was cooled to -78 oC and ethylmagnesium 
bromide (3.0 M in diethyl ether, 4.00 mL, 12.0 mmol) added. 
At time point t0, methyl crotonate (1.10 mL, 10.0 mmol) was 
added to the reaction mixture (end volume 31.0 mL, starting 
concentration of methyl crotonate 0.320 M). Aliquots were 
withdrawn under an argon counterflow at regular intervals 
(using a Pasteur pipette that had been previously cooled in 
liquid nitrogen) and immediately quenched with hydrochloric 
acid (2 M in methanol). The organic phase of each aliquot was 
analysed by GC. After 1 hour the overall reaction was 
quenched with hydrochloric acid (2 M in methanol) and the 
phases separated. All the ethereal layers were combined and 
concentrated to afford an orange oil which was purified by 
column chromatography (silica, 99:1 pentane/diethyl ether) to 
typically provide methyl 3-methylpentanoate as a colourless 
oil. 
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General procedure 5: Kinetic studies of nickel-
catalyzed 1,2-addition of trimethylaluminium to 
benzaldehyde 
 
In a flame-dried, argon filled two-necked round bottom flask; 
nickel aceteoacetate (25.0 mg, 0.10 mmol, 1 mol%), (R,S,S)-
L2 (0.5-4.0 mol%) and tridecane (1.00 mL internal standard) 
were stirred at room temperature for 30 minutes in 
tetrahydrofuran (25.0 mL). The solution was cooled to -40 oC 
and trimethylaluminium (2.0 M in hexanes, 10.0 mL, 20.0 
mmol) added. At time point t0, distilled benzaldehyde (1.0 mL, 
10.0 mmol) was added to the reaction mixture (end volume 
37.0 ml, starting concentration of benzaldehyde 0.270 M). 
Aliquots were withdrawn under an argon counter flow at 
regular intervals (using a Pasteur pipette that had been 
previously cooled to -196 oC in liquid nitrogen) and 
immediately quenched with hydrochloric acid (2 M). The 
organic phase of each aliquot was analysed by GC. After 1 h 
the overall reaction was quenched with hydrochloric acid (2 M) 
and the phases separated. All the ethereal layers were 
combined and concentrated to afford an orange oil, which was 
purified by column chromatography (hexanes/ ethyl acetate 
5:1) to typically provide 2-phenylethanol as a colourless oil. 
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 (S)-3-Ethyl-cyclohexanone (37)109 
 
Prepared via general procedures 1-3 using ligand (R,S,S)-L2 
to give the title compound as a colourless oil in 96% ee.   
1H NMR (400 MHz, CDCl3) : 0.89 (3H, t, J = 7.5 Hz, C
9H3), 
1.26-1.39 (3H, m, C8H2 and C
4H), 1.60-1.69 (2H, m, C3H2), 
1.87-1.97 (1H, m, C5H), 1.95-2.05 (2H, m, C2H2), 2.19-2.28 
(2H, m, C1H2), 2.31-2.42 (1H, m, C5H').  
13C NMR (100 MHz, CDCl3) C: 11.1 (C9), 25.3 (C2), 29.3 
(C8), 30.9 (C3), 40.8 (C4), 41.5 (C1), 47.8 (C5), 212.2 (C6).  
HRMS (ESI) C8H14O [M]
+ requires m/z 126.1045, found [M]+ 
126.1044.  
IR (CHCl3) max: 2965, 2875, 1706, 1460, 1448, 1421, 1397, 
1313, 1116 cm-1.  
[]D (c = 1.00, CH2Cl2): -19.6. (lit. -11.2, c = 1.0, CH2Cl2)
108 
GC: (Lipodex A); Tinj = 250 
oC, Tdet = 275 
oC, flow = 2.0 mL 
min-1, ti =75 
oC isothermal: (R)-isomer: tR = 8.4 min; (S)-
isomer: tR = 8.6 min.  
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(R)-3-Methyl-methylpentanoate (54)28b 
 
Prepared via general procedure 4 from copper(I) iodide and 
(R)-Tolyl-BINAP to give the title compound as a colourless oil 
in 90% ee. and purified by column chromatography (99:1 
pentane/diethyl ether). 
1H NMR (400 MHz, CDCl3) H: 0.87 (3H, t, J = 7.0 Hz, C
9H3), 
0.90 (3H, d, J = 7.0 Hz, C7H3), 1.25-1.20 (1H, m, C
8H2), 1.37-
1.32 (1H, m, C8H2), 1.89-1.84 (1H, m, C
1H), 2.07 (1H, dd, J = 
15.0, 8.0 Hz, C2H2), 2.27 (1H, dd, J = 15.0, 6.0 Hz, C
2H2), 
3.65 (3H, s, C6H3).  
13C NMR (100 MHz, CDCl3) C: 11.2 (C9), 19.2 (C7), 29.3 
(C8), 31.9 (C6), 41.2 (C1), 51.2 (C2), 173.7 (C3).  
HRMS: (EI) C7H14O2 [M]
+ requires m/z 130.0988, found [M]+ 
130.0994.  
IR (CHCl3) max: 3630, 3011, 2927, 2855, 1729, 1465, 1171, 
1016 cm-1. 
GC: (Octakis (2,6-di-O-methyl-3-O-pentyl)--
cyclodextrin); Tinj = 250 
oC, Tdet = 275 
oC, flow = 2.0 mL 
min-1, ti=60 
oC (11.0 min), (20.0 oC min-1) tf = 160 
oC (20.0 oC 
min-1): (R)-isomer: tR = 5.24 min; (S)-isomer: tR = 5.50 min. 
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(R)-1-Phenylethanol (57)110 
 
Prepared via general procedure 5 to yield a colourless oil with 
86% ee.  
1H NMR (400 MHz, CDCl3) H: 1.53 (3H, d, J = 6.5 Hz, C
8H3), 
2.01 (1H, brd s, OH), 4.92 (1H, q, J = 6.5 Hz, C7H), 7.29-7.42 
(5H, m, CHAr).  
13C NMR (100 MHz, CDCl3) C:  25.2 (C8), 70.4 (C7), 125.6 
(C1 & C3), 127.1 (C2), 127.4 (C4 and C6), 128.5 (C5). 
HRMS: (EI) C8H10O [M]
+ requires m/z 122.0726, found [M]+ 
122.0729.  
IR (CHCl3) max: 3528, 3065, 3011, 1454, 1378, 1254, 1075, 
896, 650 cm-1.  
[]D (c = 0.50, MeOH): +39.6. (lit. +45, c = 0.5, MeOH)
109 
GC: (Lipodex A); Tinj = 250 
oC, Tdet = 275 
oC, flow = 2.0 mL 
min-1, ti =75 
oC isothermal: (S)-isomer: tR = 21.3 min; (R)-
isomer: tR = 22.3 min. 
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General procedure 6: Phosphoramidite 
synthesis 
 
A flame dried round-bottom flask was charged with anhydrous 
dichloromethane (8.0 mL) and freshly distilled phosphorus 
trichloride (348 µL, 4.10 mmol, 1.0 equiv.). The reaction was 
cooled to 0 °C and neat triethylamine (2.80 mL, 20.0 mmol, 
5.0 equiv.) was added dropwise over 5 min to the vigorously 
stirred solution (the reaction becomes cloudy). Then C2-
symmetrical chiral amine (1.0 equiv.) was added to the 
reaction mixture while maintaining the temperature at 0 °C. 
After addition of the amine was complete the ice bath was 
removed and the resulting suspension was allowed warm to 
ambient temperature and stirred for an additional 4 h. After 4 
h binol or phenol (1 equiv.) was slowly added to the reaction 
mixture at 0 °C and then the suspension was stirred at 
ambient temperature overnight. The reaction mixture was 
quenched with water (20 mL), the organic layer was removed 
and the aqueous layer extracted with dichloromethane (2 x 30 
mL). The combined organic phases were dried over anhydrous 
sodium sulfate and concentrated to afford a yellow foam which 
was purified by column chromatography on neutral alumina 
(4:1 pentane/diethyl ether). 
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O,O' -(S)-(1,1' -Dinaphthyl-2,2' -diyl)-N,N' 
-di-(R,R)-1-phenylethylphosphoramidite (L2)111 
  
Prepared according to general procedure 6 from (R)-bis((R)-1-
phenyl)ethyl)amine (914 l, 4.00 mmol) and (S)-1,1'-bi-2-
naphthol (1.15 g, 4.0 mmol) to yield L2 as a white solid (1.67 
g, 3.10 mmol, 78%); RF (4:1 pentane/diethylether) 0.67. 
1H NMR (400 MHz, CDCl3) δH: 1.75 (6H, d, J = 7.0 Hz, 2 x 
CH3), 4.50–4.58 (2H, m, CHamide), 7.11–7.16 (10H, m, Ar), 
7.22–7.27 (2H, m, Ar), 7.31 (1H, d, J = 8.5 Hz, Ar), 7.39–
7.47 (4H, m, Ar), 7.62 (1H, d, J = 8.5 Hz, Ar), 7.92 (2H, dd, J 
= 8.5, 4.5 Hz, Ar), 7.96 (2H, d, J = 8.5 Hz, Ar).  
13C NMR (100 MHz, CDCl3) δC: 22.1 (d, J = 7.0 Hz), 52.4 (d, J 
= 12.0 Hz), 122.5 (d, J = 1.5 Hz), 122.6, 124.6, 124.9, 126.1 
(d, J = 3.0 Hz), 126.7, 127.3 (d, J = 5.5 Hz), 127.9, 128.1 (d, 
J = 2.0 Hz), 128.4 (d, J = 20.0 Hz), 129.6, 130.4, 130.6, 
131.5, 132.9 (d, J = 4.0 Hz), 149.7, 150.2 (d, J = 7.5 Hz). 
31P NMR (100 MHz, CDCl3) P: 145.4.  
IR (CHCl3) max: 3062, 3011, 2975, 2935, 2877, 1686, 1507, 
1070, 949 cm-1. 
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HMRS: (ESI) C44H34NO2P [M+H]
+ requires m/z 540.2070, 
found [M+H]+ 540.2077. 
m.p. 90-92 oC (lit 88-90 oC)111. 
[]D
25 (c = 1.00, CHCl3) +432.7. (lit. +456, c = 0.8, CHCl3)
111  
 
2,4,8,10-tetramethyl-N,N-bis((R)-1-(naphthalen-2- 
yl)ethyl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-amine 
(L7)112 
  
Prepared according to general procedure 6 from (R)-bis((R)-1-
(naphthalen-2-yl)ethyl)amine (651 mg, 2.00 mmol), 
phosphorus trichloride (174 mL, 2.05 mmol) and 3,3',5,5'-
tetramethyl-[1,1'-biphenyl]-2,2'-diol (484 mg, 2.0 mmol) to 
yield L7 as a white solid (692 mg, 1.16 mmol, 58%); RF (4:1 
pentane/diethyl ether) 0.59. 
1H NMR (400 MHz, CDCl3) H: 1.83 (6H, d, J = 7.0 Hz, 
2xCH3), 2.08 (3H, s, CH3), 2.33 (3H, s, CH3), 2.36 (3H, s, 
CH3), 2.52 (3H, s, CH3), 4.83–4.91 (2H, m, 2 X CHamide), 7.00 
(1H, s, CHAr), 7.04–7.05 (2H, m, Ar), 7.08–7.10 (2H, m, Ar), 
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7.26–7.32 (1H, m, Ar), 7.32–7.38 (4H, m, Ar), 7.48 (6H, app 
d, J = 8.5 Hz, Ar), 7.64–7.66 (2H, m, Ar).   
13C NMR (100 MHz, CDCl3) C: 16.6 (2 x CH3), 17.6 (2 x CH3), 
21.0 (2 x CH3amide), 52.7 (2 x CHamide), 125.6, 125.7, 126.3, 
126.9, 127.3, 127.4, 127.9, 128.3, 128.4, 129.4, 130.3, 
130.4, 131.1, 131.3, 132.4, 132.8, 133.1, 133.5.  
31P NMR (100 MHz, CDCl3) δP: 141.3. 
IR (CHCl3) max: 3059, 3010, 2974, 2924, 2863, 1477, 1192 
cm-1. 
HMRS: (ESI) C40H38NO2P [M+H]
+ requires m/z 596.2758, 
found [M+H]+ 596.2748. 
m.p. 108-110 oC. 
[]D
25 (c = 1.00, CHCl3): +318.7. 
 
O,O' -(S)-(1,1' -Dinaphthyl-2,2' -diyl)-N,N' 
-di-(R,R)-1-naphthylethylphosphoramidite (L3)111 
 
Prepared according to general procedure 6 from (R)-bis((R)-1-
(naphthalen-2-yl)ethyl)amine (1.30 g, 4.00 mmol) and (S)-
1,1'-bi-2-naphthol (1.14 g, 4.0 mmol) to yield L3 as a white 
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solid (1.48 g, 2.31 mmol, 58%); RF (4:1 pentane/diethyl 
ether) 0.61. 
1H NMR (400 MHz, CDCl3) H: 1.87 (6H, d, J = 7.0 Hz, 
2xCH3), 4.65–4.73 (2H, m, CHamide), 7.24–7.34 (5H, m, Ar), 
7.37–7.47 (10H, m, Ar), 7.51 (4H, d, J = 8.5 Hz, Ar), 7.67–
7.73 (3H, m, Ar), 7.92–8.01 (4H, m, Ar).   
13C NMR (100 MHz, CDCl3) C: 31.1 (2 x CH3), 52.5 (2 x 
CHamide), 121.9, 122.5, 124.17, 124.6, 124.9, 125.7, 126.1, 
127.2, 127.3, 127.5, 128.0, 128.3, 129.6, 130.5, 131.5, 
132.4, 133.01, 149.6.  
31P NMR (100 MHz, CDCl3) P: 145.0. 
IR (CHCl3) max: 3062, 3011, 2975, 2935, 2877, 1686, 1507, 
1070, 949 cm-1. 
HMRS: (ESI) C40H38NO2P [M+H]
+ requires m/z 640.2430, 
found [M+H]+ 640.2438. 
m.p. 210-212 oC. 
[]D
25 (c = 1.00, CHCl3): +531.1. (lit. +497, c = 0.9, 
CHCl3)
111 
General Procedure 7: Synthesis of Aryl 
SimplePhos ligands 
 
To a solution of C2-symmetric amine (2.12 mmol, 1.05 equiv.) 
in tetrahydrofuran (6 mL) was slowly added n-butyllithium 
(1.30 mL, 2.12 mmol, 1.05 equiv.) at -78 oC and stirred for 5 
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min resulting in a pale pink solution. To the amide solution 
was added neat phosphorus trichloride (174 L, 2.00 mmol, 
1.0 equiv.) at -78 °C upon which the solution turned yellow. 
After 5 min the complete consumption of phosphorus 
trichloride was verified by 31P NMR (single peak at 166.5 ppm 
in C6D6). To this was added aryl Grignard reagents (3.00 
equiv.) and the reaction mixture was allowed to warm up to 
room temperature and then was heated to reflux overnight. 
An aliquot was taken and 31P NMR confirmed the formation of 
desired ligand as the major peak. The mixture was diluted 
with pentane to remove solubilised magnesium salts and 
filtered through a pad of Celite eluting with diethyl ether (2 x 
10 mL), concentrated and purified by column chromatography 
(Acros organics Brockmann basic alumina, activity 1) to yield 
the compounds as colourless solids. 
1,1-Dixylyl-N,N-bis((S)-1-phenylethyl)phosphinamine 
(L47)113 
 
Prepared according to general procedure 7 from (S)-bis((S)-1-
phenylethyl)amine (484 µL, 2.12 mmol), n-butyllithium (1.30 
mL, 2.12 mmol), phosphorus trichloride (174 L, 2.00 mmol) 
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and 3,5-dimethylphenylmagnesium bromide (9.0 mL, 6 mmol, 
0.7 M in THF) to yield L47 as a colourless solid (309 mg, 0.66 
mmol, 33%). RF (pentane/diethyl ether 15:1) 0.69. 
1H NMR (400 MHz, CDCl3) H: 1.48 (6H, d, J = 7.0 Hz, 2 x 
CH3), 2.15 (6H, s, 2 x Ar-CH3), 2.37 (6H, s, Ar-CH3), 4.48-
4.56 (2H, m, ArCH(Me)), 6.64 (2H, d, J = 7.0 Hz, Ar), 6.85 
(1H, s, Ar), 6.94-6.96 (4H, m, Ar), 7.06 (1H, s, Ar), 7.15-7.16 
(6H, m, Ar), 7.41 (2H, d, J = 7.5 Hz, Ar).   
13C NMR (100 MHz, CDCl3) C: 21.2 (ArCH3), 21.5 (2 x 
ArCH3), 56.2 (2 x CH3), 126.7 (2 x Cxylyl-P), 127.8 (4 x 
Phortho), 128.4 (4 x xylylortho), 129.3, 129.9, 130.1, 130.7, 
131.5, 131.7, 137.0, 137.1, 137.7, 137.8, 139.1, 139.3, 
139.7, 139.8, 144.4.  
31P NMR (162 MHz, CDCl3) P: 42.4. 
HRMS: (ESI) C32H36NP [M+H]
+ requires m/z 466.2655, found 
[M+H]+ 466.2654.  
IR (CHCl3) max: 3059, 3011, 2961, 2929, 2873, 1631, 1507, 
1465, 1375, 1127 cm-1. 
m.p. 104-106 oC (lit. 105 oC)113 
[]D
25 (c = 1.00, CHCl3): -198.1. 
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1,1-Di-o-tolyl-N,N-bis((S)-1-phenylethyl) 
phosphinamine (L48)  
 
Prepared according to general procedure 7 from (S)-bis((S)-1-
phenylethyl)amine (484 µL, 2.12 mmol), n-butyllithium (1.30 
mL, 2.12 mmol), phosphorus trichloride (174 L, 2.00 mmol) 
and o-tolylmagnesium bromide (6.0 mL, 6 mmol, 1.0 M in 
diethyl ether) to yield L48 as a colourless low melting solid 
(236 mg, 0.54 mmol, 27%); RF (pentane) 0.14. 
1H NMR (400 MHz, CDCl3) δH: 1.64 (6H, d, J = 7.0 Hz 2 x 
CH3), 1.72 (3H, s, Ar-CH3), 2.42 (3H, s, Ar-CH3), 4.59-4.67 
(2H, m, ArCH(Me)), 6.90 (1H, t, J = 7.0 Hz, Ar), 6.95 - 7.03 
(6H, m, Ar), 7.10-7.15 (7H, m, Ar), 7.19-7.24 (2H, m, Ar), 
7.27-7.31 (1H, m, Ar), 7.57 - 7.60 (1H, m, Ar).   
13C NMR (100 MHz, CDCl3) δC: 20.7 (d, J = 20.0 Hz), 21.4 (d, 
J = 21.0 Hz), 22.2 (d, J = 7.0 Hz), 56.2 (d, J = 7.0 Hz), 
125.0, 125.6, 126.7, 127.7, 128.1, 128.5 (d, J = 2.0 Hz), 
129.9 (d, J = 4.0 Hz), 130.5 (d, J = 4.0 Hz), 132.6 (d, J = 2.5 
Hz), 133.1 (d, J = 3.0 Hz), 138.3 (d, J = 13.0 Hz), 139.3 (d, J 
= 18.0 Hz), 141.1 (d, J = 3.0 Hz), 141.4 (d, J = 2.0 Hz), 
144.4  
31P NMR (162 MHz, CDCl3) δP: 27.6. 
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HRMS: (ESI) C30H32NP [M+H]
+ requires m/z 438.2336, found 
[M+H]+ 438.2335.  
IR (CHCl3) max: 3059, 3011, 2961, 2929, 2873, 1631, 1507, 
1465, 1375, 1127 cm-1. 
[]D
25 (c = 1.00, CHCl3): -209.4. 
 
N,N-bis((S)-1-(4-Methoxyphenyl)ethyl)-1,1-
diphenylphosphinamine (L49)113 
 
Prepared according to general procedure 7 from (S)-bis((S)-1-
(4-methoxyphenyl)ethyl)amine (302 mg, 1.06 mmol), n-
butyllithium (0.65 mL, 1.06 mmol), phosphorus trichloride (87 
L, 1.00 mmol) and phenylmagnesium bromide (1.0 mL, 3 
mmol, 2.8 M in diethyl ether) to yield L49 as a colourless solid 
(159 mg, 0.33 mmol, 34%); RF (pentane/diethyl ether 15:1) 
0.19. 
1H NMR (400 MHz, CDCl3) δH: 1.52 (6H, d, J = 7.0 Hz, 2 x 
CH3), 3.81 (6H, s, 2 x OCH3), 4.52-4.57 (2H, m, ArCH(Me)), 
6.77 (4H, app d, J = 8.5 Hz, Ar), 6.94 (4H, app d, J = 8.5 Hz, 
Ar), 7.18-7.22 (2H, m, Ar), 7.24-7.30 (3H, m, Ar), 7.43-7.49 
(3H, m, Ar), 7.81 (2H, td, J = 7.5, 1.6 Hz, Ar).   
13C NMR (100 MHz, CDCl3) δC: 21.9 (d, J = 8.0 Hz), 55.5 (d, J 
= 8.0 Hz), 113.2, 127.8 (d, J = 5.0 Hz), 127.9, 128.4 (d, J = 
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6.5 Hz), 129.3 (d, J = 1.5 Hz), 132.6 (d, J = 19.0 Hz), 133.7 
(d, J = 22.5 Hz), 136.8, 139.9 (d, J = 6.0 Hz), 140.1, 158.3 
31P NMR (162 MHz, CDCl3) δP: 41.2. 
HRMS: (ESI) C30H32NO2P [M+H]
+ requires m/z 470.2238, 
found [M+H]+ 470.2240.  
IR (CHCl3) max: 3059, 3011, 2961, 2929, 2873, 1631, 1507, 
1465, 1375, 1127 cm-1. 
[]D
25 (c = 1.00, CHCl3): -287.4. 
m.p. 102-104 oC. 
N,N-bis((R)-1-(4-methoxyphenyl)ethyl)-1,1-
diphenylphosphinamine (L12)25 
 
Prepared according to general procedure 7 from (R)-bis((R)-1-
(naphthalen-2-yl)ethyl)amine (346 mg, 1.06 mmol), n-
butyllithium (0.65 mL, 1.06 mmol), phosphorus trichloride (87 
L, 1.00 mmol) and phenylmagnesium bromide (1.0 mL, 3 
mmol, 2.8M in tetrahydrofuran) to yield L12 as a colourless 
solid (138 mg, 0.27 mmol, 27%). RF (pentane/diethyl ether 
15:1) 0.22. 
1H NMR (400 MHz, CDCl3) δH: 1.72 (6H, d, J = 7.0 Hz, 2 x 
CH3), 4.83-4.91 (2H, m, ArCH(Me)), 7.03 - 7.05 (3H, m, Ar), 
7.26 - 7.36 (10H, m, Ar), 7.41 - 7.46 (2H, m, Ar), 7.53 - 7.56 
(5H, m, Ar), 7.66 - 7.69 (2H, m, Ar), 7.91 - 7.96 (2H, m, Ar).   
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13C NMR (100 MHz, CDCl3) δC: 21.8 (d, J = 8.0 Hz), 56.8 (d, J 
= 8.0 Hz), 125.7 (d, J = 15.5 Hz), 126.8 (d, J = 1.0 Hz), 
126.9 (d, J = 2.0 Hz), 127.4 (d, J = 6.0 Hz), 128.0 (d, J = 5.5 
Hz), 128.1, 128.3, 128.4 (d, J = 6.0 Hz), 128.8, 132.5, 132.9, 
133.2 (d, J = 9.5 Hz), 133.5 (d, J = 22.0 Hz), 139.7 (d, J = 
10.0 Hz), 139.9 (d, J = 18.0 Hz), 141.8. 
31P NMR (162 MHz, CDCl3) δP: 42.5. 
HRMS: (ESI) C36H32NP [M+H]
+ requires m/z 510.2350, found 
[M]+ 510.2352. 
IR (CHCl3) max: 3058, 3010, 2971, 2932, 2873, 1599, 1434, 
1375, 1127 cm-1. 
m.p. 58-60 oC (lit 60 oC).25 
[]D
25 (c = 1.00, CHCl3): +515.2. 
General Procedure 8: synthesis of alkyl 
SimplePhos ligands114 
 
A flame dried Schlenk tube was charged with bis((S)-1-
phenylethyl))amine (484 µL, 2.12 mmol, 1.06 equiv.) and 
tetrahydrofuran (6 mL) was added. The solution was cooled 
down to -78 °C and n-butyllithium (1.3 mL, 2.1 mmol, 1.6 M 
solution in hexane) was added which resulted in a pale pink 
solution. After 5 min phosphorus trichloride (174 µL, 2.0 
mmol, 1.0 equiv.) was added whereupon the solution turned 
pale yellow. After 5 min the complete consumption of 
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phosphorus trichloride was verified by 31P NMR spectroscopy 
(single peak at 166.5 in C6D6). Alkyl Grignard (3.0 equiv.) was 
added which resulted in a thick slurry. The slurry was then let 
warm to room temperature and an aliquot was taken showing 
the formation of the product via 31P NMR analysis. The 
reaction mixture was diluted with pentane (10 mL) to 
precipitate solubilised magnesium salts and the suspension 
was passed through celite and thoroughly rinsed with ether (2 
x 10 mL). Then the solvents were removed in vacuo and the 
crude compound was purified by column chromatography 
(Acros Organics Brockmann basic alumina; pentane/diethyl 
ether). 
1,1-dibutyl-N,N-bis((S)-1-phenylethyl)phosphinamine 
(L19)113  
  
Prepared according to general procedure 8 from bis((S)-1-
phenylethyl))amine (484 µL, 2.12 mmol, 1.06 equiv.), n-
butyllithium (1.30 mL, 2.12 mmol, 1.6 M solution in hexane), 
phosphorus trichloride (174 µL, 2.0 mmol, 1.0 equiv.) and n-
butylmagnesium chloride (3.4 mL, 6.0 mmol, 3.0 equiv, 1.76 
M solution in tetrahydrofuran) to yield L19 as a colourless oil 
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which solidified in the freezer (596 mg, 1.61 mmol, 81%). RF 
(pentane/diethyl ether 15:1) 0.81. 
1H NMR (400 MHz, CDCl3) δH: 0.71 (3H, t, J = 7.0 Hz, CH3), 
0.76-0.87 (1H ,m), 0.96 (3H, t, J = 7.0 Hz), 1.10-1.20 (2H, 
m), 1.22-1.30 (1H, m), 1.38-1.42 (2H, m), 1.45-1.51 (3H, 
m), 1.59 (6H, d, J = 7.0 Hz CH3), 1.61-1.63 (1H, m), 1.64-
1.70 (1H, m), 1.70-1.76 (1H, m), 4.30-4.38 (2H, m, CMe(H)), 
6.95-6.96 (4H, m, Ar), 7.13-7.16 (6H, m, Ar).   
13C NMR (100 MHz, CDCl3) δC: 14.0 (d, J = 15.0 Hz), 21.7 (d, 
J = 7.0 Hz), 24.2 (d, J = 13.0 Hz), 24.8 (d, J = 13.0 Hz), 27.3 
(d, J = 17.5 Hz), 28.6 (d, J = 19.0 Hz), 29.7 (d, J = 15.0 Hz), 
29.9 (d, J = 13.0 Hz), 53.3, 53.4, 126.4, 127.7, 128.0 (d, J = 
2.0 Hz), 144.7 
31P NMR (162 MHz, CDCl3) δP: 30.7. 
HRMS: (ESI) C24H36NP [M]
+ requires m/z 370.2664, found 
[M]+ 370.2653. 
IR (CHCl3) max: 2960, 2930, 2873, 1490, 1464, 1450, 1126 
cm-1. 
m.p. 50-52 oC (lit. 48 oC).114 
[]D
25 (c = 1.00, CHCl3): -127.7. 
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1,1-Dibutyl-N,N-bis((S)-2-
naphthylethyl)phosphinamine (L14)114 
 
Prepared according to general procedure 8 from bis((S)-1-
naphthylethyl))amine (306 mg, 0.94 mmol, 1.06 equiv.), n-
butyllithium (0.6 mL, 0.9 mmol, 1.6 M solution in hexane), 
phosphorus trichloride (77 µL, 0.88 mmol, 1.0 equiv.) and n-
butylmagnesium chloride (1.5 mL, 2.6 mmol, 3.0 equiv., 1.76 
M solution in tetrahydrofuran) to yield L14 as a colourless oil 
which solidified in the freezer (304 mg, 0.65 mmol, 74%). RF 
(pentane/diethyl ether 4:1) 0.80. 
1H NMR (400 MHz, CDCl3) δH: 0.71 (3H, t, J = 7.0 Hz, CH3), 
0.76-0.87 (1H, m), 0.96 (3H, t, J = 7.0 Hz), 1.10-1.20 (2H, 
m), 1.22-1.30 (1H, m), 1.38-1.42 (2H, m), 1.45-1.51 (3H, 
m), 1.59 (6H, d, J = 7.0 Hz CH3), 1.61-1.63 (1H, m), 1.64-
1.70 (1H, m), 1.70-1.76 (1H, m,), 4.30-4.38 (2H, m, 
CMe(H)), 7.04 (2H, d, J = 8.0 Hz, Ar), 7.37-7.41 (6H, m, Ar), 
7.50 (2H, d, J = 7.5 Hz, Ar), 7.54 (2H, d, 8.0 Hz, Ar), 7.71-
7.73 (2H, m, Ar).   
13C NMR (100 MHz, CDCl3) δC: 13.7, 14.1, 21.6 (d, J = 7.5 
Hz), 24.2 (d, J =  13.0 Hz), 24.8 (d, J =  13.0 Hz), 27.5 (d, J 
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= 17.5 Hz), 28.7 (d, J = 19.0 Hz), 29.6 (d, J = 15.0 Hz), 29.9 
(d, J = 13.0 Hz), 53.7 (d, J = 6.0 Hz), 125.6 (d, J = 21.0 Hz), 
126.4 (d, J = 1.0 Hz), 127.1, 127.3, 127.4 (d, J = 2.0 Hz), 
128.0, 132.4, 133.2, 142.1 
31P NMR (162 MHz, CDCl3) δP: 30.7. 
HRMS: (ESI) C32H41NP [M]
+ requires m/z 470.2976, found 
[M]+ 470.2980. 
IR (CHCl3) max: 3059, 3009, 2960, 2929, 2873, 1375, 1127, 
1119 cm-1. 
[]D
25 (c = 1.00, CHCl3): +366.7. 
m.p. 36-38 oC. 
 
1,1-Dimethyl-N,N-bis((S)-1-(naphthalen-2-yl) 
ethyl)phosphinamine (L13)113 
  
Prepared according to general procedure 8 from bis((S)-1-
naphthylethyl))amine (306 mg, 0.94 mmol, 1.06 equiv.), n-
butyllithium (0.6 mL, 0.9 mmol, 1.6 M solution in hexane), 
phosphorus trichloride (77 µL, 0.88 mmol, 1.0 equiv.) and 
methylmagnesium bromide (1.0 mL, 3.0 mmol, 3.0 equiv., 3.0 
M solution in tetrahydrofuran) to yield L13 as a colourless oil 
which solidified in the freezer (329 mg, 0.85 mmol, 85%). RF 
(pentane/diethyl ether 5:1) 0.61. 
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1H NMR (400 MHz, CDCl3) δH: 1.19 (3H, d, J = 6.0 Hz, P-
CH3), 1.31 (3H, d, J = 6.0 Hz, P-CH3), 1.74 (6H, d, J = 7.0 Hz 
CH3amide), 4.48–4.56 (2H, m, CHamide), 7.12–7.14 (2H, d, J = 
8.5 Hz, Ar), 7.37–7.43 (5H, m, Ar), 7.51–7.58 (4H, m, Ar), 
7.70–7.72 (2H, m, Ar), 7.87–7.92 (1H, m, Ar).   
13C NMR (100 MHz, CDCl3) δC: 17.0 (d, J = 14.0 Hz), 17.5 (d, 
J = 17.5 Hz), 21.3 (d, J = 9.0 Hz), 53.3 (d, J = 7.5 Hz), 
125.4, 125.6, 125.8 (d, J = 1.5 Hz), 127.2, 127.3, 127.9, 
132.2, 133.0, 141.9. 
31P NMR (162 MHz, CDCl3) δP: 12.9. 
HRMS: (ESI) C26H28NP [M+H]
+ requires m/z 386.2029, found 
[M+H]+ 386.2028. 
IR (CHCl3) max: 3059, 3009, 2970, 1355, 1129 cm
-1. 
[]D
25 (c = 1.00, CHCl3): +420.36. 
 
Bis(pentamethylcyclopentadienyl)zirconium 
dichloride115 
 
 
To a solution of pentamethylcyclopentadiene (5.00 mL, 32.0 
mmol) in toluene (70 mL) was added n-butyllithium (20 mL, 
32 mmol, 1.6M in hexane) at 0 oC. The mixture was warmed 
to ambient temperature and stirred for a further 0.5 h. To this 
solution was added zirconium tetrachloride (3.40 g, 15.0 
182 
 
mmol) in one portion and the brown heterogeneous solution 
was refluxed for 72 h. The mixture was cooled and aqueous 
hydrochloric acid (50 mL, 2 M) added and the mixture stirred 
overnight in air. The phases were separated and aqueous 
layer extracted with chloroform (3 x 30 mL). The combined 
organic layers were concentrated then redissolved in 
chloroform (50 mL) and filtered through Celite (to remove 
lithium chloride) and re-concentrated. The crude material was 
recrystallised (toluene) to yield the title compound as yellow 
needles (3.23 g, 7.46 mmol, 50%). 
1H NMR (400 MHz, CDCl3) H: 1.99 (30H, s). 
13C NMR (100 MHz, CDCl3) C: 12.0 (CH3), 123.7 (Cquat). 
IR (CHCl3)max: 3008, 2910, 1488, 1453, 1427, 1380, 1023 
cm-1. 
m.p. 310-312 oC (lit. 311 oC).115 
General procedure 9: Synthesis of dichloroalane 
adducts51b 
 
Aluminium trichloride (11.0 g, 82.5 mmol) was dissolved in 
diethyl ether (40 mL) and added, via cannula to a suspension 
of lithium aluminium hydride (1.04 g, 27.5 mmol) in diethyl 
ether (40 mL) and the mixture stirred for 20 min at ambient 
temperature. The mixture filtered via cannula and the 
corresponding Lewis base adduct added dropwise (2.0 
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equivalents for monodentate ligands or 1.0 equivalent for 
bidentate ligands) to the filtrate. The solvent was removed 
under vacuum and product washed with anhydrous pentane (3 
x 10 mL). After drying under vacuum (5 h) it was stored in a 
glove box. 
Dichloroalane•bis(diethyl ether) (67)49 
 
Prepared as above, with the solvent concentration in vacuo to 
yield 67 as a low melting solid (3.08 g, 91%).  
1H NMR (C6D6, 400 MHz) H: 0.91 (12H, t, J = 7.2 Hz, 4 x 
CH3), 3.67 (8H, m, 4 x CH2), 4.23 (1H, broad, Al-H).  
13C NMR (C6D6, 100 MHz) C: 13.5 (CH3), 69.6 (CH2). 
 
Dichloroalane•bis(tetrahydrofuran) (68)51b 
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Prepared from dichloroalane•bis(diethyl etherate) (40 mL, 
100.1 mmol, 2.5 M solution) and tetrahydrofuran (17.8 mL, 
216.3 mmol) to yield 68 as a colourless solid (22.03 g, 90%).  
1H NMR (C6D6, 400 MHz) C: 1.38 (8 H, 4 x CH2), 3.97 (8 H, 4 
x OCH2). The Al-H signal could not be detected in spectra. 
13C NMR (C6D6, 100 MHz) C: 69.9 (OCH2), 24.9 (CH2).  
IR (nujol) max: 1841, 1600 cm
-1. 
m.p. 74 - 76 oC. 
Dichloroalane•(Dioxane) adduct (70)51a 
 
Prepared from dichloroalane•bis(diethyl etherate) (6.0 mL, 
8.25 mmol, 1.37 M solution) and dioxane (0.8 mL, 9.07 
mmol) to yield 70 as a colourless solid (1.49 g, 96%).  
1H NMR (C6D6, 400 MHz) H: 3.42 (8H, s, CH2). The Al-H 
signal could not be detected in spectra. 
13C NMR (C6D6, 100 MHz) C: 67.3 (OCH2).  
IR (nujol) max: 1884, 1685 cm
-1. 
m.p. 170 - 172 oC. 
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Dichloroalane•(DABCO) adduct (99) 
 
Prepared from dichloroalane•bis(diethyl etherate) (6.0 mL, 
8.25 mmol, 1.37 M solution) and a toluene solution (8 mL) of 
DABCO (925 mg, 8.25 mmol) to yield 99 as a colourless solid 
(1.59 g, 91%).  
No NMR data could be assigned due to insolubility of complex.  
IR (nujol) max: 1930, 1633 cm
-1. 
m.p. 270 - 272 oC. 
 
Dichloroalane•(Diglyme) adduct (102) 
 
Prepared from dichloroalane•bis(diethyl etherate) (10.0 mL, 
17.90 mmol, 1.79 M solution) and diglyme (2.5 mL, 17.5 
mmol) to yield 102 as a colourless solid (3.492 g, 89%).  
1H NMR (d8-THF, 400 MHz) H: 1.46 (6H, s, OCH3), 1.63 (4H, 
m, CH2OCH2), 1.71 (4H, m, MeOCH2). The Al-H signal could 
not be detected in spectra. 
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13C NMR (d8-THF, 100 MHz) C: 71.9 (OCH2), 70.3 (OCH2), 
57.9 (OCH3).  
IR (nujol) max: 1899, 1841 cm
-1. 
m.p. 105 - 107 oC. 
 
Dichloroalane•(N,N-dimethylpiperazine) adduct (98) 
 
Prepared from dichloroalane•bis(diethyl etherate) (10.0 mL, 
12.7 mmol, 1.27 M solution) and N,N’-dimethylpiperazine 
(1.72 mL, 12.7 mmol) to yield 98 as a colourless solid (2.45 
g, 92%).  
1H NMR (d8-THF, 400 MHz) H: 0.34 (4H, s, CH2), 0.48 (3H, s, 
NCH3). The Al-H signal could not be detected in spectra. 
13C NMR (d8-THF, 100 MHz) c: 55.0 (NCH2), 45.4 (NCH3).  
IR (nujol) max: 1797 cm
-1. 
m.p. 216 - 218 oC. 
 
Dichloroalane•bis(tetrahydropyran) (73)51a 
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Prepared from dichloroalane•bis(diethyl etherate) (10 mL, 
12.7 mmol, 1.27M solution) and tetrahydropyran (2.5 mL, 
25.4 mmol) to yield 73 as a waxy colourless solid (2.67 g, 
79%).  
1H NMR (C6D6, 400 MHz) H: 1.81 (2H, m, C
4H2), 1.28 (4H, 
m, C3H2 & C
5H2), 3.80 (4H, t, J = 5.0 Hz, C
2H2 and C
6H2). The 
Al-H signal could not be detected in spectra. 
13C NMR (C6D6, 100 MHz) C: 22.2 (C
4H2), 25.4 (C
3H2 and 
C5H2), 70.7 (C
2H2 and C
6H2). 
 
Dichloroalane•(N-methylmorpholine) adduct (100) 
 
Prepared from dichloroalane•bis(diethyl etherate) (10 mL, 
12.5 mmol, 1.25 M solution) and N-methylmorpholine (1.40 
mL, 12.5 mmol) to yield 100 as a colourless solid (2.27 g, 
91%).  
1H NMR (C6D6, 400 MHz) H: 1.94 (3H, s, CH3), 2.28 (4H, s, 
NCH2), 3.18 (4H, s, OCH2). The Al-H signal could not be 
detected in spectra. 
13C NMR (C6D6 100 MHz) C: 61.4 (CH2O), 52.4 (CH2N), 41.0 
(NCH3).  
IR (nujol) max: 1843 cm
-1. 
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m.p. 140 - 142 oC. 
 
Dichloroalane•(teteamethylethylene diamine) adduct 
(103) 
 
Prepared from dichloroalane•bis(diethyl etherate) (10 mL, 
12.5 mmol, 1.25M solution) and anhydrous N,N'-tetramethyl 
ethylenediamine (1.90 mL, 12.5 mmol) to yield 103 as a 
colourless solid (2.11 g, 78%). 
1H NMR (d8-THF, 400 MHz) H: 0.41 (12H, s, NCH3), 0.58 
(4H, s, NCH2). The Al-H signal could not be detected in 
spectra. 
13C NMR (d8-THF, 100 MHz) C: 56.0 (NCH2), 43.4 (N(CH3)2).  
IR (nujol) max: 1841, 1641 cm
-1. 
m.p. 162 - 164 oC. 
 
Dichloroalane•bis(acetonitrile) adduct (101) 
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Prepared from dichloroalane•bis(diethyl etherate) (10 mL, 
12.5 mmol, 1.25M solution) and anhydrous acetonitrile (1.3 
mL, 25.0 mmol) to yield 101 as a yellow oil (2.10 g, 93%).  
1H NMR (d3-MeCN, 400 MHz) H: 1.99 (6H, s, CH3). The Al-H 
signal could not be detected in spectra.  
13C NMR (d3-MeCN) C: 117.3 (CN), 14.0 (CH3). 
 
Dichloroalane•bis(triethylamine) adduct (104) 
 
Prepared from dichloroalane•bis(diethyl etherate) (10 mL, 
12.5 mmol, 1.25 M solution) and anhydrous triethylamine (3.5 
mL, 25.0 mmol) to yield 104 as a colourless solid (3.15 g, 
84%).  
1H NMR (C6D6, 400 MHz) H: 0.86 (12H, s, 4 x CH3), 2.46 
(4H, s, 4 x CH2). The Al-H signal could not be detected in 
spectra. 
13C NMR (C6D6, 100 MHz) C: 47.2 (NCH2), 8.5 (CH3). 
IR (nujol) max: 1872, 1638 cm
-1. 
m.p. 94 - 96 oC. 
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Dibromoalane•bis(tetrahydrofuran) (105)51b 
 
A solution of aluminium chloride (609 mg, 4.5 mmol) in 
diethylether (20 mL) was added to a solution of lithium 
aluminium hydride (520 mg, 13.7 mmol) in diethyl ether (20 
mL) and stirred for 20 min. The lithium chloride was removed 
via cannula filtration under argon and a solution of aluminium 
tribromide (9.76 g, 36.6 mmol) in diethyl ether (20 mL) was 
added to the filtrate and the mixture stirred for 15 min. 
Anhydrous THF (8.9 mL, 110 mmol) was added and mixture 
stored at -20 oC overnight to yield a white solid. The mother 
liquor was removed via cannula and the solid dried in vacuo 
for 5 h to yield 105 as a white solid (13.13 g, 72%).  
1H NMR (C6D6, 400 MHz) H: 1.14 (8H, m, 4 x CH2), 3.72 (8H, 
m, 4 x OCH2). The Al-H signal could not be detected in 
spectra. 
13C NMR (C6D6, 100 MHz) C: 24.9 (CH2), 69.8 (OCH2).  
IR (nujol) max: 1851 cm
-1. 
m.p. 58 - 60 oC. 
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General Procedure 10: Cp*2ZrCl2-catalysed 
hydroalumination-cross coupling 
 
A Radley’s carousel reaction tube was charged with 
dichloroalane•bis(tetrahydrofuran) (1.02 g, 4.20 mmol, 2.1 
equiv.) and bis(pentamethylcyclopentadienyl)zirconium 
dichloride (60 mg, 0.14 mmol, 5.0 mol% based on alkyne) in 
the glove box. Under an inert atmosphere, tetrahydrofuran (4 
mL) and alkyne (2.80 mmol, 1.4 equiv.) were added, the 
reaction mixture stirred at reflux for 4 h and then removed 
from the heat. In a flame-dried, stirrer-equipped Schlenk tube 
under an inert atmosphere, X-Phos (38 mg, 0.08 mmol, 4.0 
mol% based on ArX), 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct  
(31 mg, 0.030 mmol, 1.5 mol% based on ArX) and 1,4-
diazabicyclo[2.2.2]octane (0.160 g, 1.40 mmol, 0.7 equiv.) 
were dissolved in tetrahydrofuran (4 mL) and transferred to 
the reaction mixture via cannula. Aryl halide (2.00 mmol, 1.0 
equiv.) was added and the reaction mixture was heated at 
reflux for 2 h. Hydrochloric acid (2 M, 6 mL) was added, the 
layers were separated and the aqueous phase was extracted 
with dichloromethane (3 x 5 mL). The combined organic 
extracts were evaporated under reduced pressure to give the 
crude product, which was purified by flash column 
chromatography (solid load). Alternatively, for acid sensitive 
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substrates the reaction was quenched with aqueous Rochelle's 
salt (saturated, 6 mL) and the same extraction procedure as 
above used. 
General Procedure 11: 2H{1H} and 1H NMR 
monitoring of hydroalumination  
 
Hydroaluminations were carried out as described above. The 
crude mixture of alanes (from alkyne (2.80 mmol) and 
dichloroalane bis(tetrahydrofuran) (4.20 mmol) in 
tetrahydrofuran (4 mL) was quenched with deuterium oxide 
(0.50 mL) at room temperature. The crude reaction mixture 
was apportioned into two equal parts. To the first part 
deuterated chloroform (50 L, internal standard) was added 
and the 2H{1H} spectrum acquired. 
The 2H{1H} spectra were run unlocked and the signals were 
recorded on the lock channel. Samples were shimmed by 
means of gradient shimming using the 1H signal of the 
solvent. The ‘zgig2h’ pulse sequence of a Bruker AVANCE I 
type instrument was used and the 2H spectra acquired using 
power gated 1H decoupling. Use of coupled 2H spectra was 
ineffective due to signal overlaps in the alkene region. The 
relative populations of (E)-109:(Z)-109:110:111:112:113 
(R = C8H17, Y = Cl) were determined by the integrals of the 
singlets at D 4.97 (=C(1)D), 5.03 (=C(1)D’), 5.85 (=C(2)D), 
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1.95 (≡CD), 0.93 (-CD2H), 1.31 (-CHD-) respectively of the D-
quenched products. No evidence for the formation of n-
C8H17CD2CH3 (potentially from double C(2)-Al addition) was 
detected and its concentration was assumed minimal.  The 
second part of the reaction mixture was evaporated to a crude 
oil. The alkyne conversion was determined by comparison of 
the 1H NMR spectrum of the residual 1-decyne  ≡CH integral 
at H 1.95 to integral of the non-terminal alkene signal at H 
5.85 after correction for deuterium incorporation. Total 
deuterium incorporation in the 1-decene was determined by 
GC-MS, while the fraction at C(1)/C(2) was available from the 
2H{1H} studies above. 
 
(E)-stilbene (115)116 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (59 mg, 
0.14 mmol), phenylacetylene (310 L, 2.80 mmol), X-Phos 
(39 mg, 0.080 mmol), 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct 
(31 mg, 0.03 mmol), 1,4-diazabicyclo[2.2.2]octane (157 mg, 
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1.40 mmol) and bromobenzene (210 L, 2.00 mmol) to yield 
115 (338 mg, 94 %) as a white crystalline solid; RF (pentane) 
0.30. 
1H NMR (400 MHz, CDCl3): δH 7.14 (2H, s, C
7H & C8H), 7.32-
7.26 (2H, m, C2H & C12H), 7.41-7.35 (4H, m, C1H, C3H, C11H & 
C13H), 7.56-7.50 (4H, m, C4H, C6H, C10H & C14H). 
13C NMR (100.6 MHz, CDCl3): δC 126.5 (Ar), 127.6 (Ar), 
128.7 (C7 & C8), 137.3 (Ar). 
IR (CHCl3) max: 3081, 3062, 3011, 1600, 1497, 1452, 961 
cm-1. 
m.p. 122-124 oC (lit. 122 oC).116 
HRMS: (EI) C14H12 [M]
+ requires m/z 180.0939, found [M]+ 
180.0943. 
 
(E)-(2-(Cyclohex-1-en-1-yl)vinyl)benzene (116)117 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (510 mg, 2.10 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (45 mg, 
0.10 mmol), 1-ethynylcyclohexene (164 L, 1.40 mmol), X-
Phos (19 mg, 0.040 mmol), 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct 
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(15 mg, 0.015 mmol), 1,4-diazabicyclo[2.2.2]octane (79 mg, 
0.70 mmol), and bromobenzene (100 L, 1.00 mmol) and 
quenched with Rochelle’s salt (3 mL of saturated aqueous 
solution) afforded 116 (125 mg, 68%) as a colourless oil; RF 
(pentane) 0.25. 
1H NMR (400 MHz, CDCl3): H 1.65 – 1.71 (2H, m, c-hex), 
1.74 – 1.80 (2H, m, c-hex), 2.22 – 2.24 (2H, m, c-hex), 2.33-
2.39 (2H, m, c-hex), 5.94 (1H, t, J = 4.5 Hz, C14H), 6.49 (1H, 
d, J = 16.5 Hz, C8H), 6.82 (1H, d, J = 16.5 Hz, C9H), 7.22 
(1H, tt, J = 7.0, 1.5 Hz, C3H(Ar)), 7.33 (2H, tt, J = 7.5, 1.5 
Hz, C1H(Ar), C5H(Ar)), 7.44 (2H, dt, J = 7.0, 1.5 Hz, C2H(Ar) 
and C4H(Ar)). 
13C NMR (100.6 MHz, CDCl3): C 22.5 (CH2(c-hex)), 22.6 
(CH2(c-hex)), 24.6 (CH2(c-hex)), 26.2 (CH2(c-hex)), 124.6 
(C14), 126.1 (C1 and C5), 126.8 (C3), 128.5 (C2) and C4), 
130.8 (C7), 132.6 (C8), 135.8 (C9), 138.0 (C6). 
IR (CHCl3) max: 3010, 2930, 2861, 1632, 1616, 1494, 1447, 
962 cm-1. 
HRMS: (EI) C14H16 [M]
+ requires m/z 184.1252, found [M]+ 
184.1254. 
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(E)-(6-Chlorohex-1-en-1-yl)benzene (117) 
  
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (510 mg, 2.10 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (30 mg, 
0.07 mmol), 6-chlorohexyne (169 L, 1.40 mmol), X-Phos (19 
mg, 0.040 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (15 mg, 0.015 mmol), 1,4-
diazabicyclo[2.2.2]octane (117 mg, 0.700 mmol), and 
bromobenzene (100 L, 1.00 mmol) and quenched with 
Rochelle’s salt (3 mL of saturated aqueous solution) afforded 
117 (125 mg, 68%) as a colourless oil; RF (pentane) 0.49. 
1H NMR (400 MHz, CDCl3): H 1.60–1.67 (2H, m, C
10H2), 
1.80–1.88 (2H, m, C11H2), 2.22–2.28 (2H, m, C
9H2), 3.57 (2H, 
t, J = 7.0 Hz, C12H2), 6.25 (1H, dt, J = 16.0, 7.0 Hz, C
8H), 
6.40 (1H, d, J = 16.0 Hz, C7H), 7.18–7.22 (1H, m, C2H), 
7.27–7.31 (2H, m, C1H & C3H), 7.31–7.35 (2H, m, C6H & 
C4H). 
13C NMR (100.6 MHz, CDCl3): C 26.5 (C10), 32.1 (C11), 32.2 
(C9), 44.9 (C12), 125.9 (C4 & C6), 126.9 (C8), 128.5 (C1 & 
C3), 130.1 (C2), 130.5 (C7), 137.7 (C5). 
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IR (CHCl3)max: 3058, 3025, 2935, 2860, 1493, 1447, 965 
cm-1. 
HRMS: (EI) C12H15
35Cl [M]+ requires m/z 194.0862, found 
[M]+  194.0875. 
 
 (E)-(2-Cyclopropylvinyl)benzene (118)118 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (510 mg, 2.10 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (30 mg, 
0.07 mmol), cyclopropylacetylene (118 L, 1.40 mmol), X-
Phos (19 mg, 0.040 mmol), 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct 
(15 mg, 0.015 mmol), 1,4-diazabicyclo[2.2.2]octane (117 mg, 
0.700 mmol), and bromobenzene (100 L, 1.00 mmol) and 
quenched with Rochelle’s salt (3 mL of saturated aqueous 
solution) afforded 118 (140 mg, 97%) as a colourless oil; RF 
(pentane) 0.44. 
1H NMR (400 MHz, CDCl3): H 0.44–0.63 (2H, m, 
cyclopropyl), 0.72–0.96 (2H, m, cyclopropyl), 1.50–1.68 (1H, 
m, C9H), 5.76 (1H, dd, J = 16.0, 9.0 Hz, C8H), 6.50 (1H, d, J 
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= 16.0 Hz, C7H), 7.17–7.21 (1H, m, C2H), 2.28–7.34 (4H, m, 
C1H, C3H, C4H, C6H). 
13C NMR (100.6 MHz, CDCl3): C 7.2 (C10 and C11), 14.5 
(C9), 125.6 (C4 & C6), 126.5 (C2), 127.4 (C7), 128.5 (C1 & 
C3), 134.9 (C8), 137.8 (C5). 
IR (CHCl3)max: 3081, 3024, 3004, 1650, 1489, 1428, 954 
cm-1. 
HRMS: (EI) C11H12  [M]
+ requires m/z 144.0939, found [M]+  
144.0940. 
 
(E)-1-Phenyl-1-octene (119)119 
  
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (64 mg, 
0.15 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (164 mg, 1.46 mmol) and 
bromobenzene (210 L, 2.00 mmol) afforded 119 (367 mg, 
98%) as a colourless oil; RF (pentane) 0.70.  
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1H NMR (400 MHz, CDCl3): δH 0.97-0.87 (3H, m, C
14H3), 
1.43-1.22 (6H, m, C11H2-C
13H2), 1.55-1.44 (2H, m, C
10H2), 
2.24 (2H, q, J = 7.0 Hz, C9H2), 6.26 (1H, dt, J = 16.0, 7.0 Hz, 
C8H), 6.41 (1H, d, J = 16.0 Hz, C7H), 7.22 (1H, t, J = 8.0 Hz, 
C4H), 7.32 (2H, t, J = 8.0 Hz, C5H & C3H), 7.38 (2H, d, J = 8.0 
Hz, C6H & C2H). 
13C NMR (100.6 MHz, CDCl3): δC 14.1 (C14), 22.6 (C13), 28.9 
(C12), 29.4 (C11), 31.8 (C10), 33.1 (C9), 125.9 (C5 and C3), 
126.7 (C1), 128.4 (C2 and C6), 129.7 (C7), 131.2 (C8), 138.0 
(C4). 
IR (CHCl3)max: 3062, 3009, 2958, 2928, 2856, 1494, 956 
cm-1. 
HRMS: (EI) C14H20 [M]
+ requires m/z 188.1565, found [M]+  
188.1564. 
 
 (E)-(2-Cyclohexylvinyl)benzene (121) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (510 mg, 2.10 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (45 mg, 
0.14 mmol), cyclohexylacetylene (183 L, 1.40 mmol), X-Phos 
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(19 mg, 0.040 mmol), 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct 
(15 mg, 0.015 mmol), 1,4-diazabicyclo[2.2.2]octane (158 mg, 
1.41 mmol) and bromobenzene (100 L, 1.00 mmol) afforded 
121 (175 mg, 94 %) as a pale yellow oil; RF (pentane) 0.42. 
1H NMR (400 MHz, CDCl3): δH 1.17–1.25 (3H, m, c-hex), 
1.27–1.36 (2H, m, c-hex), 1.66–1.71 (1H, m, c-hex), 1.75–
1.83 (4H, m, c-hex), 2.10–2.23 (1H, m, c-hex), 6.21 (1H, dd, 
J = 16.0, 7.0 Hz, C8H), 6.38 (1H, d, J = 16.0 Hz, C7H), 7.18–
7.20 (1H, m, C2H), 7.27–7.30 (2H, m, C1H & C3H), 7.34–7.36 
(2H, m, C4H & C6H).  
13C NMR (100.6 MHz, CDCl3): δC 26.1 (C11 and C13), 26.3 
(C12), 33.1 (C10 & C14), 41.3 (C9), 126.1 (C7), 126.8 (C6), 
127.4 (C1), 128.6 (C3), 130.4 (C8), 137.6 (C2).   
IR (CHCl3)max: 3736, 3690, 2928, 2853, 1647, 1600, 1490, 
909 cm-1. 
HRMS: (EI) C14H16 [M]
+ requires m/z 186.1409, found [M]+  
186.1415. 
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(E)-(5-(Benzyloxy)pent-1-en-1-yl)benzene (124)120 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), ((pent-4-yn-1-yloxy)methyl)benzene (487 mg, 
2.80 mmol), X-Phos (38 mg, 0.080 mmol), 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct 
(31 mg, 0.030 mmol), 1,4-diazabicyclo[2.2.2]octane (157 mg, 
1.40 mmol) and bromobenzene (210 L, 2.00 mmol) to 
afforded 124 (356.2 mg, 75%) as a colourless oil; RF 
(pentane/diethyl ether 1:1) 0.36.  
1H NMR (400 MHz, CDCl3): H 1.91 - 1.94 (2H, m, C
10H2), 
2.40 (2H, dtd, J = 8.0, 7.0, 1.0 Hz, C9H2), 3.60 (2H, t, J = 6.5 
Hz, C11H2), 4.60 (2H, s, C
19H2) 6.28 (1H, dt, J = 16.0, 7.0 Hz, 
C8H), 6.45 (1H, dt, J = 16.0, 1.0 Hz, C7H), 7.40 - 7.48 (10H, 
m, Ar). 
13C NMR (100.6 MHz, CDCl3): C 29.0 (C10), 29.5 (C9), 69.7 
(C11), 73.0 (C19), 125.7 (C4 and C6), 126.1 (C7), 127.9 
(C14 and C16 and C18), 128.2 (C15 and C17), 128.3 (C1 and 
C3), 128.9 (C2), 130.3 (C8), 137.8 (C5), 138.6 (C13). 
202 
 
IR (CHCl3) max: 3065, 3009, 2940, 2862, 1495, 1453, 1100, 
965, 909 cm-1.  
HRMS: (EI) C18H20O [M]
+ requires m/z 252.1514, found [M]+  
252.1524 
 
(E)-5-Phenylpent-4-en-1-ol (125)121 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (31 mg, 
0.070 mmol), 5-pentynol (130 L, 1.40 mmol), X-Phos (19 
mg, 0.040 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (16 mg, 0.015 mmol), 1,4-
diazabicyclo[2.2.2]octane (79 mg, 0.70 mmol), indium(III) 
chloride (31 mg, 0.14 mmol) and bromobenzene (110 L, 1.00 
mmol) afforded 125 (99.1 mg, 61%) as a yellow oil; RF 
(pentane/diethyl ether 1:1) 0.44.  
1H NMR (400 MHz, CDCl3): H 1.81 - 1.87 (2H, m, C
10H2), 
2.35 (2H, dtd, J = 8.0, 7.0, 1.5 Hz, C9H2), 3.75 (2H, t, J = 6.5 
Hz, C11H2), 6.27 (1H, dt, J = 16.0, 7.0 Hz, C
8H), 6.45 (1H, dt, 
J = 16.0, 1.5 Hz, C7H), 7.23 - 7.28 (1H, m, C2H), 7.35 - 7.40 
(4H, m, C1H, C3H, C4H and C6H).  
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13C NMR (100.6 MHz, CDCl3): C 29.3 (C9), 32.3 (C10), 62.4 
(C11), 125.9 (C4 and C6), 126.9 (C2), 128.5 (C1 and C3), 
130.3 (C7), 130.0 (C8), 137.6 (C5).  
IR (CHCl3)max: 3624, 2938, 2255, 1599, 1056, 966 cm
-1. 
HRMS: (EI) C11H14O [M]
+ requires m/z 162.1045, found [M]+  
162.1045. 
 
(E)-Methyl 4-(oct-1-en-1-yl)benzoate (128)122 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and methyl-4-
bromobenzoate (430 mg, 2.00 mmol) afforded 128 (417.8 
mg, 85%) as a yellow oil; RF (pentane/diethyl ether 10:1) 
0.44.  
1H NMR (400 MHz, CDCl3): H 0.92 (3H, t, J = 7.0 Hz, C
14H3), 
1.33 - 1.38 (6H, m, C11H2-C
13H2), 1.48 - 1.50 (2H, m, C
10H2), 
2.26 (2H, dtd, J = 7.6, 5.5, 2.0 Hz, C9H2), 3.92 (3H, s, C
18H3) 
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6.37 (1H, dt, J = 16.0, 5.5 Hz, C8H), 6.44, (1H, d, J = 16.0 
Hz, C7H), 7.41 (2H, d, J = 8.5 Hz, C4H and C6H), 7.98 (2H, d, 
J = 8.5 Hz, C1H and C3H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C14), 22.6 (C13), 28.9 
(C12), 29.1 (C11), 31.7 (C10), 33.2 (C9), 51.9 (C18), 125.7 
(C4 and C6), 128.2 (C5), 128.9 (C8), 129.9 (C1 and C3), 
134.3 (C7), 142.5 (C2), 167.0 (C15).  
IR (CHCl3)max: 3008, 2955, 2929, 2857, 1715, 1606, 1436, 
1328, 1112, 969 cm-1.  
HRMS: (EI) C16H22O2  [M]
+ requires m/z 246.1620, found [M]+  
246.1621. 
 
(E)-1-Nitro-3-(oct-1-en-1-yl)benzene (129)122 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 3-
nitrobromobenzene (404 mg, 2.00 mmol) afforded 129 (215 
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mg, 55%) as a light brown oil; RF (pentane/diethyl ether 
49:1) 0.36. 
1H NMR (400 MHz, CDCl3): H 0.92 (3H, t, J = 7.0 Hz, C
15H3), 
1.34 - 1.38 (6H, m, C12H2-C
14H2), 1.51 - 1.55 (2H, m, C
11H2), 
2.27 (2H, dtd, J = 7.0, 6.0, 2.0 Hz, C10H2), 6.38 (1H, dt, J = 
16.0, 6.0 Hz, C8H), 6.44, (1H, d, J = 16.0 Hz, C7H), 7.46 (1H, 
app t, J = 8.0 Hz, C3H), 7.63 (1H, dt, J = 7.0, 1.0 Hz, C2H), 
8.04 (1H, m, C4H), 8.20 (1H, app t, J = 2.0 Hz, C6H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C15), 22.6 (C14), 28.9 
(C13), 29.0 (C12), 31.7 (C11), 33.0 (C10), 120.5 (C4), 121.4 
(C6), 127.6 (C5), 129.3 (C8), 131.8 (C2), 134.7 (C7), 139.7 
(C3), 147.2 (C1).  
IR (CHCl3)max: 2958, 2929, 2857, 1529, 1352, 964 cm
-1.  
HRMS: (EI) C14H19NO2  [M]
+ requires m/z 233.1416, found 
[M]+ 233.1407. 
 
(E)-1-(Oct-1-en-1-yl)-4-(trifluoromethyl)benzene (130) 
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Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
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0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 4-
(trifluoromethyl)bromobenzene (280 L, 2.00 mmol) afforded 
130 (484.1 mg, 94%) as a colourless oil; RF (pentane) 0.52.  
1H NMR (400 MHz, CDCl3): H 0.93 (3H, t, J = 7.0 Hz, C
15H3), 
1.34 - 1.38 (6H, m, C12H2-C
14H2), 1.51 - 1.55 (2H, m, C
11H2), 
2.27 (2H, dtd, J = 7.5, 7.0, 1.0 Hz, C10H2), 6.35 (1H, dt, J = 
16.0, 7.5 Hz, C8H), 6.42 - 6.44, (1H, m, C7H), 7.44 (2H, d, J 
= 8.5 Hz, C1H and C3H), 7.55 (2H, d, J = 8.5 Hz, C4H and 
C6H). 
13C NMR (100.6 MHz, CDCl3): C 14.1 (C15), 22.6 (C14), 28.9 
(C13), 29.3 (C12), 31.7 (C11), 33.0 (C10), 118.6 (C1 and 
C3), 123.5 (q, J = 272.0 Hz, CF3), 129.4 (C4 and C6), 129.5 
(C7), 130.5 (C5), 131.6 (C8), 139.4 (C2).  
19F NMR (376.5 MHz, CDCl3): F -69.3.  
IR (CHCl3)max: 2958, 2929, 2857, 1615, 1329, 1166, 1124, 
968 cm-1.  
HRMS: (EI) C15H19F3 [M]
+ requires m/z 256.1439, found [M]+ 
256.1441.  
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(E)-3-(Oct-1-en-1-yl)benzonitrile (132) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 3-
bromobenzonitrile (364 mg, 2.00 mmol) afforded  132 (398.1 
mg, 94%) as a yellow oil; RF (pentane/diethyl ether 19:1) 
0.14.  
1H NMR (400 MHz, CDCl3): H 0.92 (3H, t, J = 7.0 Hz, C
15H3), 
1.33 - 1.38 (6H, m, C12H2-C
14H2), 1.50 - 1.55 (2H, m, C
11H2), 
2.24 (2H, dtd, J = 7.0, 6.0, 1.0 Hz, C10H2), 6.32 (1H, dt, J = 
16.0, 6.0 Hz, C8H), 6.36, (1H, dt, J = 16.0, 1.0 Hz, C7H), 7.40 
(1H, t, J = 8.0 Hz, C1H), 7.47 (1H, dt, J = 8.0, 1.5 Hz, C2H), 
7.55 (1H, dt, J = 8.0, 1.5 Hz, C6H), 7.62 (1H, s, C4H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C15), 22.6 (C14), 28.9 
(C13), 29.0 (C12), 31.7 (C11), 33.0 (C10), 112.6 (C5), 118.9 
(CN), 127.7 (C1), 129.2 (C2), 129.4 (C8), 130.0 (C4), 130.1 
(C6), 134.3 (C7), 139.2 (C3). 
208 
 
IR (CHCl3)max: 3009, 2958, 2929, 2857, 2232, 1651, 1598, 
1466, 964 cm-1.  
HRMS: (EI) C15H19N [M]
+ requires m/z 213.1517, found [M]+  
213.1517. 
 
(E)-1-Methyl-4-(oct-1-en-1-yl)benzene (133)124 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and from 4-
bromotoluene (342 mg, 2.00 mmol) afforded 133 (375.3 mg, 
87%) as a colourless oil; RF (pentane) 0.50.  
1H NMR (400 MHz, CDCl3): H 0.93 (3H, t, J = 7.0 Hz, C
15H3), 
1.33 - 1.38 (6H, m, C12H2-C
14H2), 1.42 - 1.45 (2H, m, C
11H2), 
2.20 (2H, dtd, J = 7.5, 7.0, 1.0 Hz, C10H2), 2.35 (3H, s, C
9H3) 
6.20 (1H, dt, J = 15.0, 7.0 Hz, C8H), 6.35, (1H, d, J = 15.0 
Hz, C7H), 7.13 (2H, d, J = 8.0 Hz, C4H and C6H), 7.25 (2H, d, 
J = 8.0, C1H and C3H). 
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13C NMR (100.6 MHz, CDCl3): C 14.1 (C15), 21.1 (C9), 22.6 
(C14), 28.9 (C13), 29.4 (C12), 31.7 (C11), 33.0 (C10), 125.8 
(C1 and C3), 129.1 (C4 and C6), 129.5 (C8), 130.2 (C7), 
136.4 (C2), 135.1 (C1).  
IR (CHCl3)max: 3009, 2958, 2928, 2857, 2735, 1702, 1512, 
1019 cm-1.  
HRMS: (EI) C15H22 [M]
+ requires m/z 202.1722, found [M]+  
202.1726. 
 
(E)-1-Methyl-3-(oct-1-en-1-yl)benzene (134) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 3-
bromotoluene (240 L, 2.00 mmol) afforded 134 (384 mg, 95 
%) as a colourless oil; RF (pentane) 0.47. 
1H NMR (400 MHz, CDCl3): H 0.93 (3H, t, J = 7.0 Hz, C
15H3), 
1.33 - 1.37 (6H, m, C12H2-C
14H2), 1.55 - 1.58 (2H, m, C
11H2), 
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2.22 (2H, dtd, J = 7.5, 7.0, 1.0 Hz, C10H2), 2.36 (3H, s, C
9H3) 
6.24 (1H, dt, J = 16.0, 7.0 Hz, C8H), 6.37, (1H, dt, J = 16.0, 
1.0 Hz, C7H), 7.03 (1H, d, J = 8.0 Hz, C2H, 7.17 - 7.19 (1H, 
m, C3H), 7.20 (1H, s, C6H), 7.22 (1H, d, J = 8.0 Hz, C4H). 
13C NMR (100.6 MHz, CDCl3): C 14.1 (C15), 21.4 (C9), 22.6 
(C14), 28.9 (C13), 29.3 (C12), 31.7 (C11) 33.1 (C10), 123.1 
(C2), 126.6 (C4), 127.7 (C3), 128.4 (C8), 129.7 (C7), 131.0 
(C6), 137.9 (C1), 137.9 (C3).  
IR (CHCl3)max: 3009, 2958, 2928, 2857, 2735, 1702, 1512, 
1019 cm-1.  
HRMS: (EI) C15H22 [M]
+ requires m/z 202.1722, found [M]+  
202.1718. 
 
(E)-1-Methyl-2-(oct-1-en-1-yl)benzene (135)122 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 2-
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bromotoluene (240 L, 2.00 mmol) afforded 135 (370.9 mg, 
92%) a colourless oil; RF (pentane) 0.54.  
1H NMR (400 MHz, CDCl3): H 0.91 (3H, t, J = 7.0 Hz, C
15H3), 
1.35 - 1.38 (6H, m, C12H2-C
14H2), 1.55 - 1.58 (2H, m, C
11H2), 
2.25 (2H, dtd, J = 7.5, 7.0, 1.0 Hz, C10H2), 2.35 (3H, s, C
9H3) 
6.12 (1H, dt, J = 15.5, 7.5 Hz, C8H), 6.60 (1H, dt, J = 15.5, 
1.0 Hz, C7H), 7.14 - 7.20 (3H, m, C1H and C2H and C6H), 7.43 
- 7.45 (m, 1H, C3H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C15), 19.8 (C9), 22.6 
(C14), 28.7 (C13), 29.4 (C12), 31.7 (C11), 33.3 (C10), 125.4 
(C2), 125.9 (C1), 126.7 (C8), 127.5 (C3), 130.1 (C6), 132.6 
(C7), 134.8 (C4), 137.1 (C5).  
IR (CHCl3)max: 3009, 2958, 2928, 2857, 2735, 1702, 1512, 
1019 cm-1.  
HRMS: (EI) C15H22 [M]
+ requires m/z 202.1722, found [M]+  
202.1726. 
 
(E)-1,3-Dimethyl-5-(oct-1-en-1-yl)benzene (137) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
212 
 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 5-bromo-
m-xylene (368 mg, 2.00 mmol) afforded 137 (412 mg, 95%) 
as a colourless oil; RF (pentane) 0.44.  
1H NMR (400 MHz, CDCl3): H 0.93 (3H, t, J = 7.0 Hz, C
16H3), 
1.34 - 1.38 (6H, m, C13H2-C
15H2), 1.50 - 1.55 (2H, m, C
12H2), 
2.21 (2H, dtd, J = 7.5, 7.0, 1.0 Hz, C11H2), 2.33 (6H, s, C
9H3 
& C10H3), 6.25 (1H, dt, J = 16.0, 7.5 Hz, C
8H), 6.37 (1H, dt, J 
= 16.0, 1.0 Hz, C7H), 6.57 (1H, s, C2H), 7.00 (2H, s,  C4H and 
C6H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C16), 21.3 (C9 and 
C10), 22.6 (C15), 28.9 (C14), 29.4 (C13), 31.8 (C12), 33.0 
(C11), 123.8 (C4) and C6), 128.5 (C8), 129.8 (C2), 130.9 
(C7), 137.8 (C5), 137.9 (C1 and C3). 
IR (CHCl3)max: 3010, 2958, 2928, 2856, 1600, 1466, 1378, 
966 cm-1.  
HRMS: (EI) C16H24 [M]
+ requires m/z 216.1878, found [M]+  
216.1880. 
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(E)-4,4,5,5-Tetramethyl-2-(2-(oct-1-en-1-yl)phenyl)-
1,3,2-dioxaborolane (138) 
  
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (510 mg, 2.10 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (45 mg, 
0.10 mmol), 1-octyne (205 L, 1.40 mmol), X-Phos (19 mg, 
0.040 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (19 mg, 0.015 mmol), 1,4-
diazabicyclo[2.2.2]octane (117 mg, 0.700 mmol) and 2-(2-
bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (219 
L, 1.00 mmol) afforded 138 (258 mg, 82%) as an orange 
oil; RF (pentane/diethyl ether 9:1) 0.69. 
1H NMR (400 MHz, CDCl3): H 0.90 (3H, t, J = 7.0 Hz, C
14H3), 
1.29–1.33 (6H, m, C11H2 - C
13H2), 1.36 (12H, s, C
17H3), 1.44–
1.54 (2H, m, C10H2), 2.19–2.26 (2H, m, C
9H2), 6.16 (1H, dt, J 
= 16.0, 7.0 Hz, C8H), 7.14–7.20 (2H, m, C7H & C6H), 7.32–
7.38 (1H, m, C2H), 7.54 (1H, d, J = 8.0 Hz, C3H), 7.74 (1H, 
dd, J = 8.0, 1.0 Hz, C1H)  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C14), 22.6 (C13), 24.9 
(C17), 28.9 (C11), 29.1 (C10), 31.8 (C12), 33.1 (C9), 83.6 
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(C15 and C16), 124.6 (C8), 125.8 (C7), 130.5 (C6), 130.8 
(C2), 131.9 (C1), 135.8 (C3), 144.2 (C5), 191.9 (C4). 
IR (CHCl3)max: 2978, 2957, 2926, 2855, 1596, 1561, 1482, 
1466, 1379, 1347, 1314, 1272, 1214, 1145, 1109, 1066, 
1041 cm-1.  
HRMS: (ESI) C20H31
10BO2 [M+Na]
+requires m/z 337.2320, 
found [M+Na]+ 337.2319. 
 
(E)-2-(Oct-1-en-1-yl)furan (139) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 2-
bromofuran (180 L, 2.00 mmol) to afforded 139 (291.6 mg, 
78%) as a yellow oil; RF (pentane) 0.48.  
1H NMR (400 MHz, CDCl3): H 0.95 (3H, t, J = 7.0 Hz, C
13H3), 
1.35 - 1.40 (6H, m, C10H2-C
12H2), 1.48 (2H, m, C
9H2), 2.21 
(2H, dt, J = 8.5, 7.0 Hz, C8H2), 6.10 (1H, d, J = 3.0 Hz, C
4H), 
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6.22 - 6.25 (2H, m, C1H and C2H), 6.39 (1H, dd, J = 3.0, 2.0 
Hz, C5H), 7.29 (1H, d, J = 2.0 Hz C6H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C13), 22.6 (C12), 28.9 
(C11), 29.3 (C10), 31.8 (C9), 33.8 (C8), 105.8 (C4), 111.1 
(C5), 118.4 (C2), 130.3 (C1), 141.3 (C6), 153.3 (C3). 
IR (CHCl3)max: 2957, 2930, 2858, 1722, 1677, 1466, 1016 
cm-1. 
HRMS: (EI) C12H18O [M]
+ requires m/z 178.1358, found [M]+  
178.1358. 
 
(E)-2-(oct-1-en-1-yl)thiophene (140)125 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 2-
bromothiophene (190 L, 2.00 mmol) afforded 140 (280.5 
mg, 72%) as a colourless oil; RF = (pentane) 0.56.  
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1H NMR (400 MHz, CDCl3): H 0.92 (3H, t, J = 7.0 Hz, C
13H3), 
1.33 - 1.40 (6H, m, C10H2-C
12H2), 1.48 - 1.52 (2H, m, C
9H2), 
2.19 (2H, dtd, J = 7.5, 7.0, 1.5 Hz, C8H2), 6.10 (1H, dt, J = 
16.0, 7.0 Hz, C2H), 6.53 (1H, ddt, J = 16.0, 1.5, 1.0 Hz, C1H), 
6.89 (1H, d, J = 3.0 Hz, C4H), 6.96 (1H, dd, J = 5.0, 3.0 Hz, 
C5H)  7.11 (1H, dt, J = 5.0, 1.0 Hz, C6H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C13), 22.6 (C12), 28.7 
(C11), 29.4 (C10), 31.7 (C9), 33.3 (C8), 122.8 (C2), 123.0 
(C6), 124.1 (C4), 127.2 (C5), 131.3 (C1), 143.3 (C3).  
IR (CHCl3)max: 3074, 3009, 2958, 2929, 2857, 1466, 955 
cm-1;  
HRMS: (EI) C12H18S [M]
+ requires m/z 194.1129, found [M]+  
194.1123. 
 
(E)-3-(Oct-1-en-1-yl)thiophene (141) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
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diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol) and 3-
bromothiophene (190 L, 2.00 mmol) afforded 141  (350.8 
mg, 90%) as a colourless oil; RF (pentane) 0.48.  
1H NMR (400 MHz, CDCl3): H 0.92 (3H, t, J = 7.0 Hz, C
13H3), 
1.32 - 1.36 (6H, m, C10H2-C
12H2), 1.47 - 1.50 (2H, m, C
9H2), 
2.19 (2H, dtd, J = 7.0, 6.0, 1.5 Hz, C8H2), 6.10 (1H, dt, J = 
16.0, 7.0 Hz, C2H), 6.41 (1H, dd, J = 16.0, 3.0 Hz, C1H), 7.07 
(1H, dd, J = 3.0, 1.5 Hz, C7H), 7.21 (1H, dd, J = 1.5, 0.5 Hz, 
C4H), 7.27 - 7.30 (1H, m, C5H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C13), 22.6 (C12), 28.9 
(C11), 29.3 (C10), 31.7 (C9), 32.9 (C8), 120.2 (C4), 123.9 
(C5), 124.9 (C7), 125.7 (C2), 131.2 (C1), 143.3 (C3).  
IR (CHCl3)max: 3009, 2958, 2928, 2856, 1495, 963 cm
-1.  
HRMS: (EI) C12H18S [M]
+ requires m/z 194.1129, found [M]+  
194.1131. 
 
(E)-3,5-Dimethyl-4-(oct-1-en-1-yl)isoxazole (143) 
  
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (510 mg, 2.10 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (45 mg, 
0.10 mmol), 1-octyne (205 L, 1.40 mmol), X-Phos (19 mg, 
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0.040 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (15 mg, 0.015 mmol), 1,4-
diazabicyclo[2.2.2]octane (117 mg, 0.700 mmol) and 4-
bromo-3,5-dimethylisoxazole (119 L, 1.00 mmol) and indium 
trichloride (46 mg, 0.21 mmol) afforded 143  (161 mg, 78%) 
as a colourless oil; RF (pentane) 0.25.  
1H NMR (400 MHz, CDCl3): δH: 0.89 (3H, t, J = 8.0 Hz, 
C15H3), 1.26–1.37 (6H, m, C
12H2-C
14H2), 1.40–1.48 (2H, m, 
C11H2), 2.15–2.21 (2H, m, C
10H2), 2.28 (3H, s, C
7H3), 2.38 
(3H, s, C6H3), 5.85 (1H, dt, J = 16.0, 7.0 Hz, C
9H), 6.00 (1H, 
dt, J = 16.0, 1.0 Hz, C8H).  
13C NMR (100.6 MHz, CDCl3): δC: 11.4 (C6), 11.6 (C7), 14.1 
(C15), 22.6 (C14), 28.8 (C12), 29.4 (C11), 31.6 (C13), 33.6 
(C10), 113.0 (C2), 117.3 (C8), 133.3 (C9), 158.3 (C3), 164.4 
(C1)  
IR (CHCl3)max: 2957, 2930, 2858, 1722, 1677, 1466, 1016 
cm-1.  
HRMS: (EI) C13H21NO [M]
+ requires m/z 207.1613, found 
[M]+  207.1623. 
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(E)-3-(Oct-1-en-1-yl)-1-tosyl-1H-indole (145) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (766 mg, 3.15 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (45 mg, 
0.11 mmol), 1-octyne (310 L, 2.10 mmol), X-Phos (19 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (16 mg, 0.015 mmol), 1,4-
diazabicyclo[2.2.2]octane (117 mg, 1.05 mmol), indium (III) 
chloride (46 mg, 0.21 mmol) and N-tosyl-3-bromoindole (350 
mg, 1.00 mmol) and quenching with Rochelle’s salt (3 mL of 
saturated aqueous solution) afforded 145 (220 mg, 77%) as a 
yellow oil; RF (pentane/diethyl ether 6:1) 0.51.  
1H NMR (400 MHz, CDCl3): H 0.94 (3H, t, J = 7.0 Hz, C
17H3), 
1.43 - 1.47 (6H, m, C14H2-C
16H2), 1.50 - 1.55 (2H, m, C
13H2), 
2.25 (2H, dtd, J = 7.5, 7.0, 1.5 Hz, C12H2), 2.35 (3H, s, 
CH3(tosyl)), 6.30 (1H, dt, J = 16.0, 7.0 Hz, C
11H), 6.45 (1H, 
d, J = 16.0 Hz, C10H), 7.20 (2H, d, J = 8.5 Hz, CH(tol)) 7.30 - 
7.40 (2H, m, C4H and C5H), 7.53 (1H, s, 1H, C8H), 7.70 (1H, 
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d, J = 7.0 Hz, C3H), 7.80 (2H, d, J = 8.5 Hz, CH(tosyl)), 8.02 
(1H, d, J = 7.0 Hz, C6H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C17), 21.5 
(CH3(tosyl)), 22.6 (C16), 28.9 (C15), 29.4 (C14), 31.7 (C13), 
33.5 (12), 113.7 (C6), 120.0 (C3), 120.3 (C4), 122.6 (C9), 
123.3 (C10), 124.7 (C8), 126.8 (C5), 126.9 (CH(tosyl) and 
CH(tosyl)), 129.3 (C2), 129.8 (CH(tosyl) and CH(tosyl)), 
132.9 (C11), 125.2 (CH(tosyl), 135.5 (C1), 144.0 (CH(tosyl)).  
IR (CHCl3)max: 3133, 3011, 2958, 2928, 2856, 1644, 1446, 
1373, 1188, 976 cm-1. 
HRMS: (EI) C23H27NO2S [M]
+ requires m/z 381.1763, found 
[M]+  381.1770. 
 
(E)-6-(Oct-1-en-1-yl)quinolone (146) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (766 mg, 3.15 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (45 mg, 
0.11 mmol), 1-octyne (310 L, 2.10 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol), indium(III) 
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chloride (46 mg, 0.21 mmol) and 6-bromoquinoline (130 L, 
1.00 mmol) and quenched with Rochelle’s salt (3 mL of 
saturated aqueous solution) afforded 146 (226 mg, 94%) as a 
yellow oil; RF (pentane/diethyl ether 1:1) 0.25. 
1H NMR (400 MHz, CDCl3): H 0.94 (3H, t, J = 7.0 Hz, C
18H3), 
1.38 - 1.42 (6H, m, C15H2-C
17H2), 1.55 - 1.60 (2H, m, C
14H2), 
2.31 (2H, dtd, J = 8.0, 7.0, 1.0 Hz, C13H2), 6.45 (1H, dt, J = 
16.0, 7.0 Hz, C12H), 6.58 (1H, d, J = 16.0 Hz, C11H), 7.42 
(1H, dd, J = 8.0, 4.0 Hz, C9H) 7.58 (1H, d, J = 1.5 Hz C3H), 
7.87 (1H, d, J = 8.5 Hz, C5H) 8.10  (1H, d, J = 8.5 Hz, C6H), 
8.18 (1H, d, J = 8.0 Hz, C8H), 8.85 (1H, dd, J = 4.0, 1.5 Hz, 
C10H).  
13C NMR (100.6 MHz, CDCl3): C 14.1 (C18), 22.6 (C17), 31.3 
(C16), 31.7 (C15), 33.1 (C14), 35.3 (C13), 124.3 (C9), 124.6 
(C4), 128.0 (C6), 128.5 (C3), 129.0 (C2), 129.3 (C11), 132.5 
(C12), 135.5 (C10), 136.2 (C5), 147.7 (C1), 149.6 (C8). 
IR (CHCl3)max: 3011, 2959, 2929, 2857, 1500, 962 cm
-1.  
HRMS: (EI) C17H21N [M]
+ requires m/z 239.1674, found [M]+ 
239.1675. 
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(1E,3E)-Deca-1,3-dien-1-ylbenzene (147)126 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (1.02 g, 4.20 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (61 mg, 
0.14 mmol), 1-octyne (410 L, 2.80 mmol), X-Phos (38 mg, 
0.080 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (31 mg, 0.030 mmol), 1,4-
diazabicyclo[2.2.2]octane (157 mg, 1.40 mmol), indium(III) 
chloride (69 mg, 0.28 mmol) and β-bromostyrene (260 L, 
2.00 mmol) afforded 147 (271 mg, 63%) as a yellow oil;  RF 
(pentane) 0.46.  
1H NMR (400 MHz, CDCl3): H 0.91 (3H, t, J = 7.0 Hz, C
16H3), 
1.31 - 1.35 (6H, m, C13H2-C
15H2), 1.45 - 1.50 (2H, m, C
12H2), 
2.17 (2H, dtd, J = 8.0, 7.0, 1.0 Hz, C11H2), 5.86 (1H, dt, J = 
15.5, 7.0 Hz, C10H), 6.25 (1H, dd, J = 15.5, 11.0 Hz, C9H), 
6.46 (1H, d, J = 15.5 Hz, C7H), 6.78 (1H, dd, J = 15.5, 11.0 
Hz, C8H) 7.28 - 7.35 (5H, m, Ar). 
13C NMR (100.6 MHz, CDCl3): C 14.1 (C16), 22.6 (C15), 29.4 
(C14), 29.7 (C13), 31.7 (C12), 33.1 (C11), 125.4 (C4) and 
C6), 126.1 (C2), 128.2 (C1) and C3), 129.9 (C8), 130.4 (C7), 
131.9 (C9), 131.3 (C10), 137.7 (C5).  
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IR (CHCl3)max: 2957, 2930, 2958, 1676, 1451, 1167, 970 
cm-1; 
HRMS: (EI) C16H22 [M]
+ requires m/z 214.1722, found [M]+ 
214.1720. 
 
(E)-Non-2-en-1-ylbenzene (148) 
 
Prepared by general procedure 10, dichloroalane 
bis(tetrahydrofuran) (510 mg, 2.10 mmol), 
bis(pentamethylcyclopentadienyl)zirconium dichloride (45 mg, 
0.10 mmol), 1-octyne (410 L, 1.40 mmol), X-Phos (19 mg, 
0.040 mmol), tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (15 mg, 0.015 mmol), 1,4-
diazabicyclo[2.2.2]octane (78 mg, 0.70 mmol), and 
benzylbromide (119 L, 1.00 mmol) afforded 148 (186 mg, 
92%) as a colourless oil;  RF (pentane) 0.60.  
1H NMR (400 MHz, CDCl3): H 0.91 (3H, t, J = 7.0 Hz, C
15H3), 
1.29–1.41 (8H, m, C11H2-C
14H2), 2.05 (2H, app dd, J = 14.0, 
7.0 Hz, C10H2), 3.35 (2H, d, J = 6.0 Hz, C
7H2), 5.49–5.62 (2H, 
m, C8H & C9H), 7.19–7.22 (3H, m, C1H, C2H, C3H), 7.29–7.32 
(2H, m, C4H & C6H). 
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13C NMR (100.6 MHz, CDCl3): C 14.1 (C15), 22.6 (C14), 28.9 
(C12), 29.5 (C11), 32.6 (C10), 34.2 (C13), 39.1 (C7), 126.9 
(C2), 128.4 (C4 & C6), 128.6 (C1 & C3), 128.8 (C9), 132.3 
(C8), 141.3 (C5).  
IR (CHCl3)max: 3084, 3064, 3009, 2958, 2928, 2855, 1602, 
1494, 1453, 969, 909 cm-1; 
HRMS: (EI) C15H22 [M]
+ requires m/z 202.1728, found [M]+ 
202.1722. 
General procedure 12: Zirconium-catalysed 
hydroalumination and conjugate addition 
 
Dichloroalane bis(tetrahydrofuran) (243 mg, 1.00 mmol, 1.0 
equiv.), decamethylzirconocene dichloride (22 mg, 0.05 mmol, 
0.05 equiv.) and 1-octyne (206 µL, 1.40 mmol, 1.4 equiv.) 
and a stir bar were added to a Schlenk tube and mixture 
heated at 80 oC for 1.5 h. Excess 1-octyne and THF was 
removed in vacuo and the mixture diluted with anhydrous 
deoxygenated diethyl ether (1.0 mL). The mixture was cooled 
to 0 oC and alkylidene malonate (0.50 mmol, 0.5 equiv.) 
added in one portion. After stirring the mixture at 0 oC (2 h) it 
was quenched with water (3.0 mL) and phases separated. The 
aqueous phase was re-extracted with dichloromethane (3 x 
3.0 mL) and the combined organics dried (sodium sulfate), 
filtered and concentrated to a crude oil. The product was 
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purified by column chromatography (silica: 9:1 
cyclohexane/ethyl acetate). 
 
(E)-Diethyl 2-(2-methylundec-4-en-3-yl)malonate (185) 
  
Prepared according to general procedure 12 from diethyl 2-(2-
methylpropylidene) malonate (108 μL, 0.500 mmol) to yield 
185 as a yellow oil (118 mg, 73%) RF (cyclohexane/ ethyl 
acetate 9:1) 0.33. 
1H NMR (400 MHz, CDCl3): δH: 0.81–0.90 (9H, m, C
5H3, C
6H3 
and C23H3); 1.21–1.29 (14H, m, C
19H2
-C22H2, C
14H3 and 
C16H3), 1.67–1.75 (1H, m C
4H), 1.96–2.00 (2H, m, C18H2); 
2.61 (1H, td, J = 10.0, 5.0 Hz, C2H); 3.48 (1H, d, J = 10.0 Hz, 
C1H); 4.10–4.23 (4H, m, C13H2 & C
15H2); 5.26 (1H, dd, J = 
15.0, 10.0 Hz, C3H); 5.47 (1H, dt, J = 15.0, 7.0 Hz, C17H). 
13C NMR (100 MHz, CDCl3) δC: 14.2 (C14), 14.3 (C16), 17.6 
(C23), 21.7 (C5 and C6), 22.8 (C20), 28.9 (C21), 29.3 (C22), 
29.6 (C4), 31.8 (C19), 32.7 (C18), 49.3 (C2), 55.6 (C1), 61.1 
(C13), 61.4 (C15), 125.9 (C3), 135.2 (C17), 168.8 and 169.9 
(C7 and C8). 
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IR (CHCl3) max: 3045, 2962, 2929, 2573, 2356, 1749, 1726 
(C=O), 1466, 1388, 1301, 1178 cm-1. 
HRMS: (EI) C19H34O4 [M]
+ requires m/z 326.2457, found [M]+ 
326.2454. 
 
(E)-Dimethyl 2-(dec-3-en-2-yl)malonate  (181) 
 
 
 
Prepared according to general procedure 12 from dimethyl 2-
ethylidenemalonate (79.1 mg, 0.500 mmol) to yield 181 as a 
colourless oil (103 mg, 76%), RF (cyclohexane/ethyl acetate 
9:1) 0.44.  
1H NMR (400 MHz, CDCl3) δH: 0.86 (3H, t, J = 7.0 Hz, C
19H3), 
1.05 (3H, d, J = 7.0 Hz, C3H3), 1.20–1.36 (8H, m, C
15H2-
C18H2), 1.93 (2H, dt, J = 7.5, 7.0 Hz, C
14H2), 2.88 - 2.95 (1H, 
m, C2H), 3.25 (1H, d, J = 9.0 Hz, C1H), 3.67 (3H, s, C12H), 
3.71 (3H, s, C13H), 5.29 (1H, dd, J = 15.0, 8.0 Hz, C4H), 5.49 
(dt, 1H, J = 15.5, 7.5 Hz, C5H). 
13C NMR (100 MHz, CDCl3) δC: 14.1 (C19), 18.7 (C3), 22.6 
(C18), 28.7 (C17), 29.4 (C16), 31.7 (C15), 32.4 (C14), 37.5 
(C2), 52.1 (C12); 52.3 (C13), 58.1 (C1); 131.1 (C5), 132.0 
(C4), 168.7 and 168.9 (C6 & C7). 
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IR (CHCl3) max: 3042, 2957, 2929, 2856, 2434, 2412, 1753, 
1732 (C=O), 1521, 1424 cm-1. 
HRMS: (EI+) C15H26O4 requires m/z 270.1831, found [M]
+ 
270.1822. 
 
(E)-Dimethyl 2-(1-cyclopropylnon-2-en-1-yl)malonate  
(186) 
  
Prepared according to general procedure 12 from dimethyl 2-
(cyclopropylmethylene) malonate (92.1 mg, 0.500 mmol) to 
yield 186 as a colourless oil (126 mg, 85%) RF (cyclohexane/ 
ethyl acetate 9:1) 0.39 
1H NMR (400 MHz, CDCl3): δH: 0.06–0.13 (1H, m, C
6H or 
C7H), 0.17–0.23 (1H, m, C6H or C7H), 0.42–0.46 (2H, m, C6H 
or C7H), 0.79–0.84 (1H, m, C3H),  0.87 (3H, t, J = 7.0 Hz, 
C21H3), 1.23–1.32 (8H, m, C
17H2-C
20H2), 1.94–1.99 (2H, m, 
C16H2), 2.07–2.13 (1H, m, C
2H), 3.49 (1H, d, J = 9.0 Hz, 
C1H), 3.69 (3H, s, C14H3), 3.75 (3H, s, C
15H3), 5.35 (1H, ddt, J 
= 15.0, 8.0, 1.0 Hz, C4H), 5.48 (1H, dt, J = 15.0, 6.0 Hz, 
C5H). 
13C NMR (100 MHz, CDCl3) δC: 3.2 and 4.8 (C6), 14.1 (C21), 
14.2 (C3), 22.7 (C20), 28.8 (C19), 29.5 (C18), 31.8 (C17), 
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32.6 (C16), 47.6 (C2), 52.3 (C14), 52.4 (C15), 57.4 (C1), 
128.8 (C4), 133.3 (C5), 168.8, (C8), 169.1 (C9). 
IR (CHCl3) max: 3082, 3007, 2955, 2928, 2872, 2856, 1753, 
1733 (C=O), 1435, 1336 cm-1. 
HRMS: (EI) C17H28O4 [M]
+ requires m/z 296.1988; found [M]+ 
296.1977. 
 
(E)-Dimethyl 2-(1-phenylnon-2-en-1-yl)malonate (189) 
  
Prepared according to general procedure 12 from dimethyl 2-
benzylidenemalonate (110 mg, 0.500 mmol) to yield 189 as a 
yellow oil (105 mg, 63%) RF (cyclohexane/ ethyl acetate 9:1) 
0.25. 
1H NMR (400 MHz, CDCl3): δH: 0.86 (3H, t, J = 7.0 Hz, 
C18H3), 1.21–1.29 (8H, m, C
14H2-C17H2), 1.93–1.98 (2H, m, 
C13H2), 3.48 (3H, s, C
9H3), 3.72 (3H, s, C
10H3), 3.82 (1H, d, J 
= 11.0 Hz, C1H), 4.02–4.07 (1H, m, C2H), 5.55–5.57 (2H, m, 
C11H and C12H), 7.20–7.22 (3H, m, C21H-C23H), 7.26–7.29 
(2H, m, C20H and C24H). 
13C NMR (100 MHz, CDCl3): δC: 14.2 (C18), 22.7 (C17), 28.8 
(C16), 29.4 (C15), 31.8 (C14), 32.6 (C13), 49.2 (C2), 52.5 
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(C9), 52.6 (C10), 58.1 (C1), 127.0 (C22), 127.9 (C20 and 
C24), 128.7 (C20 and C24), 129.3 (C11), 133.4 (C12), 141.0 
(C19), 168.1 (C3), 168.4 (C4).  
IR (CHCl3) max: 3006, 2955, 2929, 2856, 1756, 1735 (C=O), 
1454, 1435, 1318, 1260 cm-1. 
HRMS: (EI) C20H28O4 [M]
+ requires m/z 332.1988, found [M]+ 
332.1994. 
 
3-Ethylcyclohex-2-enone (8)127 
 
A flame-dried flask was charged with ethylmagnesium bromide 
(3.60 mL, 10.0 mmol) and cooled to 0 °C. The 
ethoxycyclohex-2-en-1-one (726 L, 5.00 mmol) in 
tetrahydrofuran (4 mL) was added dropwise. Once the 
addition was complete the reaction mixture was left at room 
temperature until complete disappearance of the starting 
material (1 h). The reaction was hydrolyzed by addition of 
aqueous sulfuric acid (5% w/w). Diethyl ether (5 mL) was 
added and the aqueous phase was separated and extracted 
further with diethylether (3 x 5 mL). The combined organic 
fractions were washed with aqueous sodium bicarbonate, 
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brine and water, dried over sodium sulfate, filtered and 
concentrated in vacuo. The oily residue was purified by column 
chromatography to yield 8 as a yellow oil (579 mg, 93%); RF 
(pentane/diethyl ether 4:1) 0.50. 
1H NMR (400 MHz, CDCl3) H: 1.13 (3H, t, J = 7.5 Hz, C
9H3), 
1.95-2.01 (2H, m, C2H2), 2.20-2.30 (4H, m, C
8H2 & C
3H2), 
2.35 (2H, app t, J = 6.5 Hz, C1H2), 5.87 (1H, app t, J = 1.3 
Hz, C5H). 
13C NMR (100 MHz, CDCl3) C: 11.2 (C9), 22.7 (C2), 29.7 
(C8), 30.9 (C3), 37.4 (C1), 124.5 (C5), 168.0 (C4), 200.0 
(C6). 
HRMS: (ESI) C8H12ONa [M+Na]
+
 requires 147.0764, found 
[M+Na]+ 147.0761. 
IR (CHCl3) max: 2937, 1668, 1625, 1458, 1428, 1283, 1192, 
887 cm-1  
General procedure 13: volatile alkyne 
hydroalumination and conjugate addition 
 
A 1.5 mL vial (glass screw cap vial, 854171, Supelco) was 
charged with decamethylzirconocene dichloride (21.6 mg, 
0.050 mmol, 0.05 equiv.) and dichloroalane 
bis(tetrahydrofuran) (340 mg, 1.40 mmol, 1.4 equiv.) under 
an inert atmosphere. Neat alkyne (1.00 mmol) and 
tetrahydrofuran (1.0 mL) were injected through the septum 
(9mm AG3 CenterGuide, CR246713, Varian) and mixture was 
231 
 
heated for 2 h at 80 ºC. The solution was transferred to a 
flame-dried Schlenk tube and solvent removed in vacuo and 
replaced with toluene (1.0 mL). To this was added 
methyllithium (330 L, 0.650 mmol, 2 M in diethyl ether) and 
the mixture stirred for 30 min. In a Radleys carousel tube, 
copper(I) thiophenecarboxylate (9.50 mg, 0.05 mmol) and 
ligand L3 (48 mg, 0.075 mmol) were dissolved in t-
butylmethyl ether (1.0 mL) and stirred for 15 mins. The alane 
mixture was transferred to the copper mixture via syringe and 
enone (0.5 mmol) in toluene (0.5 mL) was added over 0.5 h. 
The reaction was stirred for a further 0.5 h at 25 oC and then 
quenched with water and hydrochloric (1 M). The organic layer 
was separated and the aqueous phase was extracted with 
dichloromethane (3 x 5 mL). The combined organic phases 
were dried (sodium sulfate), filtered, and concentrated. The 
crude was purified by flash chromatography (pentane/diethyl 
ether 4:1). 
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General procedure 14: Zirconium-catalysed 
hydroalumination and conjugate addition (neat 
conditions) 
 
A dried Schlenk tube was charged dichloroalane 
bis(tetrahydrofuran) (158 mg, 0.650 mmol), 
decamethylzirconocene dichloride (14.0 mg, 0.030 mmol) and 
1-octyne (134 L, 1.40 mmol) and the mixture melted at 80 
oC for 1.5 h. The excess alkyne was removed under vacuum 
(0.1 mmHg). The resulting alane was diluted with toluene (1.0 
mL) and methyllithium added (330 L, 0.650 mmol, 2M in 
diethyl ether) and the mixture stirred for 30 min. In a Radleys 
carousel tube, copper(I) thiophenecarboxylate (9.50 mg, 
0.050 mmol) and ligand L3 (48 mg, 0.075 mmol) were and 
stirred for 15 mins in t-butylmethyl ether (1.0 mL). The 
previously prepared alane mixture was transferred to the 
copper(I) thiophenecarboxylate/L3 catalyst via syringe and 
enone (0.5 mmol) in toluene (0.5 mL) was added over 0.5 h. 
The reaction was stirred for a further 0.5 h at 25 oC and then 
quenched with water and hydrochloric acid (1 M). The organic 
layer was separated and the aqueous phase was extracted 
with dichloromethane (3 x 5 mL). The combined organic 
phases were dried (sodium sulfate), filtered, and 
concentrated. The crude was purified by flash chromatography 
(pentane/diethyl ether 4:1). 
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(S)-(E)-3-(Oct-1-en-1-yl)cyclohexanone (192)128 
 
Prepared according to general procedure 14 from 1-octyne 
(134 L, 1.40 mmol) and cyclohexenone (48 L, 0.50 mmol) 
to yield 192 as a colourless oil in 88% ee. (68 mg, 65%,) RF 
(pentane/diethyl ether 4:1) 0.56. 
1H NMR δH: 0.83 (3H, t, J = 7.0 Hz, C
15H3), 1.20–1.32 (8H, 
m, C11H2-C
14H2), 1.39–1.49 (1H, m, c-hex), 1.58–1.69 (1H, 
m, c-hex), 1.83–1.92 (1H, m, c-hex), 1.91–2.02 (3H, m, c-
hex), 2.11–2.17 (1H, m, c-hex), 2.19–2.25 (1H, m, c-hex), 
2.26–2.44 (3H, m, c-hex and C10H2), 5.31 (1H, dd, J = 16.0, 
6.0 Hz, C8H), 5.38 (1H, dt, J = 16.0, 6.5 Hz, C9H). 
13C NMR δC: 14.1 (C15), 22.6 (C2), 25.0 (C14), 28.8 (C12), 
29.4 (C11), 31.6 (C3), 31.7 (C13), 32.5 (C10), 41.3 (C1), 
41.6 (C4), 47.7 (C5), 130.0 (C9), 133.0 (C8), 211.4 (C6). 
IR (CHCl3) max: 2956, 2927, 2855, 1713, 1455, 1226, 975, 
737 cm-1. 
HRMS: (EI) C14H24O [M]
+ requires m/z 208.1827, found [M]+  
208.1833. 
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GC: (Lipodex A); Tinj = 250 
oC, Tdet = 250 
oC, flow = 2.0 mL 
min-1, ti= 75 
oC (7 min), (5 oC min-1) tf = 115 
oC (90 min), 
(0.7 oC min-1) tf = 140 
oC: (R)-enantiomer: tR = 49.19 min; 
(S)-enantiomer: tR = 49.95 min. 
[]D
25: +104.9 (c = 2.00, CHCl3). 
 
 
(S)-(E)-3-(Hex-1-en-1-yl)cyclohexanone (193)129 
 
Prepared according to general procedure 13 from 1-hexyne 
(91 L, 0.75 mmol) and cyclohexenone (48 L, 0.50 mmol) to 
yield 193 as a colourless oil in 90% ee. (62 mg, 69%) RF 
(pentane/diethyl ether 4:1) 0.58. 
1H NMR (CDCl3) δH: 0.87 (3H, t, J = 7.0 Hz, C
13H3), 1.25–
1.33 (4H, m, C11H2 & C
12H2), 1.42–1.51 (1H, m, c-hex), 1.61–
1.71 (1H, m, c-hex), 1.85–1.90 (1H, m, c-hex), 1.96–1.99 
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(2H, m, C10H2), 2.01–2.06 (1H, m, c-hex), 2.14–2.28 (2H, m, 
c-hex), 2.30–2.41 (3H, m, c-hex), 5.34 (1H, dd, J = 15.0, 6.0 
Hz, C8H), 5.41 (1H, dt, J = 15.0, 6.0 Hz, C9H). 
13C NMR (CDCl3) δC: 14.0 (C13), 22.2 (C12), 25.1 (C2), 31.6 
(C11), 31.7 (C3), 32.3 (C10), 41.4 (C4), 41.7 (C1), 47.8 (C5), 
130.1 (C9), 133 (C8), 211.8 (C6). 
IR (CHCl3)max: 2956, 2927, 2855, 1713, 1455, 1226, 975, 
737 cm-1. 
HRMS: (EI) C12H20O [M]
+ requires m/z 180.1514, found [M]+ 
180.1511. 
GC: (Lipodex A); Tinj = 250 
oC, Tdet = 250 
oC, flow = 2.0 mL 
min-1, ti= 75 
oC (7 min), (5 oC min-1) tf = 115 
oC (90 min), 
(0.7 oC min-1) tf = 140 
oC: (R)-enantiomer: tR = 22.84 min; 
(S)-enantiomer: tR = 23.12 min. 
[]D
25: -7.8 (c = 2.00, CHCl3). 
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(S)-(E)-3-(3-Methylbuta-1,3-dien-1-yl)cyclohexanone 
(194)130 
 
Prepared according to general procedure 13 from 2-methyl-1-
buten-3-yne (71 µL, 0.75 mmol) and cyclohexenone (48 L, 
0.50 mmol) to yield 194 as a colourless oil in 90% ee. (57.5 
mg, 70%) RF (pentane/diethyl ether 4:1) 0.35. 
1H NMR (CDCl3) δH: 1.49–1.59 (1H, m, c-hex), 1.64–1.76 
(1H, m, c-hex), 1.83 (3H, s, C11H3), 1.92–1.97 (1H, m, c-
hex), 2.04–2.10 (1H, m, c-hex), 2.20–2.30 (2H, m, c-hex), 
2.36–2.40 (1H, m, c-hex), 2.43–2.48 (1H, m, c-hex), 2.52–
2.61 (1H, m, c-hex), 4.92 (2H, app. s, C12H2), 5.58 (1H, dd, J 
= 16.0, 7.0 Hz, C8H), 6.14 (1H, d, J = 16.0 Hz, C9H). 
13C NMR (CDCl3) δC: 18.6 (C11), 25.0 (C2), 31.5 (C3), 41.3 
(C4), 41.7 (C1), 47.4 (C5), 115.8 (C12), 132.0 (C8), 132.8 
(C9), 141.6 (C10), 210.9 (C6). 
IR (CHCl3)max: 3083, 2942, 1707, 1608, 1448 cm
-1. 
HRMS: (EI) C11H16O [M]
+ requires m/z 164.1201, found [M]+  
164.1199. 
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GC: (Lipodex A); Tinj = 250 
oC, Tdet = 250 
oC, flow = 2.0 mL 
min-1, ti = 50 
oC, (1.0 oC min-1) tf = 160 (30 min): (R- 
enantiomer: tR = 38.56 min; (S)-enantiomer: tR = 38.70 min. 
[]D
25: -5.2 (c = 2.00, CHCl3). 
 
 
(S)-(E)-3-(2-(Cyclohex-1-en-1-yl)vinyl)cyclohexanone 
(195) 
 
Prepared according to general procedure 13 from 1-
ethynylcyclohexene (88 µL, 0.75 mmol) and cyclohexenone 
(48 L, 0.50 mmol) to yield 195 as a colourless oil in 82% ee. 
(41 mg, 40%) RF (pentane/diethyl ether 4:1) 0.31. 
1H NMR (CDCl3) δH: 1.50 - 1.54 (1H, m, c-hex), 1.56 - 1.68 
(5H, m, c-hex), 1.89 - 1.96 (1H, m, c-hex), 2.06 - 2.11 (5H, 
m, c-hex), 2.18 - 2.31 (2H, m, c-hex), 2.32 - 2.39 (1H, m, c-
hex), 2.41 - 2.46 (1H, m, c-hex), 2.49 - 2.55 (1H, m, c-hex), 
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5.46 (1H, dd, J = 16.0, 7.0 Hz, C8H), 5.69 (1H, app. s, C11H), 
6.02 (1H, d, J = 16.0 Hz, C9H). 
13C NMR (CDCl3) δC: 22.6 (C15), 22.7 (C2), 24.7 (C14), 25.2 
(C13), 25.9 (C12), 31.8 (C3), 41.2 (C4), 42.0 (C1), 47.8 (C5), 
128.8 (C11), 129.0 (C9), 132.8 (C8), 135.3 (C10), 211.4 
(C6). 
IR (CHCl3)max: 3011, 2935, 2861, 2837, 1706, 1448 cm
-1. 
HRMS: (EI) C14H20O [M]
+ requires m/z 204.1514, found [M]+  
204.1522. 
GC: (Lipodex A); Tinj = 250 
oC, Tdet = 250 
oC, flow = 2.0 mL 
min-1, ti= 75 
oC (7 min), (5 oC min-1) tf = 115 
oC (90 min), 
(0.7 oC min-1) tf = 140 
oC: (R)-enantiomer: tR = 123.96 min; 
(S)- enantiomer: tR = 125.36 min. 
[]D
25: +5.5 (c = 2.00, CHCl3). 
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(S)–(E)-3-(2-Cyclohexylvinyl)cyclohexanone (196)131 
 
Prepared according to general procedure 13 from 
cyclohexylacetylene (98 µL, 0.75 mmol) and cyclohexenone 
(48 L, 0.50 mmol) to yield 196 as a colourless oil in 82% ee. 
(53 mg, 51%) RF (pentane/diethyl ether 4:1) 0.42. 
1H NMR (CDCl3) δH: 0.98–1.08 (2H, m, c-hex), 1.11–1.31 
(4H, m, c-hex), 1.63–1.71 (6H, m, c-hex), 1.86–1.93 (2H, m, 
c-hex), 2.00–2.07 (1H, m, c-hex), 2.14–2.21 (1H, m, c-hex), 
2.23–2.29 (1H, m, c-hex), 2.32–2.36 (1H, m, c-hex), 2.37–
2.45 (2H, m, c-hex), 5.28–5.40 (2H, m, C8H & C9H). 
13C NMR (CDCl3) δC: 25.1 (C2), 26.2 (C12 & C14), 26.3 
(C13), 31.8 (C3), 32.2 (C11 & C15), 40.7 (C4), 41.4 (C10), 
41.7 (C1), 47.9 (C5), 130.4 (C8), 135.9 (C9), 211.6 (C6). 
IR (CHCl3)max: 3011, 2935, 2861, 2837, 1706, 1448 cm
-1. 
HRMS: (EI) C14H22O [M]
+ requires m/z 206.1671, found [M]+  
206.1667. 
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GC: (Lipodex A); Tinj = 250 
oC, Tdet = 250 
oC, flow = 2.0 mL 
min-1, ti = 50 
oC, (1.0 oC min-1) tf = 160 (30 min): (R)-
enantiomer: tR = 85.42 min; (S)-enantiomer: tR = 85.83 min. 
[]D
25: +3.6 (c = 2.00, CHCl3). 
 
 
(S)-(E)-3-Styrylcyclohexanone (197) 
 
Prepared according to general procedure 13 from 
phenylacetylene (82 µL, 0.75 mmol) and cyclohexenone (48 
L, 0.50 mmol) to yield 197 as a colourless oil in 80% ee. (52 
mg, 52%) RF (pentane/diethyl ether 4:1) 0.36. 
1H NMR (CDCl3) δH: 1.60–1.67 (1H, m, c-hex), 1.70–1.80 
(1H, m, c-hex), 1.99–2.06 (1H, m, c-hex), 2.07–2.14 (1H, m, 
c-hex), 2.27–2.45 (3H, m, c-hex), 2.51–2.56 (1H, m, c-hex), 
2.66–2.70 (1H, m, c-hex), 6.16 (1H, dd, J = 16.0, 7.0 Hz, 
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C8H), 6.39 (1H, d, J = 16.0 Hz, C9H), 7.21–7.24 (1H, m, 
C13H), 7.29–7.36 (4H, m, C11H, C12H, C14H, C15H). 
13C NMR (CDCl3) δC: 25.1 (C2), 31.5 (C3), 41.4 (C1), 42.1 
(C4), 47.5 (C5), 126.3 (C11 and C15), 127.5 (C13), 129.2 
(C12 & C14), 129.7 (C9), 133.0 (C8), 137.2 (C10), 211.1 
(C6). 
IR (CHCl3)max: 3402, 3058, 3026, 2936, 2865, 1711, 1598, 
1493, 1448, 1223 cm-1. 
HRMS: (EI) C14H16O [M]
+ requires m/z 200.1201, found [M]+ 
200.1203. 
HPLC: (Chircel OD-H); eluent 2% isopropanol/hexane, 1.0 
mL/min, 254 nm: (S)-enantiomer: tR = 21.6 min; (R)-
enantiomer: tR = 23.3 min. 
[]D
25: +85.5 (c = 2.00, CHCl3). 
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(S)-(E)-3-Methyl-3-(oct-1-en-1-yl)cyclohexanone (198) 
132 
 
Prepared according to general procedure 14 from 1-octyne 
(134 µL, 1.40 mmol) and 3-methyl-cyclohexenone (55 L, 
0.50 mmol) to yield 198 as a colourless oil in 94% ee. (59 
mg, 53%) RF (pentane/diethyl ether 4:1) 0.44. 
1H NMR (CDCl3) δH: 0.87 (3H, t, J = 7.0 Hz, C
15H3), 1.04 (3H, 
s, C16H3), 1.25–1.31 (8H, m, C
11H2-C
14H2), 1.57–1.62 (1H, m, 
c-hex), 1.66–1.72 (1H, m, c-hex), 1.79–1.86 (2H, m, c-hex), 
1.94–1.99 (2H, m, c-hex), 2.14 (1H, d, J = 14.0 Hz, C5H), 
2.19–2.32 (2H, m, C10H2), 2.42 (1H, dt, J = 14.0, 1.5 Hz, 
C5H), 5.28 (1H, d, J = 16.0 Hz, C8H), 5.35 (1H, dt, J = 16.0, 
6.0 Hz, C9H). 
13C NMR (CDCl3) δC: 14.2 (C15), 22.3 (C2), 22.7 (C14), 28.2 
(C16), 28.8 (C12), 29.5 (C11), 31.7 (C13), 32.8 (C10), 37.2 
(C3), 40.9 (C4), 41.0 (C1), 52.4 (C5), 128.9 (C9), 137.7 (C8), 
211.9 (C6). 
IR (CHCl3)max: 2956, 2927, 2855, 1713, 1455, 1226, 975, 
737 cm-1. 
HRMS: (EI) C15H26O [M]
+ requires m/z 222.1984, found [M]+  
222.1980. 
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GC:(octakis(2,6-di-O-methyl-3-O-pentyl--cyclodextrin); Tinj = 
250 oC, Tdet = 250 
oC, flow = 2.0 mL min-1, ti= 75 
oC (7 min), 
(5 oC min-1) tf = 115 
oC (90 min), (0.7 oC min-1) tf = 170 
oC 
(R)- enantiomer: tR = 92.94 min; (S)-enantiomer: tR = 98.54 
min. 
[]D
25: +12.7 (c = 2.00, CHCl3). 
 
 
(S)-(E)-3-(Hex-1-en-1-yl)-3-methylcyclohexanone) 
(199)133 
 
Prepared according to general procedure 13 from 1-hexyne 
(91 L, 0.75 mmol) and 3-methyl-cyclohexenone (55 L, 0.50 
mmol) to yield 199 as a colourless oil in 92% ee. (66 mg, 
68%) RF (pentane/diethyl ether 4:1) 0.47. 
1H NMR (CDCl3) δH: 0.90 (3H, t, J = 7.0 Hz, C
14H3), 1.06 (3H, 
s, C10H), 1.28–1.38 (4H, m, C12H2 & C
13H2), 1.57–1.65 (1H, 
m, c-hex), 1.65–1.74 (1H, m, c-hex), 1.81–1.90 (2H, m, c-
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hex), 1.97–2.02 (2H, m, c-hex), 2.17 (1H, d, J = 14.0 Hz, 
C5H), 2.22–2.33 (2H, m, C11H2), 2.44 (1H, dt, J = 14.0, 1.0 
Hz, C5H), 5.30 (1H, d, J = 16.0 Hz, C8H), 5.37 (1H, dt, J = 
16.0, 6.0 Hz, C9H). 
13C NMR (CDCl3) δC: 13.9 (C14), 22.1 (C2), 22.2 (C13), 28.1 
(C10), 31.6 (C12), 32.4 (C11), 37.1 (C3), 40.7 (C4), 40.9 
(C1), 52.4 (C5), 128.7 (C9), 137.5 (C8), 211.7 (C6). 
IR (CHCl3)max: 2956, 2927, 2855, 1713, 1455, 1226, 975, 
737 cm-1. 
HRMS: (EI) C13H22O [M]
+ requires m/z 194.1671, found [M]+  
194.1666. 
GC:(octakis(2,6-di-O-methyl-3-O-pentyl--cyclodextrin); Tinj = 
250 oC, Tdet = 25 
oC, flow = 2.0 mL min-1, ti=50 
oC, (1.0 oC 
min-1) tf = 160 (30 min): (R)-enantiomer: tR = 36.30 min; (S)-
enantiomer: tR = 38.22 min. 
[]D
25: +59.6 (c = 2.0, CHCl3). 
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(S)-(E)-3-Methyl-3-(3-methylbuta-1,3-dien-1-
yl)cyclohexanone (200) 
 
Prepared according to general procedure 13 from 2-methyl-1-
buten-3-yne (71 µL, 0.75 mmol)) and 3-methyl-
cyclohexenone (55 L, 0.50 mmol) to yield 200 as a 
colourless oil in 98% ee. (51 mg, 57%); RF (pentane/diethyl 
ether 4:1) 0.31. 
1H NMR (CDCl3) δH: 1.09 (3H, s, C
13H3), 1.60–1.69 (1H, m, c-
hex), 1.74–1.79 (1H, m, c-hex), 1.81 (3H, s, C12H3), 1.83–
1.92 (2H, m, c-hex), 2.20 (1H, d, J = 14.0 Hz, C5H), 2.24–
2.34 (2H, m, c-hex), 2.47 (1H, dt, J = 14.0, 1.0 Hz, C5H), 
4.93 (2H, app. s, C11H2), 5.52 (1H, d, J = 16.0 Hz, C
8H), 6.08 
(1H ,d, J = 16.0 Hz, C9H). 
13C NMR (CDCl3) δC: 18.7 (C12), 22.3 (C2), 22.7 (C13), 37.2 
(C3), 41.0 (C1), 41.1 (C4), 52.5 (C5), 116.0 (C11), 130.7 
(C9), 137.5 (C8), 141.7 (C10), 211.4 (C6). 
IR (CHCl3)max: 3010, 2959, 2929, 2872, 1704, 1455, 1378, 
972, 892 cm-1. 
HRMS: (EI) C12H18O [M]
+ requires m/z 178.1358, found [M]+  
178.1356. 
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GC:(octakis(2,6-di-O-methyl-3-O-pentyl--cyclodextrin); Tinj = 
250 oC, Tdet = 250 
oC, flow = 2.0 mL min-1, ti = 50 
oC, (1.0 oC 
min-1) tf = 160 (30 min): (R)- enantiomer: tR = 66.51 min; 
(S)- enantiomer: tR = 67.85 min. 
[]D
25: +29.0 (c = 2.00, CHCl3). 
 
 
(S)-(E)-3-(2-Cyclopropylvinyl)-3-methylcyclohexanone 
(201) 
 
Prepared according to general procedure 13 from 
cyclopropylacetylene (71 µL, 0.75 mmol) and 3-methyl-
cyclohexenone (55 L, 0.50 mmol) to yield 201 as a 
colourless oil in 94% ee. (26 mg, 30%); RF (pentane/diethyl 
ether 4:1) 0.42. 
1H NMR (CDCl3) δH: 0.29–0.32 (2H, m, c-propyl), 0.63–0.67 
(2H, m, c-propyl), 1.03 (3H, s, C13H3), 1.24–1.34 (1H, m, 
C10H), 1.55–1.61 (1H, m, c-hex), 1.66–1.71 (1H, m, c-hex), 
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1.80–1.87 (2H, m, c-hex), 2.13 (1H, d, J = 14.0 Hz, C5H), 
2.17–2.31 (2H, m, c-hex), 2.37 (1H, dt, J = 14.0, 1.5 Hz, 
C5H), 4.86 (1H, dd, J = 16.0, 8.5 Hz, C9H), 5.38 (1H, d, J = 
16.0 Hz, C8H). 
13C NMR (CDCl3) δC: 6.72 (C11 & C12), 13.9 (C10), 22.3 
(C2), 28.0 (C13), 37.2 (C3), 40.8 (C4), 41.0 (C1), 52.5 (C5), 
132.3 (C9), 136.4 (C8), 211.8 (C6). 
IR (CHCl3)max: 3038, 3010, 2959, 2873, 1704, 1454, 1426, 
1313, 1291, 1241, 968 cm-1. 
HRMS: (EI) C12H18O [M]
+ requires m/z 178.1358, found [M]+ 
178.1361. 
GC:(octakis(2,6-di-O-methyl-3-O-pentyl--cyclodextrin); Tinj = 
250 oC, Tdet = 250 
oC, flow = 2.0 mL min-1, ti = 50 
oC, (1.0 oC 
min-1) tf = 160 (30 min): (R)-enantiomer: tR = 69.64 min; (S)-
enantiomer: tR = 70.86 min. 
[]D
25: +37.4 (c = 2.00, CHCl3). 
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(S)-(E)-3-Ethyl-3-(oct-1-en-1-yl)cyclohexanone (202) 
 
Prepared according to general procedure 14 from 1-octyne 
(134 µL, 0.750 mmol) and 3-ethyl-cyclohexenone (59 L, 0.50 
mmol) to yield 202 as a colourless oil in 88% ee. (71 mg, 
60%); RF (pentane/diethyl ether 4:1) 0.50. 
1H NMR (CDCl3) δH: 0.78 (3H, t, J = 7.5 Hz, C
11H3), 0.87 (3H, 
t, J = 7.0 Hz, C17H3), 1.19–1.32 (8H, m, C
13H2-C
16H2), 1.34–
1.40 (2H, m, C10H2), 1.60–1.69 (2H, m, c-hex), 1.76–1.86 
(2H, m, c-hex), 1.96–2.02 (2H, m, c-hex), 2.10 (1H, d, J = 
14.0 Hz, C5H), 2.16–2.32 (2H, m, C12H2), 2.49 (1H, d, J = 
14.0 Hz, C5H), 5.12 (1H, d, J = 16.0 Hz, C8H), 5.31 (1H, dt, J 
= 16.0, 7.0 Hz, C9H). 
13C NMR (CDCl3) δC: 7.9 (C11), 14.1 (C17), 21.7 (C2), 22.6 
(C16), 28.7 (C14), 29.5 (C13), 31.7 (C10), 32.9 (C15), 34.2 
(C3), 35.3 (C12), 41.2 (C1), 44.1 (C4), 49.8 (C5), 131.1 (C9), 
135.3 (C8), 211.9 (C6). 
IR (CHCl3)max: 3038, 3010, 2959, 2873, 1704, 1454, 1426, 
1313, 1291, 1241, 968 cm-1 
HRMS: (EI) C16H28O [M]
+ requires m/z 236.2140, found [M]+ 
236.2138. 
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GC:(octakis(2,6-di-O-methyl-3-O-pentyl--cyclodextrin); Tinj = 
250 oC, Tdet = 250 
oC, flow = 2.0 mL min-1, ti = 50 
oC, (1.0 oC 
min-1) tf = 160 (30 min): (R)-enantiomer: tR = 100.24 min; 
(S)- enantiomer: tR = 101.02 min. 
[]D
25: +69.1 (c=2.00, CHCl3). 
 
 
(S)-(E)-3-Ethyl-3-(hex-1-en-1-yl)cyclohexanone (203) 
134 
 
Prepared according to general procedure 13 from 1-hexyne 
(71 µL, 0.75 mmol)) and 3-ethyl-cyclohexenone (59 L, 0.50 
mmol) to yield 203 as a colourless oil in 96% ee. (48 mg, 
46%); RF (pentane/diethyl ether 4:1) 0.55. 
1H NMR (CDCl3) δH: 0.80 (3H, t, J = 7.0 Hz, C
11H3), 0.90 (3H, 
t, J = 7.0 Hz, C15H3), 1.25–1.36 (4H, m, C
13H2 and C
14H2), 
1.36–1.42 (2H, m, C10H2), 1.60–1.71 (2H, m, c-hex), 1.79–
1.90 (2H, m, c-hex), 2.00–2.06 (2H, m, c-hex), 2.13 (1H, d, J 
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= 14.0 Hz, C5H), 2.18–2.33 (2H, m, C12H2), 2.49 (1H, dt, J = 
14.0, 1.5 Hz, C5H), 5.14 (1H, d, J = 16.0 Hz, C8H), 5.34 (1H, 
dt, J = 16.0, 6.5 Hz, C9H). 
13C NMR (CDCl3) δC: 7.8 (C11), 13.9 (C15), 21.7 (C2), 22.1 
(C14), 31.7 (C10), 32.6 (C13), 34.2 (C3), 35.3 (C12), 41.2 
(C1), 44.1 (C4), 49.8 (C5), 131.0 (C9), 135.3 (C8), 211.9 
(C6). 
IR (CHCl3)max: 3038, 3010, 2959, 2873, 1704, 1454, 1426, 
1313, 1291, 1241, 968 cm-1. 
HRMS: (EI) C14H24O [M]
+ requires m/z 208.1827, found [M]+ 
208.1820. 
GC:(octakis(2,6-di-O-methyl-3-O-pentyl--cyclodextrin); Tinj = 
250 oC, Tdet = 250 
oC, flow = 2.0 mL min-1, ti=50 
oC, (1.0 oC 
min-1) tf = 160 (30 min): (R)- enantiomer: tR = 81.01 min; 
(S)- enantiomer: tR = 82.19 min. 
[]D
25: +31.8 (c = 2.00, CHCl3). 
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(E)-4-Methyldec-5-en-2-one (204) 
 
Prepared according to general procedure 13 from 1-hexyne 
(71 µL, 0.75 mmol), 3-penten-2-one (49 L, 0.50 mmol), 
trimethylaluminium (0.37 mL, 0.75 mmol) and 
tricyclohexylphosphine (25 mg, 0.075 mmol) to yield 204 as a 
yellow oil (19 mg, 22%); RF (pentane/diethyl ether 4:1) 0.64. 
1H NMR (CDCl3) δH: 0.58 (3H, t, J = 7.0 Hz, C
12H3), 0.99 (3H, 
d, J = 6.5 Hz, C6H3), 1.25-1.34 (4H, m, C
10H2 & C
11H2), 1.96 
(2H, app q, J = 6.0 Hz, C9H2), 2.11 (3H, s, C
3H3), 2.33 (1H, 
dd, J = 15.5, 7.0 Hz, C4H), 2.42 (1H, dd, J = 15.5, 7.0 Hz, 
C4H), 5.30 (1H, dd, J = 15.5, 7.0 Hz, C7H), 5.40 (1H, dt, J = 
15.5, 6.0 Hz, C8H). 
13C NMR (CDCl3) δC: 14.1 (C12), 20.7 (C6), 22.3 (C11), 30.7 
(C5), 31.8 (C3), 32.9 (C9), 51.3 (C4), 129.6 (C8), 134.4 (C7), 
208.6 (C2). 
IR (CHCl3)max: 3010, 2961, 2930, 2873, 1710, 1457, 1360, 
971 cm-1. 
HRMS: (EI) C12H24O3 [M+MeOH+H2O+H
+] requires m/z 
219.1710, found [M+MeOH+H2O+H] 219.1717. 
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GC:(octakis(6-O-pentyl-2,3-di-O-methyl--cyclodextrin); Tinj = 
250 oC, Tdet = 250 
oC, flow = 2.0 mL min-1, ti=70 
oC, (45 
min)(20 oC min-1) tf = 170 (10 min): enantiomer 1: tR = 29.37 
min; enantiomer 2: tR = 30.39 min. 
 
(E)-4-Isopropyldec-5-en-2-one (205) 
 
Prepared according to general procedure 13 from 1-hexyne 
(71 µL, 0.75 mmol), 5-methyl-3-hexen-2-one (66 L, 0.50 
mmol), trimethylaluminium (0.37 mL, 0.75 mmol) and 
tricyclohexylphosphine (25 mg, 0.075 mmol) to yield 205 as a 
yellow oil (19 mg, 22%); RF (pentane/diethyl ether 4:1) 0.60. 
1H NMR (CDCl3) δH: 0.82-0.92 (9H, m, C
9H3, C
10H3, C
14H3), 
1.19-1.34 (4H, m, C12H2 & C
13H2), 1.54-1.60 (1H, m, C
6H), 
1.97 (2H, app q, J = 6.5 Hz, C11H2), 2.10 (3H, s, C
3H3), 2.31-
2.47 (3H, m, C4H2 & C
5H), 5.19 (1H, dd, J = 15.0, 8.5 Hz, 
C7H), 5.38 (1H, dt, J = 15.0, 6.5 Hz, C8H). 
13C NMR (CDCl3) δC: 14.1 (C14), 18.9 (C10), 20.6 (C9), 22.3 
(C13), 30.7 (C5), 31.8 (C3), 32.0 (C12), 32.4 (C11), 45.2 
(C6), 47.3 (C4), 130.3 (C8), 132.5 (C7), 209.3 (C2). 
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IR (CHCl3)max: 3010, 2961, 2930, 2873, 1706, 1466, 1369, 
1358, 973 cm-1. 
HRMS: (ESI) C13H25O [M+H]
+ requires m/z 197.1900, found 
[M+H]+ 197.1907. 
GC:(octakis(6-O-pentyl-2,3-di-O-methyl--cyclodextrin); Tinj = 
250 oC, Tdet = 250 
oC, flow = 2.0 mL min-1, ti = 70 
oC, (45 
min)(20 oC min-1) tf = 170 (10 min): enantiomer 1: tR = 69.26 
min; enantiomer 2: tR = 69.92 min. 
 
(E)-3-Methyl-3-(2-(trimethylsilyl)vinyl)cyclohexanone 
(207) 
 
Prepared according to general procedure 13 from 
trimethylsilylacetylene (104 µL, 0.750 mmol) and 3-methyl-
cyclohexenone (55 L, 0.50 mmol) trimethylaluminium (0.37 
mL, 0.75 mmol) and tricyclohexylphosphine (25 mg, 0.075 
mmol) to yield 207 as a colourless oil (21.1 mg, 20%); RF 
(pentane/diethyl ether 4:1) 0.36. 
1H NMR (CDCl3) δH: 0.06 (9H, s, Si(CH3)3), 1.05 (3H, s, 
C9H3), 1.56-1.62 (1H, m, c-hex), 1.69-1.85 (3H, m, c-hex), 
2.16 (1H, d, J = 14.0 Hz, C5H), 2.20-2.30 (2H, m, c-hex), 
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2.47 (1H, dt, J = 14.0, 1.0 Hz, C5H), 5.60 (1H, d, J = 19.0 Hz, 
C10H), 5.88 (1H, d, J = 19.0 Hz, C8H). 
13C NMR (CDCl3) δC: 1.06 (Si(CH3)3), 22.2 (C9), 27.1 (C2), 
36.5 (C3), 41.0 (C1), 42.9 (C4), 51.8 (C5), 127.1 (C10), 
153.3 (C8), 211.6 (C6). 
IR (CHCl3)max: 3010, 2958, 1705, 1612, 1248, 867, 841 
cm-1. 
HRMS: (EI) C12H22OSi [M]
+ requires m/z 210.1440, found 
[M]+ 210.1436. 
 
Tetracyclic compound 
 
Racemic tetracycle was identified in early optimisation studies 
using copper(I) thiophenecarboxylate/tricyclohexylphophine or 
L3 as the major mass balance element. It was purified by 
flash chromatography (pentane/diethyl ether 4:1) RF 0.28. 
1H NMR (CDCl3) δH: 0.89 (3H, t, J = 7.0 Hz, CH3), 0.99–1.18 
(3H, m), 1.27- 1.32 (8H, m, CH2), 1.41–1.54 (3H, m), 1.66–
2.45 (16H, m), 2.50 (1H, d, J = 10.5 Hz), 2.61 (1H, m), 2.97 
(1H, app t, J = 11.0 Hz), 4.42 (1H, s), 5.20 (1H, app dd, J = 
15.0, 8.0 Hz), 5.45 (1H, dt, J = 15.0, 7.0 Hz). 
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13C NMR (CDCl3) δC: 14.2, 20.6, 20.7, 22.7, 27.6, 28.8, 29.8, 
31.8, 32.8, 34.4. 38.1, 41.9, 45.5, 55.1, 55.9, 75.5, 130.7, 
134.8, 213.7, 219.3. 
IR (CHCl3)max: 3598, 3546, 3047. 3005, 2976, 2950, 2925, 
2862, 1705, 1478, 1436, 1323, 1118 cm-1. 
HRMS: (ESI) C26H40O3 [M]
+ requires m/z 422.2989, found 
[M]+ 422.2982. 
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Ligand optimisation plot primary data
Copper(II) acetate (1 mol%), L39 (0.5 – 2.5 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
0.5 mol% 1.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 17.966 24.986 60 4.565 31.479
180 32.138 13.548 180 16.939 20.626
300 36.877 11.101 300 23.169 19.515
540 41.278 8.509 540 31.092 10.482
900 43.784 6.781 900 34.029 13.944
1200 46.294 6.457 1200 37.02 11.319
1500 47.873 5.783 1500 39.706 7.352
2100 47.759 4.035 2100 41.852 8.304
2700 48.212 3.968 2700 43.077 7.375
3600 48.273 4.304 3600 45.287 6.27
1.5 mol% 2.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 8.721 30.971 60 7.444 26.136
180 20.322 18.866 180 19.525 21.661
300 26.302 16.647 300 22.541 21.339
540 32.637 13.949 540 28.752 16.131
900 37.3 12.862 900 33.734 13.959
1200 40.339 9.301 1200 34.625 14.343
1500 41.438 10.041 1500 38.631 12.732
2100 43.939 8.668 2100 40.405 10.145
2700 45.195 6.715 2700 43.055 9.443
3600 46.722 6.326 3600 44.105 7.528
2.5 mol%
60 4.099 30.011
180 9.912 24.049
300 12.271 24.288
540 17.918 21.232
900 23.538 17.656
1200 26.546 18.085
1500 29.473 16.116
2100 32.93 15.437
2700 35.92 12.024
3600 41.848 6.776
60 4.099 30.011
180 9.912 24.049
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Copper(II) acetate (1 mol%), PMe3 (0.5 – 2.5 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
0.5 mol% 1.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 6.161 30.158 60 4.736 35.447
180 17.179 26.592 180 10.224 30.317
300 26.023 21.824 300 17.116 24.533
540 38.374 13.999 540 26.188 17.495
900 48.424 8.093 900 36.631 14.33
1200 49.252 6.047 1200 41.478 10.036
1500 51.38 5.033 1500 44.392 8.317
2100 53.505 4.13 2100 47.186 7.227
2700 53.539 3.666 2700 48.495 5.875
3600 53.899 2.895 3600 47.903 6.365
1.5 mol% 2.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 9.628 26.949 60 7.074 33.834
180 27.43 13.672 180 25.94 20.704
300 39.847 11.317 300 41.067 9.628
540 49.223 5.987 540 48.606 6.66
900 53.242 3.336 900 52.87 4.243
1200 52.894 3.04 1200 53.491 3.233
1500 54.691 2.632 1500 53.44 3.529
2100 55.779 2.259 2100 56.283 2.774
2700 55.21 2.066 2700 56.249 2.523
3600 55.939 2.53
2.5 mol%
t sec integ Prod integ SM
60 6.978 31.755
180 24.12 22.059
300 38.002 14.128
540 48.605 6.979
900 52.123 4.283
1200 55.435 3.424
1500 54.904 2.842
2100 53.975 2.304
2700 55.435 2.636
3600 56.508 2.355
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Copper(II) acetate (1 mol%), PMe3 (0.5 – 2.5 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
0.5 mol% 1.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 6.161 30.158 60 4.736 35.447
180 17.179 26.592 180 10.224 30.317
300 26.023 21.824 300 17.116 24.533
540 38.374 13.999 540 26.188 17.495
900 48.424 8.093 900 36.631 14.33
1200 49.252 6.047 1200 41.478 10.036
1500 51.38 5.033 1500 44.392 8.317
2100 53.505 4.13 2100 47.186 7.227
2700 53.539 3.666 2700 48.495 5.875
3600 53.899 2.895 3600 47.903 6.365
1.5 mol% 2.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 9.628 26.949 60 7.074 33.834
180 27.43 13.672 180 25.94 20.704
300 39.847 11.317 300 41.067 9.628
540 49.223 5.987 540 48.606 6.66
900 53.242 3.336 900 52.87 4.243
1200 52.894 3.04 1200 53.491 3.233
1500 54.691 2.632 1500 53.44 3.529
2100 55.779 2.259 2100 56.283 2.774
2700 55.21 2.066 2700 56.249 2.523
3600 55.939 2.53
2.5 mol%
t sec integ Prod integ SM
60 6.978 31.755
180 24.12 22.059
300 38.002 14.128
540 48.605 6.979
900 52.123 4.283
1200 55.435 3.424
1500 54.904 2.842
2100 53.975 2.304
2700 55.435 2.636
3600 56.508 2.355
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Copper(II) acetate (1 mol%), PCy3 (1.0 – 2.5 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
1.0 mol% 1.5 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 3.673 32.785 60 7.994 31.889
180 12.182 27.799 180 29.015 17.49
300 24.298 20.459 300 40.86 10.472
540 38.598 12.096 540 49.137 5.92
900 48.622 5.132 900 53.257 3.073
1200 48.807 4.32 1200 52.921 2.841
1500 52.063 5 1500 55.116 2.204
2100 55.097 3.761 2100 56.17 2.07
2700 53.782 3.713 2700 56.653 1.645
3600 57.681 3.12 3600 57.339 1.25
2.0 mol% 2.5 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 8.206 32.261 60 8.541 29.534
180 29.305 16.493 180 26.437 20.443
300 39.769 12.053 300 38.857 11.714
540 48.381 6.264 540 47.811 6.771
900 51.904 3.768 900 51.3 3.373
1200 53.779 2.624 1200 55.915 3.315
1500 57.834 2.404 1500 56.472 2.379
2100 57.608 2.017 2100 56.918 2.091
2700 58.057 1.56 2700 56.382 1.616
3600 40.265 0.943 3600 59.366 1.51
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Copper(II) acetate (1 mol%), PPh3 (1.0 – 3.0 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
1.0 mol% 1.5 mol%
t sec Integ. Pro Integ. SM t sec Integ. Pro Integ. SM
60 3.912 40.067 60 2.587 43.162
180 9.957 38.698 180 7.199 41.563
300 25.713 23.942 300 18.107 23.794
540 48.625 7.571 540 40.583 11.593
900 55.431 3.869 900 52.239 3.692
1200 56.347 3.200 1200 53.692 2.955
1500 57.646 2.638 1500 54.285 1.695
2100 55.121 1.434 2100 56.047 2.459
2700 52.735 1.38 2700 56.274 1.994
3600 59.888 1.045 3600 57.412 0.819
2.0 mol% 2.5 mol%
t sec Integ. Pro Integ. SM t sec Integ. Pro Integ. SM
60 1.681 42.283 60 5.081 37.068
180 3.279 33.425 180 1.336 42.175
300 6.379 32.021 300 4.389 43.059
540 14.369 32.796 540 4.181 40.027
900 30.073 20.643 900 7.095 33.521
1200 39.238 10.752 1200 10.305 38.042
1500 44.074 9.751 1500 14.128 38.034
2100 49.244 6.359 2100 23.355 29.663
2700 53.597 4.087 2700 29.575 22.446
3600 52.594 3.114 3600 34.662 20.753
3.0 mol%
t sec Integ. Pro Integ. SM
60 4.079 37.49
180 3.02 40.963
300 4.267 32.656
540 11.196 32.931
900 11.225 36.775
1200 17.985 25.987
1500 23.103 26.045
2100 31.351 17.374
2700 40.264 17.34
3600 44.16 10.243
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Copper(II) acetate (1 mol%), P(2-furanyl)3 (1.0 – 3.0 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
1.0 mol% 1.5 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 2.032 34.198 60 2.26 36.572
180 2.466 33.487 180 2.467 36.534
300 2.709 33.188 300 3.621 37.06
540 3.213 29.902 540 6.432 31.58
900 4.539 33.262 900 9.829 29.565
1200 5.791 30.389 1200 14.445 26.554
1500 6.894 29.513 1500 18.632 23.685
2100 10.086 26.096 2100 25.754 18.546
2700 12.475 25.275 2700 32.161 15.672
3600 16.625 25.474 3600 43.406 8.108
2.0 mol% 2.5 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 1.526 38.879 60 1.763 36.698
180 2.612 33.855 180 2.328 34.171
300 3.105 32.175 300 2.185 33.942
540 5.014 32.288 540 3.044 29.758
900 8.494 34.243 900 4.014 32.085
1200 11.241 31.872 1200 5.968 31.455
1500 15.872 21.499 1500 7.401 30.42
2100 22.278 18.092 2100 12.387 27.958
2700 28.415 18.308 2700 17.432 21.744
3600 38.458 10.995 3600 22.395 22.008
3.0 mol%
t sec integ Prod integ SM
60 1.015 35.163
180 1.394 33.696
300 1.147 38.205
540 1.465 34.711
900 2.348 34.941
1200 2.516 36.087
1500 2.946 32.973
2100 4.756 29.634
2700 6.293 31.607
3600 10.24 32.38
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Copper(II) acetate (1 mol%), P(4-FC6H4)3 (0.5 – 2.0 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
0.5 mol% 1.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 2.297 33.774 60 6.958 32.536
180 6.915 28.975 180 28.472 20.72
300 15.005 24.509 300 42.374 11.482
540 29.298 18.131 540 52.094 7.033
900 41.607 10.561 900 57.521 3.637
1200 45.242 7.478 1200 56.89 3.521
1500 46.761 8.528 1500 60.024 2.729
2100 50.035 5.755 2100 61.251 2.403
2700 53.336 5.231 2700 60.508 2.255
3600 56.661 4.42 3600 61.875 2.058
1.5 mol% 2.0 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 12.994 29.771 60 1.716 41.885
180 37.213 14.901 180 4.656 34.806
300 46.058 9.565 300 9.818 29.664
540 53.39 4.966 540 28.062 16.311
900 56.348 2.481 900 42.099 10.718
1200 52.921 3.172 1200 46.723 7.851
1500 57.948 3.065 1500 41.97 7.497
2100 60.039 1.617 2100 55.024 4.682
2700 60.271 1.959 - - -
3600 60.734 1.86 3600 56.281 3.119
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Copper(II) acetate (1 mol%), L2 (0.5 – 3.0 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
0.5 mol% 1.0 mol%
t sec integ Prod integ SM ee t sec integ Prod integ SM ee
60 17.966 24.986 68 60 17.498 52.666 94
180 32.138 13.548 76 180 26.923 43.478 96
300 36.877 11.101 80 300 31.526 37.325 96
540 41.278 8.509 86 540 43.222 31.226 96
900 43.784 6.781 90 900 47.877 24.834 97
1200 46.294 6.457 92 1200 54.048 21.602 98
1500 47.873 5.783 94 1500 58.067 15.888 98
2100 47.759 4.035 96 2100 61.099 10.859 98
2700 48.212 3.968 96 2700 64.675 12.631 98
3600 48.273 4.304 96 3600 52.006 6.596 98
1.5 mol% 2.0 mol%
t sec integ Prod integ SM ee t sec integ Prod integ SM ee
60 10.85 89.15 70 60 17.193 46.907 90
180 29.13 70.87 85 180 22.524 39.744 94
300 34.61 65.39 88 300 28.777 31.309 94
540 57.38 42.62 92 540 36.238 29.365 94
900 84.93 15.07 - 900 43.192 20.2 94
1200 99.82 0.18 96 1200 49.403 19.14 94
1500 87.21 12.79 96 1500 55.27 16.843 94
2100 99.77 0.23 96 2100 58.297 12.089 94
2700 96.54 3.46 96 2700 66.26 8.655 94
3600 99.04 0.96 96 3600 72.424 3.573 94
2.5 mol% 3.0 mol%
t sec integ Prod integ SM ee t sec integ Prod integ SM ee
60 16.197 47.197 86 60 14.744 53.821 96
180 32.901 33.533 92 180 29.003 43.538 98
300 43.619 24.885 94 300 36.367 36.016 98
540 57.724 14.903 94 540 45.353 30.292 98
900 62.109 12.041 94 900 55.696 20.652 98
1200 75.147 6.242 94 1200 58.979 16.545 98
1500 70.955 6.239 94 1500 61.917 13.648 98
2100 74.013 4.362 94 2100 65.652 8.765 98
2700 72.084 4.83 94 2700 69.803 7.879 98
3600 72.233 3.996 94 3600 69.235 6.762 98
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Copper(II) acetate (1 mol%), P(OPh)3 (1.0 – 3.0 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
1.0 mol% 1.5 mol%
t sec Integ. Pro Integ. SM t sec Integ. Pro Integ. SM
60 3.364 43.173 60 3.613 40.437
180 5.004 42.539 180 4.423 40.663
300 4.161 42.273 300 6.090 40.390
540 7.352 40.977 540 10.360 36.644
900 10.931 37.493 900 20.582 29.892
1200 13.357 33.814 1200 32.634 21.167
1500 16.803 34.386 1500 41.307 13.556
2100 45.645 7.201
2700 30.284 22.616 2700 52.187 4.465
3600 45.018 12.972 3600 48.268 2.745
2.0 mol% 3.0 mol%
t sec Integ. Pro Integ. SM t sec Integ. Pro Integ. SM
60 5.514 38.087 60 4.044 42.930
180 7.443 29.876 180 9.536 40.353
300 10.687 37.167 360 11.966 36.601
540 25.960 23.989 540
900 44.591 13.271 900 40.350 13.550
1200 48.032 7.507 1200 50.011 6.172
1500 54.614 4.366 1500 57.235 4.536
2100 58.774 2.560 2100 65.631 2.539
2700 55.422 1.593 2700 63.803 1.914
3600 59.215 1.439 3600 63.118 1.273
Copper(II) triflate (1 mol%), PPh3 (1.0 – 2.5 mol%), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe
1.0 mol% 1.5 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 7.32 27.913 60 10.572 30.46
180 17.101 25.376 180 29.059 16.116
300 26.009 20.253 300 41.597 9.434
540 43.198 10.292 540 54.81 2.057
900 50.968 4.316 900 56.091 2.125
1200 54.166 4.84 1200 56.759 2.049
1500 50.882 4.216 1500 55.61 2.385
2100 51.189 4.321 2700 57.457 1.451
2700 51.293 3.881 3300 56.228 1.672
3600 51.697 4.948 3600 53.546 1.823
2.0 mol% 2.5 mol%
t sec integ Prod integ SM t sec integ Prod integ SM
60 16.466 25.049 60 2.963 32.65
180 38.965 12.919 180 6.737 30.711
300 52.277 4.524 300 11.727 26.303
540 58.997 1.357 540 24.29 18.983
900 59.717 1.425 900 37.485 12.511
1200 56.532 1.363 1200 47.511 6.924
1500 56.596 1.503 1500 50.641 4.565
2100 59.241 0.939 2100 52.42 2.259
2700 58.885 1.157 2700 55.582 2.207
3600 55.698 1.228 3600 56.295 2.554
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Copper(II) acetate (1 mol%), L2 (1.0 – 2.5 mol%), AlEt3 (12 mmol),
cyclohexenone (10 mmol), Et2O
0.5 mol% 1.0 mol%
t sec integ Pro integ SM ee t sec integ Pro integ SM ee
60 19.107 31.659 46 60 11.314 44.075 54
180 21.145 37.116 66 180 28.893 34.369 72
300 28.705 28.782 72 300 37.647 23.911 78
540 39.908 19.937 78 540 51.369 13.321 82
900 53.972 12.106 80 900 61.014 7.303 82
1200 59.27 8.098 82 1200 31.48 3.86 82
1500 70.959 5.719 82 1500 65.795 3.497 82
2100 67.644 3.012 82 2100 66.852 3.445 82
2700 67.209 3.399 82 2700 66.139 3.162 82
3600 67.659 4.237 82 3600 67.108 2.825 82
1.5 mol% 2.0 mol%
t sec integ Pro integ SM ee t sec integ Pro integ SM ee
60 17.832 37.196 40 60 10.666 40.679 52
180 30.226 29.9 70 180 25.361 34.041 72
300 43.405 21.337 76 300 40.115 20.178 78
540 58.87 9.951 80 540 56.926 7.502 82
900 65.483 5.384 82 900 65.458 3.095 82
1200 67.622 2.93 82 1200 65.024 2.976 82
1500 66.447 3.536 82 1500 64.925 2.69 82
2100 68.137 3.427 82 2100 65.642 2.496 82
2700 68.32 3.455 82 2700 65.87 2.304 82
3600 67.959 2.705 82 3600 65.729 2.306 82
2.5 mol% 3.0 mol%
t sec integ Pro integ SM ee t sec integ Pro integ SM ee
60 18.535 23.036 46 60 24.515 37.557 42
180 21.531 24.531 62 180 34.948 28.586 60
300 30.573 17.076 70 300 47.348 17.634 70
540 46.084 9.023 76 540 63.42 5.357 76
900 53.723 3.221 78 900 66.866 3.622 76
1200 52.807 2.821 78 1200 66.955 2.917 76
1500 57.586 2.344 78 1500 74.525 2.846 76
2100 55.658 2.828 78 2100 67.469 2.841 76
2700 55.007 2.14 78 2700 67.432 2.907 76
3600 56.336 2.199 78 3600 66.932 2.724 76
3.5 mol% 4.5 mol%
t sec integ Pro integ SM ee t sec integ Pro integ SM ee
60 5.078 15.370 70 60 3.498 29.986 58
180 11.483 10.168 78 180 7.630 24.782 72
300 16.382 8.941 80 300 12.081 23.161 74
540 24.259 4.589 82 540 20.607 13.554 78
900 26.983 1.814 84 900 28.101 10.210 80
1200 28.496 1.341 84 1200 30.609 6.192 80
1500 29.223 1.761 84 1500 32.591 5.781 80
2100 28.809 1.669 84 2100 30.622 2.998 80
2700 28.918 1.589 84 2700 35.473 4.999 80
3600 28.893 1.459 84 3600 33.844 3.346 80
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5.0 mol%
t sec integ Pro integ SM ee
60 5.737 19.171 20
180 10.116 18.270 32
300 11.840 11.926 40
540 18.024 11.505 52
900 26.268 10.134 58
1200 31.852 7.994 64
1500 35.564 5.535 66
2100 39.260 2.841 70
2700 41.013 3.118 70
3600 39.961 1.987 70
Copper(I) bromide dimethylsulfide (1 mol%), L27 (0.5 – 1.5 mol%), EtMgBr (12
mmol), methylcrotonate (10 mmol), CH2Cl2
0.5 mol% 0.75 mol%
t sec integ Pro integ SM t sec integ Pro integ SM
60 21.338 19.324 60 35.398 11.627
180 30.484 16.701 180 29.428 15.806
300 30.271 14.644 300 36.861 10.056
540 35.985 15.549 540 36.901 8.07
900 36.449 13.447 900 39.832 7.118
1200 35.13 11.082 1200 43.034 6.433
1500 34.483 10.088 1500 37.228 5.069
2100 34.42 9.321 2100 39.203 4.687
2700 34.568 8.859 2700 38.927 4.254
3600 35.119 8.13 3600 40.025 4.234
1.0 mol% 1.25 mol%
t sec integ Pro integ SM t sec integ Pro integ SM
60 35.851 8.21 60 35.246 6.582
180 41.592 6.137 180 43.143 5.084
300 43.207 5.843 300 43.291 4.477
540 42.572 5.144 540 42.638 3.605
900 41.137 4.736 900 44.215 3.356
1200 39.129 4.24 1200 45.781 3.219
1500 39.305 4.386 1500 45.41 3.225
2100 39.988 4.465 2100 41.72 3.212
2700 37.718 3.843 2700 40.7 2.829
3600 38.908 4.437 3600 40.997 2.814
1.5 mol%
t sec integ Pro integ SM
180 39.684 12.172
300 38.237 10.303
540 39.875 8.767
900 46.633 9.162
1200 47.604 8.569
1500 48.827 8.702
2100 47.561 8.056
2700 47.606 8.165
3600 48.34 8.234
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Copper(I) iodide (1 mol%), L28 (0.5 – 2.5 mol%), EtMgBr (12 mmol),
methylcrotonate (10 mmol), CH2Cl2
0.5 mol% 1.0 mol%
t sec integ Pro integ SM t sec integ Pro integ SM
60 4.367 39.464 60 9.676 28.651
180 6.754 35.515 180 11.146 18.35
300 8.543 38.129 300 12.774 17.055
540 9.611 32.446 540 14.441 15.89
900 10.473 28.392 900 16.2 15.759
1200 11.966 28.574 1200 16.598 14.38
1500 12.856 27.716 1500 16.352 13.625
2100 14.574 28.359 2100 18.384 14.311
2700 16.292 28.686 2700 18.802 13.63
3600 19.57 31.422 3600 19.573 13.221
1.5 mol% 2.0 mol%
t sec integ Pro integ SM t sec integ Pro integ SM
60 2.428 29.512 60 5.15 40.174
180 3.755 24.874 180 8.561 36.962
300 4.522 21.645 300 9.185 37.692
540 5.745 21.102 540 10.53 37.753
900 7.092 21.178 900 9.541 31.396
1200 7.71 19.557 1200 10.248 31.813
1500 7.968 17.865 1500 11.396 30.72
2100 10.274 20.408 2100 10.734 28.306
2700 9.956 16.601 2700 11.694 28.38
3600 11.206 17.053 3600 12.359 28.088
2.5 mol%
t sec integ Pro integ SM
60 0.632 42.004
180 0.951 39.436
300 1.341 39.084
540 1.697 39.396
900 2.44 40.581
1200 2.211 37.404
1500 2.472 37.674
2100 2.571 37.223
2700 2.95 37.005
3600 3.4 36.631
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Ni(acac)2 (1 mol%), L2 (0.5 – 4.0 mol%), AlMe3 (12 mmol), benzaldehyde (10
mmol), THF
0.5 mol% 1.0 mol%
t sec integ Pro integ SM t sec integ Pro integ SM
60 0 38.635 60 2.547 48.556
180 0.737 43.146 180 5.284 45.827
300 0.764 42.973 300 7.319 44.595
540 2.64 40.983 540 11.989 40.43
900 7.538 34.924 900 25.619 26.53
1200 14.683 31.082 1200 40.383 11.195
1500 22.271 21 1500 53.924 0.128
2100 42.424 0.393 2100 54.23 0.11
2700 44.232 0.1 2700 48.673 0.102
3600 45.04 0.093 3600 52.307 0.088
2.0 mol% 3.0 mol%
t sec integ Pro integ SM t sec integ Pro integ SM
60 0.192 43.689 60 0.573 40.254
180 1.722 43.065 180 1.637 42.167
300 1.182 37.667 300 2.126 37.308
540 7.136 34.546 540 5.667 38.969
900 19.385 20.432 900 11.923 30.683
1200 33.506 12.132 1200 17.703 24.212
1500 37.762 2.584 1500 24.537 23.056
2100 42.487 0.097 2100 30.428 12.224
2700 42.651 0.102 2700 41.361 6.081
3600 39.989 0.089
4.0 mol%
t sec integ Pro integ SM
180 1.659 36.728
300 2.474 35.195
540 2.776 32.858
900 5.57 30.85
1200 6.321 25.971
1500 8.383 24.61
2100 16.252 20.605
2700 21.133 16.021
3600 27.384 14.456
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Effect of dichloromethane
Copper(II) acetate (1 mol%), L2 (2.0 mol%), ZnEt2 (12 mmol), cyclohexenone (10
mmol), PhMe, Ch2Cl2 (2 mL – 10 mL)
2 mL CH2Cl2 5 mL CH2Cl2
t sec integ Pro integ SM ee t sec integ Pro integ SM ee
60 28.831 18.654 92 60 15.99 35.256 93
180 40.454 3.296 96 180 19.857 37.839 95
300 48.111 14.178 96 300 38.813 22.595 96
540 49.17 16.761 96 540 39.267 15.329 97
900 56.8 5.66 96 900 54.694 8.37 98
1200 57.139 4.561 97 1200 55.95 3.725 98
1500 63.162 9.095 98 1500 59.499 4.101 98
2100 63.221 2.996 98 2100 57.174 0.927 98
2700 68.841 4.827 98 2700 66.83 1.558 98
3600 68.33 1.64 98
10 mL CH2Cl2
t sec integ Pro integ SM ee
60 24.96 35.158 95
180 34.813 14.543 97
300 56.663 10.908 98
540 65.082 5.766 98
900 59.287 2.377 98
1200 70.445 3.204 98
1500 66.292 2.776 98
2100 67.118 2.603 98
2700 65.29 2.285 98
4500 61.917 2.411 98
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Kinetic data for activation derivation
Copper(II) acetate (1 mol%), L2 (2.0 mol%, 50% ee), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe.
-50 oC -45 oC
t sec integ Pro integ SM t sec integ Pro integ SM
60 16.147 83.853 60 23.169 32.805
180 30.665 69.335 180 26.639 21.85
300 59.777 40.223 300 30.923 32.05
540 40.152 59.848 540 32.403 34.773
900 56.012 43.988 900 40.454 25.221
1200 77.875 22.125 1200 40.205 16.935
1500 73.276 26.724 1500 44.063 27.578
2100 79.228 20.772 2100 48.644 18.999
2700 89.982 10.018 2700 53.152 17.565
3600 86.966 13.034 3600 55.9 15.215
-40 oC -35 oC
t sec integ Pro integ SM t sec integ Pro integ SM
60 17.193 46.907 60 12.184 47.552
180 22.524 39.744 180 15.144 46.22
300 28.777 31.309 300 21.567 44.829
540 36.238 29.365 540 33.512 17.284
900 43.192 20.2 900 45.418 26.558
1200 49.403 19.14 1200 51.273 17.875
1500 55.27 16.843 1500 55.571 3.232
2100 58.297 12.089 2100 60.063 8.316
2700 66.26 8.655 2700 54.265 0.418
3600 72.424 3.573 3600 73.655 4.885
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Job’s plots analysis
Copper(II) acetate L39 (4.5 mol% total), ZnEt2 (12 mmol), cyclohexenone (10
mmol), PhMe.
Cu(OAc)2 = 1 mol%, SImes =
3.5 mol% [ (Cu) =0.22]
Cu(OAc)2 = 1.5 mol%, SImes =
3 mol% [ (Cu) =0.333]
t sec integ Pro integ SM t sec integ Pro integ SM
60 40.101 7.974 60 31.766 18.175
180 39.799 12.062 180 23.987 29.201
300 34.125 15.562 300 22.21 34.073
540 30.769 20.074 540 18.068 39.209
900 29.169 23.981 900 16.762 44.5
1200 30.795 26.614 1200 14.794 48.182
1500 25.264 35.567 1500 12.261 53.842
2100 23.807 33.41 2100 11.303 55.244
2700 22.56 36.872 2700 10.702 56.752
3600 17.376 40.996 3600 9.759 56.913
Cu(OAc)2 = 2 mol%,SImes =
2.5 mol% [ (Cu) =0.44]
Cu(OAc)2 = 2.2 mol%, SImes =
2.3 mol% [ (Cu) =0.48]
t sec integ Pro integ SM t sec integ Pro integ SM
60 25.738 33.47 60 28.113 28.032
180 13.509 47.677 180 22.266 38.684
300 12.959 53.041 300 16.311 46.034
540 8.606 58.083 540 13.121 51.038
900 9.511 57.774 900 11.05 54.716
1200 7.436 62.039 1200 9.902 55.692
1500 7.023 63.929 1500 7.907 59.642
2100 6.574 64.98 2100 7.918 61.779
2700 5.327 63.195 2700 7.572 61.09
3600 4.438 67.884 3600 6.363 62.927
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Copper(II) acetate PPh3 (4.5 mol% total), ZnEt2 (12 mmol), cyclohexenone (10
mmol), PhMe.
Cu(OAc)2 = 1 mol%, SImes =
3.5 mol% [ (Cu) =0.22]
Cu(OAc)2 = 1.5 mol%, SImes =
3 mol% [ (Cu) =0.333]
t sec integ Pro integ SM t sec integ Prod integ SM
60 48.045 4.634 60 39.292 4.955
180 45.23 5.283 180 36.826 14.005
300 43.559 9.288 300 29.381 25.062
540 31.634 20.643 540 13.47 52.444
900 22.614 36.104 900 9.431 60.054
1200 19.575 42.608 1200 5.285 64.345
1500 13.233 46.931 1500 4.926 66.483
2100 12.382 55.573 2100 3.531 69.333
2700 9.278 60.217 2700 3.083 69.717
3600 7.075 61.293 3600 3.307 69.877
Cu(OAc)2 = 2 mol%,SImes =
2.5 mol% [ (Cu) =0.44]
Cu(OAc)2 = 2.2 mol%, SImes =
2.3 mol% [ (Cu) =0.48]
t sec integ Pro integ SM t sec integ Prod integ SM
60 19.968 38.674 60 46.653 4.274
180 6.969 63.412 180 39.786 13.12
300 4.021 67.952 300 32.376 25.702
540 1.85 72.958 540 19.575 42.993
900 1.94 77.301 900 13.226 50.695
1200 1.379 72.556 1200 8.066 65.737
1500 1.072 75.91 1500 8.225 58.328
2100 1.121 73.996 2100 5.123 73.595
2700 0.711 71.273 2700 4.483 72.861
3600 0.633 74.26 3600 4.018 73.292
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Copper(II) acetate P(OPh)3 (4.5 mol% total), ZnEt2 (12 mmol), cyclohexenone
(10 mmol), PhMe.
Cu(OAc)2 = 1 mol%, SImes =
3.5 mol% [ (Cu) =0.22]
Cu(OAc)2 = 1.5 mol%, SImes =
3 mol% [ (Cu) =0.333]
t sec integ Prod integ SM t sec integ Prod integ SM
60 41.403 5.022 60 43.181 9.189
180 38.189 14.553 180 33.124 20.009
300 30.046 25.845 300 26.671 34.057
540 16.85 46.078 540 14.112 52.53
900 9.494 56.208 900 8.082 66.116
1200 6.409 64.119 1200 5.991 68.034
1500 5.215 66.139 1500 4.445 70.624
2100 3.976 69.268 2100 3.881 69.606
2700 3.425 68.603 2700 3.848 68.513
3600 3.258 69.711 3600 3.664 69.675
Cu(OAc)2 = 2 mol%,SImes =
2.5 mol% [ (Cu) =0.44]
Cu(OAc)2 = 2.2 mol%, SImes =
2.3 mol% [ (Cu) =0.48]
t sec integ Prod integ SM t sec integ Prod integ SM
60 41.814 8.188 60 48.237 3.617
180 32.158 22.357 180 42.397 8.158
300 23.428 36.398 300 39.207 15.562
540 12.632 55.584 540 26.757 32.598
900 5.819 67.378 900 15.587 51.082
1200 3.839 69.738 1200 9.578 58.605
1500 2.339 71.02 1500 5.894 66.526
2100 1.774 72.294 2100 3.2 68.974
2700 1.654 71.456 2700 2.314 70.23
3600 1.524 71.335 3600 2.236 67.143
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Copper(II) acetate P(4-FC6H4)3 (4.5 mol% total), ZnEt2 (12 mmol),
cyclohexenone (10 mmol), PhMe.
Cu(OAc)2 = 1 mol%, SImes =
3.5 mol% [ (Cu) =0.22]
Cu(OAc)2 = 1.5 mol%, SImes =
3 mol% [ (Cu) =0.333]
t sec integ Prod integ SM t sec integ Prod integ SM
60 47.178 1.559 60 29.91 22.575
180 44.421 4.292 180 12.416 49.117
300 37.805 10.222 300 8.602 55.53
540 31.957 26.518 540 4.588 64.727
900 15.655 48.431 900 3.289 68.639
1200 11.782 52.802 1200 2.425 67.62
1500 10.069 58.527 1500 2.093 66.823
2100 7.691 64.767 2100 1.855 69.519
2700 6.928 68.473 2700 1.276 71.655
3600 5.845 69.158 3600 1.283 71.573
Cu(OAc)2 = 2 mol%,SImes =
2.5 mol% [(Cu) =0.44]
Cu(OAc)2 = 2.2 mol%, SImes =
2.3 mol% [ (Cu) =0.48]
t sec integ Prod integ SM t sec integ Prod integ SM
60 31.113 26.187 60 45.326 6.324
180 12.646 56.117 180 24.205 34.428
300 8.492 61.607 300 17.704 43.698
540 5.509 64.431 540 9.246 59.557
900 4.168 70.606 900 6.341 65.379
1200 3.192 73.689 1200 4.822 71.324
1500 2.797 70.656 1500 4.392 70.82
2100 2.456 72.645 2100 3.808 74.514
2700 1.95 76.689 2700 3.513 72.475
3600 1.997 75.616 3600 2.934 75.294
